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Ausführliche deutschprachige Zusammenfassung 
 
Die Chinol:Fumarat Reduktase (QFR) ist die terminale Reduktase der anaeroben Fumarat-
Atmung, welche die häufigste Art der anaeroben Atmung darstellt. Dieser Membranprotein-
komplex  koppelt  die  Oxidation  von  Menachinon  zu  Menachinol  an  die  Reduktion  von 
Fumarat  zu  Succinat.  Die  dreidimensionale  Kristallstruktur  der  QFR  von  Wolinella 
succinogenes wurde zuvor mit einer Auflösung von 2,2 Å gelöst. 
Obwohl die dihäm-haltige QFR von W. succinogenes erwiesenermaßen einen elektroneutralen 
Prozeß katalysiert, hat die strukturelle und funktionelle Charakterisierung des Wild-Typ-
Enzyms und verschiedener Enzymvarianten ergeben, dass die Lage der aktiven Zentren auf 
einen  über  die  Membran  elektrogenen  katalytischen  Prozeß  hindeutet.  Der  scheinbare 
Widerspruch konnte durch die sogenannte „E-Weg“ Hypothese überwunden werden. Sie 
besagt, dass der transmembrane Elektronentransfer über die Hämgruppen strikt an einen 
parallelen, die Ladung kompensierenden Protonentransfer gekoppelt ist, Dieser erfolgt über 
einen  im  reduzierten  Zustand  vorübergehend  aktiven  Transportweg,  der  im  oxidierten 
Zustand des Enzyms blockiert ist. Als wesentliche Bestandteile dieses „E-Weges“ werden die 
Seitenkette von Glu C180 und das Ring-C Propionat der distalen Hämgruppe angenommen. 
Frühere experimentelle Ergebnisse weisen deutlich auf eine Beteiligung von Glu C180 hin. 
Ein  Ziel  der  vorliegenden  Arbeit  war  es,  mit  Hilfe  einer  Kombination  aus 
13C-
Isotopenmarkierung  der  Hämpropionate  der  QFR  und  anschließender  FTIR-
Differenzspektroskopie  experimentell  nachzuweisen,  dass  dem  Ring-C  Propionat  der 
distalen Hämgruppe eine entsprechende Rolle im redox-gekoppelten Protonentransfer in der 
QFR von W. succinogenes zukommt. 
Zusätzlich  zu  W.  succinogenes  sind  auch  die  Primärstrukturen  zweier  weiterer  ε-
Proteobakterien, nämlich Campylobacter jejuni und Helicobacter pylori, bekannt. Beide Spezies 
sind im Gegensatz zu W. succinogenes humanpathogen und in der Lage, Schleimhäute zu 
kolonisieren und verschiedene Krankheiten auszulösen. Die QFR von H. pylori wurde schon 
früher  als  potentieller  Angriffspunkt  für  eine  medikamentöse  Behandlung  identifiziert. 
Gleiches  ist  auch  für  die  QFR  von  C.  jejuni  wahrscheinlich.  Die  Möglichkeit,  die  beiden 
Chinol:Fumarat  Reduktasen  der  genannten  Bakterien  zu  studieren  und  somit 
möglicherweise effizientere Medikamente gegen sie zu entwickeln, hängt empfindlich davon 
ab, über größere Mengen qualitativ hochwertiger Proteinsubstanz zu verfügen. Weiterhin 
können  die  biochemische  und  strukturelle  Untersuchung  der  QFR  Enzyme  anderer  ε-Zusammenfassung 
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Proteobakterien  als  W.  succinogenes  hilfreich  sein,  neue  Aspekte  dieser  Klasse  von 
Membranproteinen zu beleuchten und deren allgemeines Verständnis zu vertiefen.  
 
1.  Heterologe Expression in W. succinogenes. In dieser Arbeit wird zum ersten Mal die 
erfolgreiche Überproduktion von Membranproteinen in dem anaeroben Bakterium 
W. succinogenes in großem Maßtab vorgestellt. Da sich die homologe Produktion von 
QFR aus C. jejuni und H. pylori bis dato nur durch geringe Mengen kaum aktiven und 
unreinen Enzyms auszeichnete, wurde eine Methode der heterologen Produktion in 
W. succinogenes entwickelt. Zu diesem Zweck wurde das vollständige frdCAB Operon 
das  die  drei Untereinheiten der  Chinol:Fumarat  Reduktase  codiert,  in das  Genom 
einer  Deletionsmutante  ∆frdCAB  von  W.  succinogenes  eingefügt.  Im  Genom  dieser 
Mutante wurde vorher der komplette Abschnitt, der frdCAB codiert, entfernt, was zu 
einem vollständigen Verlust der Fähigkeit der Zellen zur Fumarat-Atmung führte. 
Der Austausch der Gene von W. succinogenes durch das heterologe Gen-Cluster ergab 
Mutanten, die in vollem Umfang zur Fumarat-Atmung fähig waren. Die QFR der ε-
Proteobakterien ist eine Succinat:Chinon Oxidoreduktase (SQOR) des Typs B, welche 
aus drei Untereinheiten besteht: Einer hydrophoben Untereinheit (FrdC), die zwei 
Häm  b  Gruppen  enthält,  einer  großen  hydrophilen  Untereinheit  (FrdA),  die  ein 
Flavinadenindinukleotid (FAD) als prosthetische Gruppe bindet, und einer kleineren 
hydrophilen Untereinheit (FrdB), welche die Eisen-Schwefel-Zentren [2Fe-2S], [4Fe-
4S]  und  [3Fe-4S]  umfasst.  Es  konnte  gezeigt  werden,  dass  alle  diese  Kofaktoren 
korrekt in die beiden heterolog produzierten Proteine eingebaut wurden. Dank dieses 
neuen  heterologen  Expressionssystems,  konnten  die  frdCAB  Operons  der  beiden 
pathogenen Spezies C. jejuni und H. pylori kloniert und exprimiert werden, so dass 
die korrespondierenden Enzyme isoliert und charakterisiert werden konnten.  
2.  Reinigung der QFR von H. pylori und C. jejuni. Um die QFR der beiden pathogenen 
Spezies  zu  untersuchen,  sind  große  Mengen  stabilen,  reinen  und  aktiven  Enzyms 
erforderlich.  Eine  solche  Verfügbarkeit  würde  eine  Charakterisierung  und 
Kristallisation  der  beiden  Enzyme  im  Hinblick  auf  Röntgenbeugungsexperimente 
ermöglichen. Im Vergleich zu früher publizierten Reinigungsprozeduren, wie sie für 
die Isolierung der W. succinogenes QFR etabliert wurden, und die im Wesentlichen 
aus  Anionenaustausch-Chromatographie  und  isoelektrischer  Fokussierung 
bestanden,  erlaubte  es  die  Hinzufügung  einer  Gel-Filtration  als  Reinigungsschritt  
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eine Proteinverunreinigung mit der ungefähren Größe von 55-60 kDa zu eliminieren. 
Die  relativ  einfache  Handhabung  von  W.  succinogenes  und  der  hohe  Ertrag  der 
Proteinexpression ermöglichten es, nach dem letzten Reinigungsschritt bis zu 100 mg 
C. jejuni QFR und bis zu 150 mg H. pylori QFR je Proteinpräparation zu erhalten. 
Dennoch war im Falle der H. pylori QFR nach erfolgter Gelfiltration eine drastische 
Abnahme wenn diese durch Verfolgung der Oxidation von DMNH2 durch Fumarat 
gemessen  wurde  Enzymaktivität  zu  verzeichnen.  Daher  wurden  verschiedene 
Methoden  zur  Bestimmung  von  an  die  H.  pylori  QFR  gebundenen  Phospholipide 
herangezogen, die schließlich die Präsenz von Cardiolipin während der Reinigung 
enthüllten. Durch die Zugabe dieses Lipids konnte die enzymatische Aktivität der 
QFR vollständig wiederhergestellt werden. Desweiteren verbesserte die Zugabe von 
Cardiolipin  auch  die  Kristallisationseigenschaften  des  Enzyms.  Verschiedene 
biochemische  Analysen,  wie  z.  B.  SDS-PAGE  und  Messungen  der  enzymatischen 
Aktivität,  zeigten,  dass  sich  die  durchgeführten  Proteinpräparationen  durch  hohe 
Reinheit und Homogenität auszeichnen. Der abschließende Beweis für den Erfolg des 
entwickelten heterologen Systems zur Proteinüberproduktion war dadurch gegeben, 
dass es möglich war, gut beugende dreidimensionale Proteinkristalle zu erhalten. Die 
Kristalle der H. pylori QFR beugten bis zu einer Auflösung von 8 Å und C. jejuni QFR 
Kristalle bis zu 3,1 Å.  
3.  Ausführliche  Enzymcharakterisierung  und  Kristallisation  der  heterolog 
produzierten QFRs. Die hohe Qualität der Präparation ermöglichte eine vollständige 
Charakterisierung  der  beiden  Membranproteinkomplexe  mit:  i)  akkurater 
Bestimmung  der  Oxidations/Reduktions-Mittelpunktspotentiale  aller  sechs 
Kofaktoren  mit  Hilfe  von  EPR-Spektroskopie  und  UV/VIS-Spektroskopie;  ii) 
Bestimmung  der  Elektronentransportkettenaktivitäten  (ETC)  der  beiden  QFR 
Enzyme in Membranen gekoppelt an die Formiatdehydrogenase; iii) Berechnung der 
Michaelis-Konstanten und maximalen Aktivität in drei verschiedenen enzymatischen 
Tests;  iv)    Berechnung  der  Inhibierungskonstanten  und  –arten  von  Oxantel, 
Thiabendazol und Omeprazol, die zwar schon früher als QFR-Inhibitoren bekannt, 
jedoch kaum charakterisiert waren; v) endgültige und eindeutige Bestimmung des 
oligomeren Zustandes der QFR von W. succinogenes, C. jejuni und H. pylori mit Hilfe 
von  analytischer  Ultrazentrifugation,  die  bestätigte,  dass  die  in  Gegenwart  von 
Detergenz  gelösten  Enzyme  in  einem  physiologischen  homodimeren  Zustand Zusammenfassung 
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vorliegen; vi) Identifizierung eines nativen Phospholipids das, wie früher erwähnt, 
mit  dem  Proteinkomplex  zusammen  gereinigt  wird.  Die  verfeinerte 
Charakterisierung  einiger  der  Eigenschaften  der  W.  succinogenes  QFR  sowie  die 
umfassende Charakterisierung der heterolog produzierten QFR Enzyme verbessert 
somit das Verständnis der physiologischen und funktionellen Eigenschaften dieser 
Enzymklasse. 
4.  Bestimmung  der  dreidimensionalen  Kristallstruktur  der  C.  jejuni  QFR.  Die  3D-
Kristallstruktur der QFR der C. jejuni Spezies wurde mit einer Auflösung von 3,24 Å 
gelöst.  Trotz  der  zufriedenstellenden  Statistik  der  Datensammlung  und  der 
Verfeinerung des Strukturmodells konnten die Positionen einiger Aminosäuren nicht 
zugeordnet  werden.  Im  Allgemeinen  gab  es  einige  Regionen,  wie  z.  B.  die 
Chinonbindungstelle  und  die  „Verschluß“-Domäne,  die  nur  über  eine  schlecht 
definierte  Elektronendichte  verfügten  und  für  welche  daher  kein  Modell  gebildet 
werden konnte. Dennoch erschienen andere Bereiche sehr deutlich, und die Struktur 
konnte  in  den  meisten  Regionen  eindeutig  zugeordnet  werden.  Obwohl  sich  die 
primärstrukture Identität der QFR von W. succinogenes und C. jejuni über alle drei 
Untereinheiten  hinweg  zwischen  50  %  und  70  %  bewegt,  sind  die  Tertiär 
Strukturunterschiede nur unbedeutend. 
5.  Erzeugung  einer  W.  succinogenes  Mutante  zur 
13C-Markierung  der  QFR 
Hämpropionate.  Anders  als  für  Aminosäureseitenketten,  deren  Bedeutung  mit 
ortsgerichteter Mutagenese untersucht werden kann, erfordert die Zuordnung von 
potentiellen  Signalen,  die  von  den  Hämpropionaten  ausgehen,  eine  andere 
Herangehensweise  wie  z.  B.  die  selektive 
13C-Isotopenmarkierung  der 
Carboxykohlenstoffpositionen  der  Hämpropionate.  In  W.  succinogenes  ist  die 
Glutamat-1-Semialdehyd-2,1-Aminomutase  (hemL  Gen)  verantwortlich  für  die 
Synthese des Hämgruppenvorläufers 5-Aminolävulinat. Die Deletion des hemL Gens 
aus dem W. succinogenes Genom resultierte in einer Mutante, die nur mit extern zur 
Verfügung  gestelltem  5-Aminolävulinat  wuchs.  Des  weiteren  zeichnete  sich  die 
Mutante durch eine verzögerte Wachstumsphase aus und konnte nur nach Animpfen 
mit  einem  hochkonzentrierten  Inokulum  zum  Wachstum  gebracht  werden.  Die 
spezifische  Markierung  wurde  durch  die  Erzeugung  einer  in  Bezug  auf  den 
Hämgruppenvorläufer  5-Aminolävulinat  auxotrophen  W.  succinogenes  Mutante  
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(∆hemL)  und  durch  externe  Zugabe  von  [1-
13C]-5-Aminolevulinat  zum  Medium 
erreicht.  
6.  Produktion reiner W. succinogenes QFR mit 
13C-markierten Hämpropionaten zur 
Charakterisierung durch FTIR-Differenzspektroskopie. Die markierte QFR wurde 
mit  Hilfe  der  bereits  erwähnten  W.  succinogenes  Mutante  ∆hemL  produziert.  Eine 
MALDI-TOF  Analyse  zeigte  eindeutig,  dass  die 
13C-Markierung  der  Hämgruppen 
dieser QFR vollständig war. Durch weitere biochemische Analysen wurden eventuell 
störende Unterschiede zwischen markierter und unmarkierter QFR ausgeschlossen. 
Da sich die Oxidations/Reduktions-Mittelpunktspotentiale der beiden Hämgruppen 
der QFR um fast 150 mV unterscheiden, war es möglich, die zugehörigen Signale 
eindeutig zu trennen, und die distale bzw. proximale Hämgruppe durch die Wahl 
geeigneter  Referenzpotentiale  im  Experiment  getrennt  zu  untersuchen.  Die 
charakteristischen  Beiträge  deprotonierter  Carboxylgruppen  konnten  im 
Infrarotspektrum  nachgewiesen  werden.  Durch  die 
13C-Markierung  wurde  eine 
signifikante Verschiebung der Signale hin zu niedrigeren Wellenzahlen beobachtet. 
Diese FTIR-Ergebnisse konnten als (De)Protonierung, möglicherweise überlagert von 
einer  Umgebungsänderung,  mindestens  einer  der  beiden  Hämpropionate  der 
distalen Hämgruppe interpretiert werden kann. Diese experimentelle Beobachtung 
steht  in  exzellentem  Einklang  mit  der  vorgeschlagenen  „E-Weg“  Hypothese  des 
gekoppelten transmembranen Elektronen- und Protonentransfers. 
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Summary 
 
The  quinol:fumarate  reductase  (QFR)  is  the  terminal  reductase  of  anaerobic  fumarate 
respiration,  the  most  commonly  occurring  type  of  anaerobic  respiration.  This  membrane 
protein complex couples the oxidation of menaquinol to menaquinone to the reduction of 
fumarate  to  succinate. The  three-dimensional  crystal structure  of  the  QFR  from Wolinella 
succinogenes has previoulsy been solved at 2.2 Å resolution.  
Although  the  diheme-containing  QFR  from  W.  succinogenes  is  known  to  catalyze  an 
electroneutral  process,  structural  and  functional  characterization  of  parental  and  variant 
enzymes has revealed active site locations which indicate electrogenic catalysis across the 
membrane. A solution to this apparent controversy was proposed with the so-called “E-
pathway  hypothesis”.  According  to  this,  transmembrane  electron  transfer  via  the  heme 
groups is strictly coupled to a parallel, compensatory transfer of protons via a transiently 
established  pathway,  which  is  inactive  in  the  oxidized  state  of  the  enzyme.  Proposed 
constituents of the E-pathway are the side chain of Glu C180, and the ring C propionate of 
the distal heme. Previous experimental evidence strongly supports such a role for the former 
constituent. One aim of this thesis is to investigate by a combination of specific 
13C-heme 
propionate labeling and FTIR difference spectroscopy whether the ring C propionate of the 
distal heme is involved in redox-coupled proton transfer in the QFR from W. succinogenes. 
In addition to W. succinogenes, the primary structures of the QFR enzymes of two other ε-
proteobacteria are known. These are Campylobacter jejuni and Helicobacter pylori, which unlike 
W.  succinogenes  are  human  pathogens.  The  QFR  from  H.  pylori  has  previously  been 
established to be a potential drug target, and the same is likely for the QFR from C. jejuni. 
The  two  pathogenic  species  colonize  mucosal  surfaces  causing  several  diseases.  The 
possibility  of  studying these QFRs from these bacteria  and  creating  more  efficient drugs 
specifically active for this enzyme depends substantially on the availability of large amounts 
of high-quality protein. Further, biochemical and structural studies on QFR enzymes from ε-
proteobacteria species other than W. succinogenes can be valuable to enlighten new aspects or 
corroborate the current understanding of this class of membrane proteins. 
 
1.  Heterologous expression in W. succinogenes. In this thesis is presented, for the first 
time, a successful large-scale heterologous overproduction of membrane proteins in 
the anaerobic bacterium W. succinogenes. Since homologous production of the QFR 
from C. jejuni and H. pylori has so far only been characterized by low amounts of  
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scarcely  pure  and  active  enzymes,  a  heterologous  (large-scale)  production  in  W. 
succinogenes has been developed. To this end, the respective intact frdCAB operons 
were restored in the genome of the deletion mutant W. succinogenes ∆frdCAB. In the 
genome  of  this  mutant,  the  complete  frdCAB-coding  region  had  been  deleted, 
resulting  in  the  inability  of  the  cells  to  grow  by  fumarate  respiration.  The 
replacement of the homologous enzyme from W. succinogenes with the heterologous 
enzymes yielded mutants where fumarate respiration was still fully functional. The 
QFR from ε-proteobacteria is a B-type succinate:quinone oxidoreductase (SQOR) that 
is made of one hydrophobic subunit (FrdC), which contains two heme b groups; a 
large hydrophilic subunit (FrdA), which binds a flavin adenosine dinucleotide (FAD) 
prosthetic group; and a smaller hydrophilic subunit (FrdB), which contains the iron-
sulfur clusters [2Fe-2S], [4Fe-4S], and [3Fe-4S]. It was demonstrated that all of these 
cofactors  were  correctly  inserted  in  the  two  heterologously  produced  proteins. 
Thanks to this novel heterologous expression system, the frdCAB operons from the 
pathogen  species  C.  jejuni  and  H.  pylori  were  cloned  and  expressed  under  safe 
laboratory  conditions,  so  that  the  corresponding  enzymes  could  be  isolated  and 
characterized. 
 
2.  Large-scale purification of QFR from H. pylori and C. jejuni. In order to study the 
QFR from these two pathogens, large amounts of stable, pure and active enzymes are 
required. This achievement would allow the characterization and crystallization of 
these two enzymes for X-ray diffraction experiments. In comparison to previously 
published purification procedures established for the isolation of the W. succinogenes 
QFR, which consisted of an anion exchange chromatography and isoelectric focusing, 
the  addition  of  a  gel  filtration  purification  step  permitted  the  discarding  of  a 
contaminant protein of approximately 55-60 kDa. The relative simplicity of working 
with W. succinogenes and its high yield of expression enabled to obtain, at the final 
stage of purification, up to 100 mg of C. jejuni QFR and 150 mg of H. pylori QFR per 
protein preparation. However, when the H. pylori QFR sample was subjected to gel 
filtration, the total QFR enzymatic activity, as measured by the DMNH2-to-fumarate 
assay, decreased drastically. For this reason, several methods were adopted for the 
identification of phospholipids bound to the H. pylori QFR complex, and revealed the 
loss  of  cardiolipin  during  this  purification  step.  Strikingly,  addition  of  this  lipid 
allowed full recovery of the enzymatic activity of the enzyme. Moreover, addition of Summary 
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cardiolipin  improved  the  crystallization  properties  of  the  enzyme.  Several 
biochemical analyses performed on the purified samples, like for instance SDS-PAGE 
and  enzymatic  activity,  have  demonstrated  that  these  protein  preparations  are 
characterized by a high purity and a high homogeneity. The final evidence of the 
success of the established heterologous overproduction system is that these enzyme 
preparations supported the formation of well-diffracting 3D crystals. The H. pylori 
QFR crystals diffracted up to 8 Å, whereas the C. jejuni QFR crystals diffracted up to 
3.1 Å. 
 
3.  Extensive  enzyme  characterization  and  crystallization  of  the  heterologously 
produced QFRs. The high quality of the preparation permitted to fully characterize 
these  two  membrane  protein  complexes  with:  i)  accurate  determination  of  the 
midpoint  potential  of  all  the  six  cofactors  by  EPR  spectroscopy  and  UV/VIS-
spectroscopy; ii) determination of the electron transport chain (ETC) activities of the 
two QFRs coupled to formate dehydrogenase in membranes; iii) calculation of the 
Michaelis  constants  and  maximal  activity  by  three  different  enzymatic  assays;  iv) 
calculation  of  the  inhibition  constants  and  types  of  inhibition  of  oxantel, 
thiabendazole, and omeprazole, which were previously reported as QFR-inhibitors 
but  poorly characterized;  v) final  and unambiguous  assignment  of the oligomeric 
state  of  the QFR  from W.  succinogenes, C. jejuni,  and  H.  pylori by  analytical  ultra-
centrifugation, which has ascertained that these detergent-solubilized enzymes are in 
a physiological homodimeric state; vi) identification of the native phospholipids that 
are co-purifying with the H. pylori complex (as mentioned previously). The improved 
characterization  of  some  of  the  properties  of  W.  succinogenes  QFR,  and  the  full 
characterization  of  the  heterologously  produced  QFRs  provides  a  better 
understanding of the physiological and functional properties of this class of enzymes. 
 
4.  Determination of the  C. jejuni  QFR  three-dimensional crystal structure.  The 3D 
crystal structure of the QFR from the C. jejuni species was solved at the resolution of 
3.24Å. In spite of reasonable statistics for data collection and refinement, such as low 
values of crystal mosaicity  (0.09), Rsym (8.2 %) and  Rfree  (25.8 %),  some amino  acid 
positions could not be assigned. In general, some important regions of the electron 
density maps, such as the quinone binding site and part of the capping domain, were 
poorly defined and model building was prevented. However, other areas of the maps  
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appeared  very  clearly  defined,  and  the  structure  was  unambiguously  assigned  in 
most parts of the protein. Interestingly, although the primary structure identity of the 
QFR from W. succinogenes and C. jejuni ranges from 50% to 70% amongst the three 
subunits, differences between the two quaternary structures are only minor. In other 
words, although slight differences between the two species cannot be ruled out at the 
present stage of analysis, the positions and the orientations of the cofactors, as well as 
numerous other features, appear to be conserved.  
 
5.  Creation  of  a  W.  succinogenes  mutant  for 
13C-labeling  of  the  QFR  heme 
propionates. Unlike amino acid side chains, whose role can be investigated by site-
directed mutagenesis, assignment of potential signals arising from heme propionates 
requires a different approach, such as selective 
13C isotope labeling at the carboxy 
carbon  positions  of  the  heme  propionates.  In  W.  succinogenes,  the  glutamate-1-
semialdehyde-2,1-amino-mutase  (hemL  gene)  is  responsible  for  the  synthesis  of  5-
aminolevulinate, a heme precursor. The specific labeling was achieved by creating a 
W. succinogenes mutant (∆hemL) that was auxotrophic for 5-aminolevulinate and by 
providing [1-
13C]-5-aminolevulinate to the medium. The deletion of the hemL gene 
from  the  genome  of  W.  succinogenes  resulted  in  a  strain  that,  together  with  the 
auxotrophy  for  5-aminolevulinate,  was  characterized  by  a  longer  lag-phase  and 
irreproducible cell growth. In order to overcome this latter severe complication, the 
mutant  strain  required  an  increased  ratio  of  inoculated  cells  per  fresh  medium 
volume.  
 
6.  Production of pure W. succinogenes QFR containing
 13C-labeled heme propionates 
for  characterization  by  FTIR  difference  spectroscopy.  The  labeled  QFR  was 
produced  using  the  ∆hemL  mutant  strain  previously  introduced.  MALDI  TOF 
analysis  indicated  that  the  hemes  of  this  QFR  were  fully  labeled,  whereas  other 
biochemical  analyses  excluded  further  differences  to  the  unlabeled  QFR  enzyme. 
FTIR spectroscopy was adopted to analyze and compare the labeled and unlabeled 
enzymes when redox changes are induced. Since the midpoint potentials of the two 
heme groups differ by almost 150 mV, it was feasible to separate the corresponding 
signals  and  address  the  distal  and  proximal  hemes  individually  by  setting  the 
appropriate  reference  potentials  in  the  experiment.  Contributions  from  stretching 
modes  of  deprotonated  carboxyl  groups  can  be  localized  at  specific  infrared Summary 
xiii 
wavenumbers, and the 
13C-labeling of the heme propionate carboxyl groups results in 
significant  modifications  of  the  corresponding  bands.  The  interpretation  of  the 
obtained  FTIR  double-difference  spectrum  (reduced-minus-oxidized  and  labeled-
minus-unlabeled) in terms of a (de)protonation event possibly accompanied by an 
environmental effect, which could well be a conformational change, agreed very well 
with the suggested role of this propionate in the proposed “E-pathway” hypothesis 
of coupled transmembrane electron and proton transfer. 
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1.  INTRODUCTION 
1.1.  Respiration and the Chemiosmotic Theory 
1.1.1.  Cellular respiration and ATP creation 
Cellular respiration is the process that exploits the energetic content of “food” molecules 
(nutrients)  to  produce  forms  of  readily  available  energy  to  be  used  in  all  the  non-
spontaneous/endergonic  activities  of  the  cell.  These  molecules,  for  example  glucose,  are 
oxidized to carbon dioxide and water, and the released energy is stored in the form of ATP 
(Lodish, et al., 1999). 
The process occurs in two phases: glycolysis, where the glucose is converted to pyruvic acid, 
and  the  oxidative  phosphorylation, where  pyruvic acid  is completely oxidized to  carbon 
dioxide and water. This latter process is the main one responsible for the production of ATP 
from ADP and inorganic phosphate, using energy derived from the transfer of electrons in 
an electron transport system (the respiratory chain), and is driven by chemiosmosis. 
1.1.2.  The chemiosmotic theory is at the basis of energy production 
Peter Mitchell, who formulated the chemiosmotic theory (Mitchell, 1979), postulated that a 
proton electrochemical gradient is produced by a sequential transfer of electrons through a 
series of membrane-bound proteins, and that the flow of protons back across the membrane 
in  the  energetically  favorable  direction  is  then  coupled  to  ATP  synthesis.  Thus,  the 
intermediate  stage  that  couples  electron  transport  to  ATP  synthesis  is  a  proton 
electrochemical gradient across the membrane. The chemiosmotic theory is the basis for the 
generation  of  ATP  during  oxidative  phosphorylation  and  photosynthesis  in  bacteria, 
mitochondria, and chloroplasts, and also for the energy-requiring secondary transport of a 
variety of molecules across cell membranes. 
1.1.3.  Aerobic respiration makes use of molecular oxygen as terminal 
electron acceptor 
Aerobic respiration is so named because the molecular oxygen (O2) contained in air is used 
as a terminal electron acceptor in the electron transport system. In eukaryotic cells, oxidative 
phosphorylation occurs entirely within the mitochondria. In prokaryotes, the enzymes and Section 1.1: Respiration and the Chemiosmotic Theory 
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carrier molecules involved in the aerobic pathways are embedded in the plasma membrane, 
and the reactions occur at the surfaces of the membrane. The electron transport machinery of 
aerobic  respiration  consists  of  five  complexes  of  transmembrane  enzymes:  complex  I,  or 
NADH quinone oxidoreductase; complex II, or succinate:quinone reductase; complex III, or 
ubiquinol:cytochrome c oxidoreductase; complex IV, or cytochrome c oxidase; and complex 
V, or ATP synthase. The complex IV is also referred to as terminal oxidase, since it catalyses 
the last substrate (cytochrome c) oxidation in order to reduce oxygen to water. Complexes I, 
III, and IV pump protons out of the cytoplasm (or mitochondrial matrix), building a proton 
gradient. Then, the energetically favorable flow of protons back to the cytoplasm is mediated 
by complex V, which generates ATP. 
1.1.4.  Anaerobic respiration makes use of other substrates as terminal 
electron acceptors 
Most of the anaerobic or facultative bacteria perform ATP synthesis not only by the substrate 
level  phosphorylation  described  above,  but  also  by  electron  transport  coupled 
phosphorylation (ETP) (Thauer, et al., 1977, Thauer & Morris, 1984, Kröger, et al., 1992). This 
process, generally performed during anaerobic respiration, is also termed the ‘redox loop 
mechanism’ (Berks, et al., 1995). It resembles oxidative phosphorylation with respect to the 
mechanism  of  energy  transduction,  but  differs  by  the  terminal  electron  acceptor  used. 
Indeed,  in  anaerobic  respiration,  oxygen  is  replaced  by  other  substrates  -  organic  or 
inorganic  compounds,  or  certain  heavy  metal  ions.  In  turn,  the  terminal  oxidase  of  the 
respiratory  chain,  thus  the  enzyme  that  catalyzes  the  oxidation  of  the  terminal  electron 
donor (by the reduction of the terminal electron acceptor), varies with the variation of the 
type of substrate.  
Depending  on  the  species  and  on  the  environmental  situation,  bacteria  can  perform 
respiration with a variety of redox reactions involving different electron donors, such as 
molecular  hydrogen  (H2),  formate  or  sulfide,  and  different  electron  acceptors,  such  as 
fumarate,  nitrate,  nitrite,  nitrous  oxide,  polysulfide  ([S]),  and  dimethyl  sulfoxide.  As  a 
consequence,  the  composition  of  the  respiratory  chains  and  the  mechanism  of 
electrochemical proton gradient generation may vary greatly (Kröger, et al., 2002). Anaerobic 
respiration with fumarate (Kröger, 1978, Lancaster, 2004a) is called “fumarate respiration” 
(see Figure 1-1). 1. Introduction 
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1.1.5.  Fumarate respiration in Wolinella succinogenes 
In analogy to aerobic respiration, the energy released in fumarate respiration is transiently 
stored in the form of an electrochemical proton potential across the membrane. Probably 
because  fumarate  can  be  formed  via  two  different  metabolic  pathways,  this  kind  of 
respiration  is  the  most  widespread  kind  of  anaerobic  respiration  (Kröger,  et  al.,  1992). 
Besides, other membrane proteins are indirectly involved in this energy production system, 
such as C4-dicarboxylate carriers, which are essential for functions like transport or uptake of 
C4-dicarboxylates (i.e. fumarate and succinate) across the membrane (Janausch, et al., 2002). 
Wolinella succinogenes, a member of the ε-subclass of the proteobacteria, has been adopted as 
a model system to study fumarate respiration at the physiological and structural level. Since 
the objects of this thesis studies are the QFRs from ε-proteobacteria, next paragraphs will 
specifically focus on aspects concerning this subclass of proteobacteria. 
 
 
 
Figure 1-1: Cartoon representation of fumarate respiration. MK and MKH2 stand for menaquinone and 
menaquinol, respectively. The little parallelograms represent cofactors associated with the enzymes. Color 
codes  are:  red  squares,  hemes;  blue  squares,  iron-sulfur  clusters;  yellow  squares,  flavin  groups;  green 
squares, [NiFe] or [FeFe] groups; purple squares, molybdopterin guanine dinucleotide. The fading red and 
blue  colors  in  the  background  represent  the  negative  and  positive  environmental  redox  potentials, 
respectively. (Figure was modified from Lancaster, 2002b) Section 1.1: Respiration and the Chemiosmotic Theory 
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Figure  1-1  depicts  fumarate  respiration,  consisting  of  three  electron  transport  enzymes 
coupled to the complex V (ATP synthase), which generates ATP. The redox couples here 
involved are: H
+/H2, with a standard (pH 7, 25°C) reduction-oxidation (redox) potential of   
–420 mV (Kröger, 1978); menaquinone/menaquinol, with a standard redox potential of –75 
mV (Wagner, et al., 1974, Kröger & Innerhofer, 1976a); fumarate/succinate, with a standard 
redox potential of +30 mV (Clark, 1960); carbonate/formate, with a standard redox potential 
of –420 mV (Ljungdahl & Wood, 1969, Kröger, 1978, Jormakka, et al., 2002). 
As indicated in the reaction legends and in Figure 1-1, the reactions are catalyzed by the 
formate dehydrogenase (Fdh, Reaction 1-1), the quinol:fumarate reductase (QFR, Reaction 
1-2), the hydrogenase (Reaction 1-3), and ATP synthase (Reaction 1-4). 
 
H2      +      MK      ⇌      MKH2 
Reaction 1-1: Molecular hydrogen (H2) is oxidized and two electrons are released and transported to the 
menaquinone (MK)  to  form  menaquinol  (MKH2).  The  hydrogenase  catalyzes  this  reaction,  whose  total 
standard redox different potential (∆E’0) is: -345 mV. 
 
fumarate      +      MKH2      ⇌      succinate      +      MK 
Reaction 1-2: The two electrons released from menaquinol are transported to the fumarate, which is thereby 
reduced to succinate. The quinol:fumarate reductase catalyzes this reaction, whose ∆E’0 is: -105 mV. 
 
HCO2¯      +      H2O      +      MK      ⇌      HCO3¯      +      MKH2 
Reaction 1-3: Formate is oxidized and two electrons are released and transferred to the menaquinone (MK) 
to form menaquinol (MKH2). The formate dehydrogenase catalyzes this reaction, whose ∆E’0 is: -341 mV. 
 
nH
+
out      +      ADP/Pi      ⇌      nH
+
in      +      ATP 
Reaction 1-4: The flow of protons across the electrochemical proton gradient leads to ADP phosphorylation 
for the formation of ATP. The ATP synthase catalyzes this reaction. 
 
 
The  overall  reaction  catalyzed  by  the  QFR  (Reaction  1-2)  implies  the  exchange  of  two 
protons and two electrons, and can be divided in two half-reactions, as shown in   Reaction 
1-5 and Reaction 1-6. 
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Reaction 1-5:   fumarate + 2H
+ + 2e
–      ⇌ ⇌ ⇌ ⇌      succinate     
 
Reaction 1-6:   menaquinol      ⇌ ⇌ ⇌ ⇌      menaquinone + 2H
+ + 2e
– 
 
The electron transport chain is at the basis of respiration, and involves the connection of two 
enzymes, such as hydrogenase and QFR or formate dehydrogenase and QFR. The presence 
of  low-potential  quinones,  i.e.  menaquinone  (Figure  1-2-A)  and  8-methyl-menaquinone 
(Figure 1-2-B) (Dietrich & Klimmek, 2002, MacMillan F. & Klimmek O., unpublished), whose 
molar amount in the cellular membrane is at least 10-fold more abundant than the enzymes 
(Kröger  &  Innerhofer,  1976b,  Unden,  et  al.,  1983),  is  the  link  between  all  the  respiratory 
components (Lemma, et al., 1990). Because the high-potential quinones that are normally 
operating in aerobic respiration (e.g. ubiquinone, Figure 1-2-C) have higher redox midpoint 
potentials than the terminal electron acceptor (i.e. fumarate),
 in anaerobic respiration they 
have been replaced by low-potential quinones
a. 
 
 
 
 
 
 
 
Figure 1-2: Chemical structure of menaquinone (A), 8-methyl-menaquinone (B), and ubiquinone (C). 
 
 
Hydrogenase (Gross, et al., 1998) and formate dehydrogenase (Kröger, et al., 1979, Jormakka, 
et al., 2003b) are large membrane protein complexes, which use of the exergonic hydrogen or 
formate  oxidation  reaction,  to  generate  an  electrochemical  proton  gradient  across  the 
membrane. ATP synthase is a large protein complex (Bokranz, et al., 1985) that consists of 
two subcomplexes of several protein subunits, named F0- (the membrane integral base-piece) 
                                                
a The fumarate/succinate and ubiquinone/ubiquinol redox couples have a standard redox potential of 
+30 mV and +100 mV, respectively, therefore the reaction catalyzed by the QFR would be endergonic 
(hence energetically unfavorable). Section 1.1: Respiration and the Chemiosmotic Theory 
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and  F1-ATPase (the soluble domain). This enzyme  couples  the vectorial  proton  transport 
across a membrane with the synthesis (or cleavage) of the energy rich compound ATP. The 
QFR  is  the  terminal  electron  transport  component  (or  terminal  reductase)  of  fumarate 
respiration,  as  it  uses  fumarate  instead  of  oxygen  as  the  terminal  electron  acceptor 
(Lancaster, 2004a). 
1.2.  The Quinol:Fumarate Reductase 
The  QFR  catalyzes  the  reaction  that  couples  the  two-electron  reduction  of  fumarate  to 
succinate to the oxidation of the low-potential menaquinol to menaquinone (Reaction 1-2-C), 
as well as the reverse reaction. The overall reaction implies the exchange of two protons and 
two electrons, and can be divided in two half-reactions, as shown in Reaction 1-2-A and -B. 
The  major  quinone  species  (Lancaster  &  Simon,  2002)  used  from  this  enzyme  are 
menaquinone-6 and methyl-menaquinone-6 (Figure 1-2-A and -B), both derivatives of 1,4-
naphthoquinone with a chain of six isoprenyl units. 
1.2.1.  QFR is a member of the succinate:quinone oxidoreductases (SQORs) 
superfamily 
QFR  is  the  physiological  antagonist  of  succinate:quinone  reductase  (SQR),  which  is  the 
complex II of cellular aerobic respiration and a component of the Krebs cycle (for recent 
reviews on complex II see (Lancaster, , Cecchini, 2003, Cecchini, et al., 2003, and Lancaster, 
2004b).  The  SQR  and  QFR  complexes  together  are  referred  to  as  succinate:quinone 
oxidoreductases (SQORs, Lancaster, 2002a), a membrane protein superfamily which consists 
of two hydrophilic subunits and one or two hydrophobic subunits. The hydrophobic milieu 
can carry either one, two, or no heme groups. Depending on the hydrophobic domain and 
heme content, the SQORs can be divided into five different classes (type-A to type-E, Figure 
1-3). They are classified as EC 1.3.5.1 (international union of biochemistry and molecular 
biology –or IUBMB- enzyme nomenclature), and since they catalyze Reaction 1-2 in both 
directions,  the  distinction  between  SQR  and  QFR  depends  only  on  the  direction  of  the 
reaction catalyzed in vivo.  
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Figure 1-3: The succinate:quinone oxidoreductase (SQOR) superfamily and its classification. The integral 
transmembrane subunits (in green) can contain heme groups (yellow rectangles). The hydrophilic subunits 
are drawn in red (subunit B) and blue (subunit A) (modified from Lancaster, 2002a). 
 
 
In recent years, the three-dimensional crystal structures of three different SQORs, such as 
type-D QFR from E. coli (Iverson, et al., 1999), type-B QFR from W. succinogenes (Lancaster, et 
al.,  1999),  and  type-C  SQR  from  E.  coli  (Yankovskaya,  et  al.,  2003),  have  been  solved.  A 
detailed analysis of the QFR structure from W. succinogenes is presented in chapter 1.4. 
1.2.2.  The QFR cofactors are at the basis of the electron transfer 
mechanism 
The QFR from W. succinogenes is a membrane protein complex containing one hydrophobic 
subunit  and  several  cofactors  (Lancaster,  2001b)  including  two  heme  b  groups,  a  flavin 
adenosine dinucleotide (FAD) prosthetic group, and the iron sulfur clusters [2Fe-2S], [4Fe-
4S], and [4Fe-4S]. The UV/VIS absorbance spectrum of this enzyme is dominated by the α, β, 
and γ (or Soret) bands, which arise from the two heme groups. The iron-sulfur cluster can be 
better monitored with the use of EPR (Albracht, et al., 1981, Unden, et al., 1984, Maguire, et 
al., 1985), linear electric field effect (LEFE) EPR (Ackrell, et al., 1984), and magnetic circular 
dichroism (MCD, Johnson, et al., 1985) spectroscopy.  
In the last decades, the use of these various spectroscopic methods allowed characterization 
of some of these cofactors (Beinert, 2002). The redox midpoint potentials (Em) of the cofactors 
are summarized in Table 1-I and taken from the references Lancaster, et al., 2000, Lancaster, 
2001b,  Haas  &  Lancaster,  2004.  Furthermore,  calculation  of  the  electron  transfer  rate Section 1.2: The Quinol:Fumarate Reductase 
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constants  between  cofactors  has  allowed  identification  of  the  rate-limiting  steps  of  the 
catalytic reaction (Figure 1-4). 
 
Table 1-I: Redox midpoint potential (Em) of the cofactors from the 
W. succinogenes QFR. 
Cofactor type  Em (mV) 
FAD  – 20 
S1  – 59 
S2  < – 250 
S3  – 24 
Proximal heme   – 9 
Distal heme  – 152 
 
 
 
DMNH2
cyt. b S1 S2 S3
S1 S2 S3 FAD
FAD
fumarate
cyt. b
143 s
-1
50 s
-1
172 s
-1
155 s
-1
50 s
-1 45 s
-1 140 s
-1
A
B
 
 
Figure 1-4: Electron transfer rate constants between cofactors of the QFR from W. succinogenes. (Kröger, 
et al., 2002) The rate constants refer to the reduction of components in the fully oxidized enzyme upon the 
addition of DMNH2 (A), and their oxidation in the fully reduced enzyme by fumarate (B) at 20°C. The 
arrows indicate an electron transfer. S3, S2 and S1 designate the [3Fe-4S], [4Fe-4S] and [2Fe-2S] iron-sulfur 
clusters, respectively. 
 
 
The  establishment  of  various  enzymatic  activity  assays  on  QFR  (Lancaster,  2001b)  has 
provided  powerful  methods  for  its  functional  study.  The  QFR  from  W.  succinogenes  is  a 
highly active membrane protein complex with turnover times (i.e. the inverse of turnover 
rates) in the range of tens of milliseconds (calculated from a specific activity of 7.4 U mg
-1, 
Lancaster, et al., 2000). 1. Introduction 
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1.3.  The Wolinella succinogenes Species 
1.3.1.  Phylogeny and morphology of W. succinogenes 
W. succinogenes is a member of the helicobacteraceae, a family belonging to the ε-subclass of 
the proteobacteria. The typical habitat of this bacterium is the rumen of cattle. 
 
Wolinella succinogenes 
Helicobacter hepaticus 
Helicobacter pylori 
 
Sulfurospirillum barnesii 
Sulfurospirillum delyianum  
Arcobacter cryaerophilus 
Arcobacter butzleri  
Campylobacter jejuni 
Campylobacter rectus 
 
Figure 1-5: Phylogenetic tree of Wolinella succinogenes and its closest neighbors. (Simon, et al., 2000a) 
 
 
W.  succinogenes  is  Gram-negative,  and  it  was  originally  classified  with  the  name  Vibrio 
succinogenes. It is an anaerobic, non-spore-forming, rod-shaped bacterium that possesses a 
single polar flagellum able to confer a rapid, darting motility. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6: A transmission electron microscopy (TEM) picture of the W. succinogenes. (Picture kindly 
provided by Dr. S. Schuster) 
 
 
Helicobacteraceae 
Campylobacteraceae Section 1.3: The Wolinella succinogenes Species 
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The cells are helical, curved or straight, with a diameter of 0.5-1.0 µm and a length of 2-6 µm 
(Simon, et al., 2000a). They do not ferment carbohydrates, but can grow only by anaerobic 
respiration in liquid and in solid media. Fumarate respiration (Figure 1-1) of W. succinogenes 
is the best investigated system of this type. 
1.3.2.  The W. succinogenes QFR: operon organization, genetic 
manipulation and protein production 
The open reading frames (ORF) coding for the QFR of W. succinogenes, as well as all other 
proteobacteria, are organized in one operon. Thus, the three structural genes, in the order 
frdC, frdA, frdB, are concatenated and preceded by a common promoter and followed by a 
common terminator of transcription (Kortner, et al., 1990). 
The development of some genetic manipulation tools suitable for W. succinogenes (Simon, et 
al., 2000a) allowed the generation of a QFR deletion mutant (∆frdCAB) of this species (Simon, 
et al., 1998) In the genome of this mutant, the complete frdCAB coding region was replaced 
by the kanamycin resistance gene resulting in the inability of the cells to grow by fumarate 
respiration. This strain does not induce an alternative fumarate reductase and cannot grow 
in media containing fumarate as a unique source of terminal electron acceptor. Instead, this 
deletion strain can be grown on media containing nitrate as a terminal electron acceptor, 
implying  that  fumarate  respiration  was  impaired.  The  homologous  frdCAB  operon  was 
restored at its genomic locus in W. succinogenes ∆frdCAB by integration of plasmid pFrdcat2 
via homologous recombination between the frd promoter present both on the plasmid and 
on the genome of the deletion mutant (Simon, et al., 1998). The resulting strain (named K4) 
showed  wild  type  properties  in  terms  of  fumarate  respiration  and  fumarate  reductase 
activity.  
The previous expression of W. succinogenes QFR from the native source and the established 
purification  procedure  consisting  of  anion  exchange  chromatography  and  isoelectric 
focusing, demonstrated that this bacterium is able to yield high amounts of stable and pure 
material, which was also suitable for crystallization purposes (Lancaster, 2003b). 
 1. Introduction 
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1.4.  Structural Properties of the QFR from W. succinogenes 
1.4.1.  The three dimensional structure of QFR from W. succinogenes 
The 3D-crystal structures of the QFR from W. succinogenes (Figure 1-7) were solved from 
three different crystal forms, named A, B (2.20 and 2.33 Å resolution, respectively, Lancaster, 
et al., 1999) and C (3.10 Å resolution, Lancaster, et al., 2001). Very recently, a further crystal 
structure  of  this  enzyme  has  been  solved  even  at  higher  resolution  (Lancaster,  C.R.D., 
unpublished). 
The complex is a type-B member of the SQORs, and consists of the hydrophilic subunits 
FrdA and FrdB, and a transmembrane subunit FrdC. This latter subunit, which contains the 
domain where the menaquinol oxidation takes place (Reaction 1-6), binds the two heme b 
groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-7: X-ray crystal structure of the W. succinogenes QFR. (Lancaster, 2001a) The enzyme consists of a 
homodimer of a heterotrimer, consisting of flavoprotein subunit A, iron-sulfur protein subunit B, and the 
transmembrane diheme-containing subunit C. The Cα traces of the two A subunits are shown in turquoise 
and blue, those of the two B subunits in purple and red, and those of the two C subunits in green and light 
blue.  The  atomic  structures  of  the  six  prosthetic  groups  per  heterotrimer  are  superimposed  for  better 
visibility. From top to bottom, there are the covalently bound FAD, the [2Fe-2S], the [4Fe-4S], the [3Fe-4S] 
iron-sulfur clusters, the proximal and the distal heme b groups. The position of the bound quinone was 
determined crystallographically (PDB entry code 2BS2, Lancaster, C.R.D., unpublished). Section 1.4: Structural Properties of the QFR from W. succinogenes 
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The  position  of  the  cofactors,  which  were  previously  identified  by  biochemical  and 
spectroscopical  techniques  and  then  clearly  resolved  in  the  crystal  structure,  contributed 
enormously to the understanding of the catalytic mechanism of this enzyme. Based on their 
relative  distance  to  the  hydrophilic  subunits,  the  heme  b  groups  are  referred  to  as  the 
“proximal”  heme  bP  and  the  “distal”  heme  bD,  respectively.  Thanks  to  the  structural 
information available, the location of the high and low potential hemes of the W. succinogenes 
QFR have been assigned to the proximal and distal heme, respectively (Haas & Lancaster, 
2004). 
1.4.2.  Catalytic mechanism and electron transfer in QFR 
The  availability  of  high-resolution  X-ray  structures  of  this  enzyme  has  contributed 
significantly to the understanding of the mechanism of fumarate reduction by the Sdh/Frd 
family of flavoproteins. The polar nature of the hydrogen bonding environment around the 
carboxylic  groups  has  been  suggested  to  polarize  the  fumarate.  The  combined  effect  of 
twisting of the substrate and electronic effects generates a positive charge at the C2 position 
of the fumarate, making it a candidate for nucleophilic attack from the flavin cofactor. The 
hydride transfer from the FAD group is compensated by protonation at the C3 position by 
an arginine lining the opposite side of the fumarate catalytic site. 
By a combination of site-directed mutagenesis (Lancaster, et al., 2000) and crystal structure 
analysis (Lancaster, C.R.D., unpublished) it was concluded that quinol oxidation relies on 
the distal heme of the W. succinogenes QFR, where the electrons enter the electron transfer 
pathway.    A  glutamate  residue  (FrdC-E66)  lines  a  cavity  which  extends  from  the 
hydrophobic  phase  of  the  membrane  to  the  periplasmic  aqueous  phase,  and  could  be 
involved in the acceptance of the protons liberated upon oxidation of the menaquinol.  
For the function of QFR, electrons have to be transferred from the quinol-oxidizing site in the 
membrane  to  the  fumarate–reducing  site,  protruding  into  the  cytoplasm.  The  linear 
arrangement  of  the  cofactors  in  the  complex    (Figure  1-8)  provides  a  straightforward 
pathway  by  which  electrons  could  be  transferred  efficiently  between  the  two  sites  of 
catalysis (Lancaster, 2004b). In accordance to what has been postulated by Page, et al., 1999, 
the  edge-to-edge distances between cofactors of  each heterotrimer is  sufficiently short to 
allow an efficient electron tunneling. However, a physiological electron tunneling between 
cofactors belonging to different homomers cannot be supported due to the prohibitive edge-
to-edge distances (>14Å). 1. Introduction 
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Figure 1-8: Catalytic sites and electron transfer pathway of the W. succinogenes QFR. (Lancaster, et al., 
2000) The cofactors of the QFR dimer are displayed (coordinates retrieved from the PDB entry 1QLA). 
Distances between prosthetic groups are edge-to-edge distances in Å. Also drawn are the side chains of 
Glu-C66 (in red) and of the subunit C Trp residues (violet), which are used as markers for the hydrophobic 
surface-to-polar transition zone of the membrane. The position of bound fumarate (Fum) is taken from PDB 
entry 1QLB and the tentative model of menaquinol (in green) binding was proposed in Lancaster, et al., 
2000. The positive (+) and negative (-) sides of the membrane are indicated. 
 
 
1.5.  The Wolinella Paradox and the E-Pathway Hypothesis 
1.5.1.  The Wolinella paradox 
If  menaquinol  oxidation  by  fumarate  would  be  coupled  to  the  generation  of  an 
electrochemical  proton  gradient,  the  theoretical  ratio  of  transferred  protons  per  electron 
(H
+/e
–) in physiological conditions should be far below 1, as calculated by the available free 
energy of the reaction
b catalyzed by the QFR (Kröger, et al., 2002). Accordingly, a number of 
                                                
b The standard redox difference potential (∆E’0) is only –105 mV. Section 1.5: The Wolinella Paradox and the E-Pathway Hypothesis 
14 
experiments on QFR from W. succinogenes in inverted vesicles (Kröger & Innerhofer, 1976a, 
Kröger & Innerhofer, 1976b, Kröger, 1978, Kröger, et al., 1980, Mell, et al., 1986, Geisler, et al., 
1994,)  or  in  reconstituted  proteoliposomes  have  permitted  the  examination  of  QFR’s 
physiological properties and the coupling of this enzyme with the hydrogenase (Graf, et al., 
1985, Biel, et al., 2002) or formate dehydrogenase enzymes (Unden & Kröger, 1982, Unden, et 
al.,  1983,  Unden  &  Kröger,  1986).  These  electrophysiological  experiments  indicated  that 
whereas  the  hydrogenase  and  formate  dehydrogenase  are  generating  a  transmembrane 
electrochemical  proton  potential  (∆p)  by  a  scalar  proton  transfer  across  the  plasma 
membrane  (see  also  ref.  Jormakka,  et  al.,  2003a),  the  reaction  catalyzed  by  the  diheme-
containing QFR from W. succinogenes is not directly associated with the generation of ∆p (i.e. 
is an electroneutral process ) (Biel, et al., 2002, Kröger, et al., 2002). 
Nevertheless, the three-dimensional structure of this membrane protein complex (Lancaster, 
et  al.,  1999)  and  the  characterization  of  variant  enzymes  (Lancaster,  et  al.,  2000),  point 
towards a model for quinone/quinol binding in which the  redox-active Q-site is located 
towards the periplasmic side of the membrane anchor domain. Thus, the quinol oxidation 
site, where two protons are released, and the fumarate oxidation site, where two protons are 
consumed,  are  oriented  towards  opposite  sides  of  the  membrane  (Figure  1-7).  This 
arrangement of catalytic sites suggests that menaquinol oxidation by fumarate, as catalyzed 
by W. succinogenes QFR, is associated directly with the establishment of an electrochemical 
proton  potential  across  the  membrane,  which  is  in  contrast  to  the  directly  measured 
evidences found previously (Kröger, et al., 2002, Lancaster, 2002b). 
Similar structural properties have been assigned to the SQR complex from the Gram-positive 
bacterium Bacillus subtilis, whose quinol oxidizing site is also occurring at the periplasmic 
site of the membrane (Matsson, et al., 2000). Indeed, this enzyme has been demonstrated to 
generate  a  proton  potential  when  forced  to  operate  as  a  quinol:fumarate  reductase 
(Schnorpfeil, et al., 2001). 
1.5.2.  The E-pathway hypothesis of coupled transmembrane electron and 
proton transfer 
Prior to the “E-pathway hypothesis”, proposed in a seminal article by C. Roy D. Lancaster in 
2002 (Lancaster, 2002b), there was no satisfactory explanation for the apparent discrepancies 
stated above. According to this hypothesis, the transfer of two electrons via the two QFR 
heme groups is strictly coupled to a compensatory, parallel transfer of two protons across 1. Introduction 
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the membrane via a proton transfer pathway (Figure 1-9), which is transiently open upon 
reduction  of  the  two  hemes  and  closed  in  the  oxidized  state  of  the  enzyme.  The  most 
prominent constituents of the proposed pathway were suggested to be the ring C propionate 
of  the  distal  heme  bD  and  amino  acid  residue  Glu  C180,  which  are  both  not  in  direct 
association with the quinol binding site.  
The  role  of  Glu  C180  in  this  context  is  supported  by  two  previous  reports  involving  a 
combination of site-directed mutagenesis and structural and functional characterization of 
the  enzyme  (Lancaster,  et  al.,  2005)  as  well  as  electrochemically-induced  FTIR  difference 
spectroscopy  (Haas,  et  al.,  2005).  Moreover,  in  accordance  with  the  proposed  proton 
pathway, the FrdC-E180 residue of the W. succinogenes QFR is not conserved in the Bacillus 
subtilis SQR complex, which indeed catalyzes an electrogenic reaction and it is not supposed 
to host any compensatory proton transfer similar to the E-pathway. 
The  involvement  of  heme  propionates  in  a  proton  transfer  pathway  has  already  been 
proposed  for  the  respiratory  protein  cytochrome  c  oxidase  (Behr,  et  al.,  2000,  Richter  & 
Ludwig, 2003). Unlike most of the heme propionates found in heme b-containing protein 
structures solved so far (QFR, PDB entry 1QLA, Lancaster, 2003a; SQR, PDB entry 1NEK 
Yankovskaya, et al., 2003; chicken bc1 complex, PDB entry 1BCC, Zhang, et al., 1998; yeast bc1 
complex, PDB entry 1KB9, Lange, et al., 2001; nitrate reductase, PDB entry 1Q16, Bertero, et 
al., 2003; formate dehydrogenase, PDB entry 1KQF, Jormakka, et al., 2002; etc.), the ring C 
propionate of the W. succinogenes QFR distal heme does not point towards the membrane 
surface, but displays a peculiar conformation that points towards a region that was proposed 
to  host  the  E-pathway.  Furthermore,  as  calculated  by  multiconformation  continuum 
electrostatics (MCCE), this propionate was the only one that was protonated in all simulated 
heme protonation states, indicating a possible role as a transient proton donor/acceptor in 
the E-pathway (Haas & Lancaster, 2004). 
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Figure 1-9:  Electron  and proton  transfer  in  the  W.  succinogenes  QFR  and  the  E-pathway  hypothesis. 
(Lancaster, 2002b) The prosthetic groups of the W. succinogenes QFR dimer are displayed (coordinate set 
1QLA;  Lancaster,  et  al.,  1999).  Also  indicated  are  the  side  chain  of  Glu  C66  and  a  tentative  model  of 
menaquinol  (MKH2)  binding.  The  hypothetical  transfer  of  one  proton  (H
+)  per  electron  (e
-)  across  the 
membrane is shown in red. The two protons that are liberated upon oxidation of menaquinol (MKH2) are 
released to the periplasm (bottom) via the residue Glu C66. In compensation, coupled to electron transfer 
via the two heme groups, protons are transferred from the periplasm via the ring C propionate of the distal 
heme (heme bD) and the residue Glu C180 to the cytoplasm (top), where they replace those protons which 
are bound during fumarate reduction. In the oxidized state of the enzyme, the “E-pathway” is blocked. 
Positive and negative sides of the membrane are indicated. 
 
 
1.6.  The Campylobacter jejuni and Helicobacter pylori Species 
Campylobacter jejuni (Wassenaar & Newell, 2001) and Helicobacter pylori (Dunn, et al., 1997, 
Solnick,  et  al.,  2003)  are  human  pathogens  and  are  members  of  the  ε-subclass  of  the 
proteobacteria. These two bacteria are microaerophilic, Gram-negative, and flagellate species 
that colonize the mucous overlying the mucosal surfaces in humans and animals, and their 
genomic sequence is known (Parkhill, et al., 2000, Tomb, et al., 1997). These organisms are 2 
to 5 µm long and 0.5 to 1 µm wide, and they typically assume a spiral or rod-like shape 
(Figure 1-10). 
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Figure  1-10:  Transmission  electron  micrographs  of  Campylobacter  jejuni  (A)  and  Helicobacter  pylori 
species (B). The polar flagella conferring motility are visible. (Pictures taken from Wassenaar & Newell, 
2001 and Solnick, et al., 2003). 
 
 
1.6.1.  Campylobacter jejuni: habitat and diseases 
C.  jejuni  belongs to  the  family  of  the  Campylobacteraceae  and  can  colonize  the  mucosal 
surfaces  of  the  intestinal  tracts,  oral  cavities,  or  urogenital  tracts  of  humans.  It  is  a 
thermophilic organism that is also typically found in birds, whose body temperature is 42°C. 
In this habitat, the organism appears to act as a commensal. The microaerophilic nature and 
temperature  dependence  of  this  organism  precludes  growth  outside  the  mucosal  niches. 
Nevertheless, this species can be isolated from fecally contaminated environmental sources, 
such as surface water and animal products, including meat and milk (Wassenaar & Newell, 
2001). 
C. jejuni is very common throughout the world as it is the etiological factor for the bacterial 
food-borne diarrhoeal disease (Butzler, 2004, Mead, et al., 1999), known as “traveler disease”. 
This  bacterium  is  also  responsible  for  gastroenteritis  and  a  very  severe  disease  called 
Guillain-Barré syndrome (GBS) (Chowdhury & Arora, 2001, (Blaser, 1997), which is an acute 
type of nerve inflammation involving progressive muscle weakness or paralysis. Recently, C. 
jejuni has also been found to be associated with the immunoproliferative small intestinal 
disease  (IPSID)  (Lecuit,  et  al.,  2004),  a  mucosa-associated  lymphoid  tissue  (MALT) 
lymphoma.
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1.6.2.  Helicobacter pylori: habitat and diseases 
The typical H. pylori’s niche is the mucus-lined surface of the antrum of the human stomach. 
Despite being able to colonize this extreme environment, where the lumenal pH is around 1-
2, H. pylori is not acidophilic, and must therefore rapidly gain access to the mucous layer 
where  the  pH  is  closer  to  neutrality  (Kelly,  1998).  The  bacterium  is  most  probably  a 
neutrophile that  has adapted itself to the acidic environment of the stomach and  can be 
classified as an acid-tolerant neutrophile. The physiological strategies used to survive this 
environment are mainly a strong production of urease, which induces the accumulation of 
ammonia and carbon dioxide, providing an acid-neutralizing cloud around the cells, and 
production of basic amines from amino acid decarboxylates (Marais, et al., 1999a). Moreover, 
together with a special ability in regulating the proton motive force (PMF), this bacterium 
adopts  a  mechanism  that  consents  to  mitigate  the  force  against  which  protons  must  be 
extruded  by  concentrating  cations  at  the  cytoplasmic  side.  In  this  way,  the  membrane 
potential is inverted to a positive-inside mode (Matin, et al., 1996, Marais, et al., 1999a).  
H. pylori inhabits approximately 50% of the world human population (Covacci, et al., 1999, 
(Bardhan, 1997). After colonization of the mammalian stomach it may cause peptic ulcers, 
gastric  atrophy,  gastric  MALT  lymphoma  (Cover  &  Blaser,  1999,  Parsonnet,  et  al.,  1994, 
Hussell, et al., 1993, Wotherspoon, et al., 1993, Fujimori, et al., 2005) and, importantly, it is 
associated  with  the  development  of  gastric  adenocarcinoma,  the  world’s  second  leading 
cause of cancer-related death (Peek & Blaser, 2002, Uemura, et al., 2001, Kuniyasu, et al., 2000, 
Hansson, 2000, Correa, 1996, Correa, 2003a, Correa, 2003b). Finally, H. pylori was proposed 
to be weakly correlated with an increased risk of coronary heart disease (CHD), even though 
current results are controversial (Gaby, 2001). 
 
Although  chemotherapies  for the eradication of these species are currently  available,  the 
development of more efficient, economic, and adequate drugs is needed in order to cope 
with the drawbacks of the therapies, especially the for the treatment of H. pylori infection, 
and with the continuous emergence of antibiotic resistance (Ge, 2002). 
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1.6.3.  The QFR as a potential drug target 
The  quinol:fumarate reductase (QFR)  has been considered a  potential  drug target  for  H. 
pylori eradication (Mendz, et al., 1995). More recently, this consideration has been highly 
enforced by the finding that the QFR from H. pylori is essential for the colonization of the 
mouse  stomach  (Ge,  et  al.,  2000).  In  parallel,  strains  of  Salmonella  typhimurium  lacking  a 
functional  QFR  have  also  lost  the  ability  to  colonize  murine  intestine  (Antje  Kahnert, 
unpublished). 
The  QFR from C. jejuni and  H. pylori  have  an identical  subunit  composition and  operon 
organization compared to the W. succinogenes species, consisting of three concatenated open 
reading frames in the order frdC, -A and -B (Ge, et al., 1997, Parkhill, et al., 2000). 
Although  culturing  these  two  pathogenic  species  is  quite  demanding  (Kelly,  2001), 
homologous production of the H. pylori QFR has been attempted, resulting in a very low 
yield and minimal enzymatic activity (Birkholz, et al., 1994). First attempts at heterologous 
production in Escherichia coli of the FrdA and FrdB subunits from an ε-proteobacterium like 
W. succinogenes (Lauterbach, et al., 1987, Lauterbach, et al., 1990) achieved EPR signals of the 
bi- and trinuclear iron-sulfur centers of the enzyme, but did not result in the synthesis of 
functional proteins. Later, Ge and co-workers (Ge, et al., 1997) attempted to express the entire 
frdCAB  operon  from  H.  pylori  in  E.  coli.  Nevertheless,  no  documentation  of  successful 
heterologous expression of a functional QFR from H. pylori or C. jejuni is available at present.  
 In the past it has been reported that in vitro treatment with some antihelmintics such as 
morantel, oxantel, thiabendazole (Mendz, et al., 1995), and other compounds like nizatidine, 
omeprazole (Chen, et al., 2002), metronidazole (Hoffman, et al., 1996), levamisole (Smith, et 
al., 1999), and TTFA (Grivennikova & Vinogradov, 1982) were found to have an effect on 
QFR enzymes from C. jejuni or H. pylori. The antihelmintics impaired cell growth in liquid 
cultures  but  the  minimal  inhibitory  and  minimal  bactericidal  concentrations  were  in  the 
millimolar  range,  which  is  not  suited  for  therapeutic  treatment.  In  fact,  since  the 
succinate:quinone  oxidoreductase  is  assumed  not  to  be  essential  for  growth  under  the 
conditions used for the inhibitor studies, it is likely that these antiparasitics affected other 
targets besides fumarate reduction (Lancaster & Simon, 2002). 
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1.7.  Goals of this Work 
1.7.1.  Production, characterization, and crystallization of the QFR from the 
pathogenic bacteria H. pylori and C. jejuni 
The QFR membrane protein complexes from the pathogens C. jejuni and H. pylori can be 
considered potential drug targets for the eradication of these ε-proteobacteria (Ge, 2002). The 
development of novel chemotherapies for the eradication of these species based on drugs 
with new active principles is strongly needed (Ge, 2002). The possibility of creating new 
drugs active on the QFR from these bacteria is substantially depending on the availability of 
high-quality protein. 
Well diffracting crystals, leading to a high-resolution crystal structure, would be helpful for 
a better understanding of the structure-function relationships of this protein superfamily, 
and for obtaining highly efficient inhibitors, for example by structure-based drug design. 
Up to now, the lack of large amounts of highly pure and active QFR enzymes from H. pylori 
and C. jejuni (Lancaster & Simon, 2002) makes their characterization and crystallization very 
difficult if not impossible. Therefore, the first aim of this thesis work was to establish the 
successful large-scale heterologous overproduction of these enzymes.  
Further, biochemical and structural studies on  QFR enzymes from species other than W. 
succinogenes  will  be  valuable  for  a  complete  understanding  of  this  class  of  membrane 
proteins. 
1.7.2.  Investigation of the distal heme propionate and its involvement in 
the E-pathway hypothesis 
Another aim of this study was to clarify the possible heme propionate involvement in the 
coupling of transmembrane electron and proton transfer as it has been suggested for W. 
succinogenes QFR in the context of the E-pathway hypothesis.  The orientation of the ring C 
propionate (Lancaster, et al., 1999) together with the results from electrostatic calculations 
concerning  its  protonation  state  (Haas  &  Lancaster,  2004)  indicated  that  this  propionate 
might act as a proton donor/acceptor in the proposed “E-pathway” (Lancaster, 2002b). 
In  principle,  electrochemically  induced  FTIR  difference  spectroscopy  is  the  appropriate 
method for  detecting  reaction-induced protonation  and/or  environmental changes of  the 
heme propionates experimentally. However, unlike amino acid side chains, whose role can 
be  investigated  by  site-directed  mutagenesis  (Haas,  et  al.,  2005),  assignment  of  potential 
signals arising from heme propionates requires a different approach, such as selective 
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isotope labeling at the carboxy carbon positions of the heme propionates, which is expected 
to result in the downshift of the corresponding bands to smaller wavenumbers in the FTIR 
difference spectra. 
Heme is composed of porphyrin, a large circular molecule made from four pyrrole rings 
(tetrapyrrole), whose electron pairs derived from the nitrogen atoms are coordinating an 
iron  atom,  which  sits  at  its  center.  The  first  committed  precursor  in  the  tetrapyrrole 
biosynthetic  pathway  is  5-aminolevulinic  acid  (ALA).  Two  different  routes  for  ALA 
biosynthesis are found in nature: the succinyl-coenzyme-A pathway, and the glutamate (C5) 
pathway (Michal, 1999).  In the α-group of the proteobacteria, in yeast and in mammalian 
cells, ALA is synthesized by a one-step condensation of succinyl-CoA and glycine along the 
‘Shemin’ route mediated by the hemA gene, encoding for the ALA synthase (Warren & Scott, 
1990).  In  higher  plants,  algae  and  many  prokaryotic  systems,  this  aminoketo  acid  is 
synthesized  from  the  intact  carbon  skeleton  of  glutamate  using  the  C5  pathway.  This 
pathway involves an unusual activation of the carboxyl group by formation of Glu-tRNA
Glu 
for the subsequent reduction to glutamate-1-semialdehyde (Kannangara, et al., 1988). In a 
third  step,  5-aminolevulinate  is  formed  by  an  ‘internal  transaminase  reaction’,  which 
transfers the amino group from the C-1 to the C-2 position. This reaction is catalyzed by the 
glutamate-1-semialdehyde 2,1-amino-mutase, which is encoded by the hemL gene.  In the 
genome sequence of W. succinogenes, the hemL gene of the C5 pathway is readily identified, 
but there is no evidence for a hemA gene of the ‘Shemin route’. 
The combined approach of 
13C heme propionate labeling and electrochemically induced FTIR 
difference spectroscopy has previously been successfully employed to investigate the role of 
heme  propionates  in  Paracoccus  denitrificans  cytochrome  c  oxidase  (Behr,  et  al.,  1998). 
However, this approach involved disruption of the hemA gene of the ‘Shemin route’ rather 
than the disruption of the hemL gene of the C5 pathway as performed in the work described 
here. 
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2.  MATERIALS AND METHODS 
2.1.  Materials 
2.1.1.  Suppliers 
Table 2-I: Supplier list. 
Company  Location   Web address 
Agilent Technologies  Böblingen, DE  http://www.agilent.com 
Aldrich, Sigma-Aldrich Laborchemik. 
GmbH 
Seelze, DE  http://www.sigmaaldrich.com 
Amersham Biosciences / Pharmacia 
Biotech 
Freiburg, DE  http://www.amersham.com/ 
Applied Biosystems  Framingham, MA, US  http://www.appliedbiosystems.com/ 
Avanti Polar Lipids Inc.  Alabaster, AL, US  http://www.avantilipids.com/ 
Beckman Coulter  Krefeld, DE  http://www.beckman.com/ 
Biometra  Goettingen, DE  http://www.biometra.de/ 
Bio-Tek Instruments GmbH  Bad Friedrichshall, DE  http://www.biotek.com/ 
Bio-Rad Laboratories GmbH  Muenchen, DE  http://www.bio-rad.com/ 
Biozym Scientific GmbH  Hess. Oldendorf, DE  http://www.biozym.com/ 
Branson  Danbury, CT, US  http://www.bransonultrasonics.com/ 
Bruker  Rheinstetten, DE  http://www.bruker.de/ 
Cartesian Dispensing Systems, 
Genomic Solutions Ltd 
Huntingdon, UK  http://www.cartesiantech.com/ 
http://www.genomicsolutions.com/ 
C/D/N Isotopes  Pointe Claire, CA  http://www.cdniso.com/ 
DIFCO (provider: Merck)  Kansas City, KS, US  http://service.merck.de/microbiology 
Dr. Ehrenstorfer GmbH  Augsburg, DE  http://www.analytical-
standards.com/ 
Eppendorf  Hamburg, DE  http://www.eppendorf.com/ 
Eurogentec  Seraing, BE  http://www.eurogentec.com/ 
Fermentas  St. Leon-Rot, DE  http://www.fermentas.de/ 
Fluka, Sigma-Aldrich 
Laborchemikalien GmbH 
Seelze, DE  http://www.sigmaaldrich.com 
GERBU Biochemical Mart   Gaiberg, DE  http://www.gerbu.de/ 
Gilson / ABIMED, Gilson 
International B.V. 
Bad Camberg, DE  http://www.gilson.com/ 
Glycon Biochemicals  Luckenwalde, DE  http://www.glycon.de/ 
GMI, Inc.  Ramsey, MN, US  http://www.gmi-inc.com/ 
Hampton Research  Aliso Viejo, CA, US  http://www.hamptonresearch.com/ 
Hellma  Muellheim, DE  http://www.hellma-worldwide.de/ 
Heraeus  Hanau, DE  http://www.wc-heraeus.com/ 
HI-TECH Scientific  Salisbury, UK  http://www.hi-techsci.com/ 
Holzner GmbH  Nussloch, Heidelberg, DE  http://www.holzner.net/2.htm 
H+P Labortechnik  Oberschleissheim, DE  http://www.hp-lab.de/ 
Jena Bioscience GmbH  Jena, DE  http://www.jenabioscience.com/ 
Infors AG  Bottmingen-Basel, CH  http://www.infors-ht.com/ 
 
IKA Labortechnik  Staufen, DE  http://www.ika.de/ 
Lambda Physik  Goettingen, DE  http://www.lambdaphysik.com/ 
Maag Technic AG  Duebendorf, CH  http://www.maagtechnic.ch/ 
MAGV  Rabenau, DE  http://www.magv-gmbh.de/ 
MEMMERT  Schwabach, DE  http://www.memmert.com/ 
Merck / VWR International  Darmstadt, DE  http://de.vwr.com/app/Home 
Merck-Hitachi Ltd.  Tokyo, JP   
Mettler-Toledo GmbH  Giessen,DE  http://www.mt.com/ 
Millipore  Schwalbach, DE  www.millipore.com 
Molecular Dimensions Ltd.  Soham, UK, DE  http://www.moleculardimensions.co
m/ Section 2.1: Materials 
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New England Biolabs GmbH  Frankfurt/Main, DE  http://www.neb.com/ 
NUNC GmbH  Wiesbaden, DE  www.nunc.de/ 
Olympus  Hamburg, DE  http://www.olympus.de/ 
Oxford Instruments  Wiesbaden, DE  http://www.oxford.de/ 
Pall  Dreieich, DE  http://www.pall.com/ 
Pierce Biotechnology (Perbio Science 
D. GmbH) 
Bonn, DE  http://www.piercenet.com/ 
http://www.perbio.com/ 
Qiagen  Hilden, DE  http://www1.qiagen.com/ 
Rainin Instrument LLC (Mettler-
Toledo) 
Giessen, DE  http://www.rainin.com/ 
Roche Diagnostics GmbH, Roche 
Applied Science 
Mannheim, DE  http://www.roche.de/ 
Riedel De Haen AG  Hannover, DE  http://www.riedeldehaen.com/ 
Roth, Carl Roth GmbH + Co. KG  Karlsruhe, DE  http://www.carl-roth.de/ 
SANOclav  Bad Überkingen-Hausen, 
DE 
wolf-sanoclav-macryl@t-online.de 
Sartorius AG  Goettingen, DE  http://www.sartorius.de/ 
Scientific & Educational Software  Cary, US  http://www.scied.com/ 
SeqLab  Goettingen, DE  http://www.seqlab.de/ 
Sedere (ERC)  Riemerling, DE  http://www.erc-hplc.de/ 
SERVA Electrophoresis GmbH  Heidelberg  http://www.serva.de/ 
Sigma-Aldrich Laborchemikalien 
GmbH 
Seelze, DE  http://www.sigmaaldrich.com 
SLM-Instruments, Inc.  Rochester, NY, US   
Stratagene  La Jolla, CA, US  http://www.stratagene.com/ 
Systec  Wettenberg, DE  http://www.systec-lab.de/ 
ThermoHybaid  Ulm, DE  http://www.thermo.com/ 
Toepffer Lab Systems  Göppingen, DE  http://www.glovebox.de/english.htm 
TOSOH Bioscience  Stuttgart, DE  http://www.tosohbioscience.com/ 
Vivascience  Hannover, DE  http://www.vivascience.com/ 
Zeiss, Carl Zeiss AG  Oberkochen, DE  http://www.zeiss.de/ 
 
2.1.2.  Equipment 
The equipment that have been used for the accomplishment of the experiments presented in 
the thesis are listed and described in more details in the following table. 
 
Table 2-II: Equipment list. 
Device  Type  Supplier 
Äkta  Äkta Purifier 10  Amersham 
Biosciences 
Anaerobic tent  Anaerobic glove box (Coy Laboratory Products Inc.)  Toepffer 
Autoclave   V150  Systec 
Autoclave   La-VA-MCS  SANOclav 
Autoclave   DSL 676-1-FD  Holzner 
Centrifuge   Sigma 4K10  Sigma 
Centrifuge (6x1 liter)  Avanti J20 XPI  Beckman 
Centrifuge  Centrifuge 5415 D  Eppendorf 
Chromatography column  LiChroCART 250-4 (LiCroSphere Si60, 5 µm, for 
HPLC) 
Merck 
Chromatography column  LiChroCART 250-10 (LiCrosorb RP-18, for HPLC)  Merck 
Chromatography column   PD-10 columns, Sephadex G-25 (gel filtration)  Amersham 
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Biosciences 
Chromatography columns  Plastic columns for ion exchange chromatography  home-made, MPIBP 
Chromatography column  TSK-GEL G4000SW 60 cm x 21.5 mm (gel filtration)  TOSOH 
Concentrators  Amicon cells, 50 ml and 250 ml capacity  Millipore 
Concentrators  centrisart I filtration, 2.5 ml tube  Sartorius 
Concentrators  Microcon filtration cell (Amicon)  Millipore 
Concentrators  Vivaspin, 500 µl tube  Vivascience 
Crystallization Robot  Synquad Dispensing System  Cartesian 
Technologies 
Cuvettes     114 QS, 5mm path (quartz)  Hellma 
Degassing station    home-made, MPIBP 
Digital camera  C3030 zoom  Olympus 
Agarose gel imaging 
station 
DNA gel documentation system (UV) (+ PC maxdata)  Bio-Rad 
Electroporation device  Gene Pulser  Bio-Rad 
Elisa reader  PowerWave X  Bio-Tek Instruments 
French-press (+ chamber)  SLM-AMINCO  SLM Instrum., Inc. 
HPLC instrument  LaChrom D-7000 HPLC System  Merck-Hitachi 
HPLC detector  Sedex 75 ELS  Sedere 
Glassware and stoppers  Anaerobic glassware and equipment  Maag Technic 
IEF  ECPS 3000/150  Amersham 
Pharmacia 
Incubator    MEMMERT 
Incubator  BK-600  Heraeus 
Incubators    Infors 
Laminar flow bench  Microflow / Laminar Flow  NUNC GmbH 
Magnetic stirrer   VARIOMAG (10 lit. flasks)  H+P Labortechnik 
Magnetic stirrer  RET IKAMAG  IKA Labortechnik 
Magnetic stirrer  Multipoint HP VARIOMAG (multiple stirrer)  H+P Labortechnik 
Multipipette  (for greiner 96-well plates)  Rainin 
Optical microscope   Axiovert 35 (for cells)  Zeiss 
Optical microscope  SZ40 (for crystals)  Olympus 
Peristaltic pump  Miniplus 3  Gilson / ABIMED 
pH meter   SevenEasy Mettler Toledo (for buffer)  Roth 
Pipettes  P10- P5000  Gilson 
Redox micro-electrode    Mettler-Toledo 
Resin for protein washing  vivapure Q resin maxi  Vivascience 
Rotors  70Ti, 60Ti, 45Ti  Beckman 
Rotors  SLA3000, GS3  Sorvall (GMI, Inc) 
Scaler  BL1500S  Sartorius 
Scaler  R180D  Sartorius 
Sonifier  SONIFIER 250  Branson 
Souther blotting device  Vacuum chamber + porous carrier  Kröger’s lab, JWGU 
Spectrophotometer  Agilent 8453 UV-visible Spectroscopy System (diode 
array) 
Agilent 
Spectrophotometer   Ultrospec 2100 pro (UV-VIS)  Amersham 
Pharmacia 
Spectrophotometer  Power wave X (for 96-wells plates)  Bio-Tek Instrum., 
Inc. 
Spectrometer (EPR)  Bruker spectrometer E500 or ESP300  Bruker Section 2.1: Materials 
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Speedvacuum  Concentrator 5301  Eppendorf 
Thermostatic room 18°     
Thermostatic room 4°     
Thermocycler (x PCR)  T3 Thermocycler  Biometra 
Ultracentrifuge  L8-60M  Beckman 
Ultracentrifuge  Optima MAX UC (Benchtop)  Beckman 
Vacuum blotting device  Vacugene Apparatus 2016 (Pharmacia LBK)  Amersham 
Pharmacia 
Vacuum pumps    Biometra 
Water bath   (60L culture)  home-made, MPIBP 
Water bath  Julabo 5  MAGV 
Water   Destamat (bi-distilled)  Heraeus 
Water  Milli-Q plus  Millipore 
 
2.1.3.  Computing 
2.1.3.1.  Computational equipment 
The hardware that have been used for computational activities are: 
o  Alpha server ES40 system (Hewlett-Packard) 
o  Thin Client, ezConnect Connection Management Tool, version 2.0 (Neoware Systems, 
Inc.) 
o  Silicon Graphics (SGI) workstation Octane MIPS R10000 (Silicon Graphics, Inc.) 
o  PC computers 
 
2.1.3.2.  Software 
The software that have been used for computational activities are: 
o  Compaq Tru64 UNIX V5.1B (for the Alpha server), Linux Suse, SGI platform (IRIX64-
6.5), and Windows as operative systems 
o  SECentral (Scientific & Educational Software), for molecular biology 
o  Unicorn v3.20 control system, for the control of the Äkta chromatography system 
(Amersham Biosciences) 
o  VMD 1.8.2 (University of Illinois) and PyMOL 0.96 (DeLano Scientific), for protein 
structure drawings 
o  ProDC, for hardware control and data set collection at the ESRF synchrotron 
o  HKL  package  (XDISPLAY,  DENZO,  and  SCALEPACK,  HKL  research, 
Charlottesville, NC), for data set processing 2. Materials and Methods 
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o  O, for model building; Origin 7 and KaleidaGraph 3.52, for curve fitting and graphs 
o  CNS (Crystallography and NMR Software) version 1.0, for refinement 
o  Moleman (by Gerard J. Kleywegt, Uppsala Software Factory), for manipulation of 
PDB-files 
o  Molscript (by Per Kralius, Avatar Software AB), Bobscript (by Robert Esnouf, Oxford 
University), and Raster3D (by Ethan A. Merritt, University of Washington, US) for 
generating high quality images of protein structures 
o  Other softwares: Office 2000 (Microsoft), Corel draw 10 (Corel Corporation), GIMP 
(GNU  Image  Manipulation  Program,  Free  Software  Foundation),  Photoshop  6.0 
(Adobe),  WinDrawChem  1.6.2  (by  Brian  Herger),  Acrobat  (Adobe),  EndNote  6.0 
(Thomson ISI ResearchSoft), Mozilla Firefox 1.0.3 (Mozilla Foundation), Sophos Anti-
Virus (Sophos Plc), SSH secure shell 2.1.0 (SSH Communication Security Ltd.) 
 
The web-based software that have been used for the work are:  
EMBL-EBI (http://www.ebi.ac.uk/services/) 
ExPASy (http://www.expasy.org/tools/peptide-mass.html) 
Blast (NCBI) (http://www.ncbi.nlm.nih.gov/BLAST/) 
WebCutter 2.0 (http://rna.lundberg.gu.se/cutter2/) 
Ovid (http://ovid1.gwdg.de/) 
PubMed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) 
 
 
2.1.4.  Chemicals 
The chemicals that have been used for the accomplishment of the experiments presented in 
the thesis are listed and described in more details in the following table. 
 
Table 2-III: Chemicals list.   
Name  Supplier 
Acetonitrile, HPLC UGG  Roth 
Agarose (LE)  Cambrex (Biozym) 
1-
13C-ALA hydrochloride (99 % purity)  (C/D/N Isotopes) 
ALA (non-labeled)  Fluka 
Al’s oil  Hampton 
Ammonium chloride (NH4Cl)  Roth Section 2.1: Materials 
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Ammonium sulfate ((NH4)2SO4)  Roth 
Anti-DIG-AP antibody  Roche 
Antifoam 204  Sigma 
benzamidine hydrochloride hydrate  Fluka 
Bio-Beads SM-2 Adsorbent  Bio-Rad 
Brain Heart Infusion  Difco 
boric acid (H3BO3)  Merck 
calcium chloride (CaCl2)  Merck 
chloramphenicol  GERBU 
chloroform, 99%  Roth 
di-chloro di-methylsilane  Aldrich 
cobalt chloride (CoCl2*6H2O)  Riedel De Haen 
copper chloride (CuCl2*2H2O)  Riedel De Haen 
CSPD kit, di-sodium 3-(-4-methoxyspiro{1,2-dioxetane-3,2’-(5’chloro) tricyclo 
[3.3.1.1
3,7] decan}-4-yl) phenyl phosphate 
Roche 
L-(+)-cysteine  Merck 
DEAE-sepharose chromatography medium  Amersham Biosciences 
DM , n-decyl-β-D-maltoside  Glycon 
DMF, dimethyl formamide  Merck 
DMSO, dimethylsulfoxyde  Merck 
EDTA, ethylene diamine tetra-acetic acid, di-sodium salt  GERBU 
Ethyl acetate  Aldrich 
ferrous chloride (FeCl2*4H2O)  Riedel De Haen 
formic acid, sodium salt (HCOONa)  Sigma 
fumaric acid  Roth 
fumaric acid, disodium salt  Fluka 
L-(+)-glutamic acid hydrochloride  Roth 
glycerol (99.5 %)  GERBU 
HEPES, 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid  GERBU 
heptane-1,2,3-triol (>98 %)  Fluka 
hydrochloridric acid (HCl)  Roth 
Isopropanol (p.a.)  Roth 
kanamycin  GERBU 
LDAO, N-lauryl-N,N-dimethylamine-N-oxide  Fluka 
lipids (synthetic lipids, see the lipid analysis chapter)  Avanti Polar Lipids 
lithium chloride (LiCl)  Merck 
LM, n-dodecyl-β-D-maltoside (cmc = 0.17 mM, Vanaken, et al., 1986)  Glycon 
magnesium chloride hexahydrate (MgCl2*6 H2O)  Merck 
manganese chloride tetrahydrate (MnCl2*4H2O)  Merck 
mediators: see mediators list, next chapter  Sigma/Aldrich/Fluka 
Menaquinone-4 (MK4 or VitK2)  Sigma 
methanol, 99.9%  Roth 
metronidazole   Sigma 
morantel  Sigma 
nichel chloride (NiCl2*6H2O)  Riedel De Haen 
OG, n-octyl-β-D-glucopyranoside  Glycon 
omeprazole  Sigma 
oxantel  Sigma 
maleic acid  Sigma 2. Materials and Methods 
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nizatidine  Sigma 
PCR DIG Probe Synthesis Kit  Roche 
PEG, polyethylene glycol (MME)  Hampton Research 
phosphatidic acid  Fluka 
orto-phosphoric acid (H3PO4)  Fluka 
potassium hexacyanoferrate (III), K3Fe(CN)6  Sigma 
di-potassium hydrogenphosphate trihydrate (K2HPO4*3H2O)  Roth 
potassium di-hydrogenphosphate trihydrate (KH2PO4*3H2O)  Roth 
potassium hydroxide (KOH)  Roth 
potassium nitrate (KNO3)  Roth or Merck 
potassium sulfate (K2SO4)  Merck 
Servalyt 5-8  SERVA 
sodium acetate (CH3COONa)  Roth 
sodium azide (NaN3)  Merck 
sodium borohydride (NaBH4)  Sigma 
sodium chloride (NaCl)  GERBU 
tri-sodium citrate dihydrate  Merck 
sodium dithionite (Na2S2O4)  Sigma 
SDS, sodium dodecyl sulfate  GERBU 
sodium hydroxide (NaOH)  GERBU 
sodium molybdate (Na2MoO4*2H2O)  Riedel De Haen 
sulfuric acid (H2SO4)  Roth 
Thesit, polyoxyethylene 9-dodecyl  Boehringer Mannheim 
(Roche) 
Thiabendazole (99 %)  Sigma 
1,1,1-tri-chloroethane  Merck 
Tris, tris-hydroxymethyl-9-aminomethane (99.9 %)  Roth 
Triton-X 100  GERBU or Sigma 
TTFA, 2-thenoyltrifluoroacetone  Fluka 
Tween 20  GERBU 
UM, n-undecyl-β-D-maltoside  Glycon 
Vitamin K1, 2-Methyl-3-phytyl-1,4-naphthoquinone (phylloquinone)  Sigma 
zinc chloride (ZnCl2)  Roth 
 
 
2.1.4.1.  Mediators 
The mediators that have been used for the titration of cofactors are listed and described in 
more details in the following table. The standard (pH 7.0, 25°C) redox midpoint potential 
(Em) and the solvent used for solubilization are also indicated. 
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Table  2-IV:  List  of  mediators  for  enzymatic  titrations.  All  listed  mediators  were 
purchased from Sigma/Aldrich/Fluka. 
Mediator  Em,7 vs. H2/H
+  Solvent 
tetrachlorobenzoquinone  + 280  diethyl ether 
N,N,N’,N’-tetramethyl-phenylene-diamine  + 270  water 
2,6-dichlorophenolindophenol  + 217  ethanol 
ruthenium hexaminchloride  + 200  water 
anthraquinone-2,6-disulphonate  + 185  water 
1,2-naphtoquinone  + 145  ethanol 
anthraquinone  + 100  ethanol 
trimethylhydroquinone  + 100  ethanol 
phenazine-methosulfate,  + 80  DMSO 
5-hydroxy-1,4-naphtoquinone  + 50  ethanol 
methylene blue  + 11  DMSO 
duroquinone  + 10  ethanol 
menadione  -12  acetone 
resorufin  -50  DMSO 
indigotrisulfonate  -70  water 
2-hydroxy-1,4-naphtoquinone  - 125  ethanol 
anthraquinone-2-sulphonate  - 225  ethanol 
phenosafranine  -239  DMSO 
neutral red  - 307  ethanol 
benzyl viologen  - 360  water 
methyl viologen  - 420  water 
 
2.1.4.2.  Phospholipids 
The phospholipids that have been used in this work are listed in the following table. Their. 
 
Table 2-V: Synthetic phospholipids. All lipids were purchased from Avanti Polar Lipids. Abbreviation 
name, chemical  formula, composition of  the fatty acid (FA)  chains,  and  molecular  weight (MW;  m.: 
mostly) are also indicated. 
Name  Chemical 
formula 
MW  FA chains 
1,2-di-oleoyl-sn-glycero-3-phosphoethanolamine (DOPE)  C41H78NO8P  744.05  18:1, 18:1 
1,2-di-palmitelaidoyl-sn-glycero-3-phosphocholine (PC)  C40H76NO8P  730.02  16:1, 16:1 
1,1',2,2'-tetra-oleoyl-cardiolipin (CA)  C81H148O17P2Na2  1,502.0  18:1, 18:1 
1,2-di-oleoyl -sn-glycero-3-[phospho-rac-(1-glycerol)] (DOPG)  C42H78O10PNa  797.04  18:1, 18:1 
1,2-di-palmitelaidoyl-sn-glycero-3-phosphoethanolamine (PE)  C37H70NO8P  687.93  16:1, 16:1 
1,2-di-oleoyl-sn-glycero-3-phosphocholine (DOPC)  C44H84NO8P  786.15  18:1, 18:1 
1,2-dipalmitoyl -sn-glycero-3-phosphoethanolamine (DPPE)  C37H74NO8P  691.97  16:0, 16:0 
1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
(DPPG) 
C38H74O10PNa  744.96  16:0, 16:0 
1,2-dipalmitoyl-sn- glycero-3-phosphocholine (DPPC)  C40H80NO8P  734.05  16:0, 16:0 
Brain L-α-phosphatidylserine (Brain PS, Porcine)  C42H79NO10PNa  812.05  m. 18:0, 18:1 
L-α-Phosphatidylinositol (PI, Soy)  C43H78O13PNa  857.05  m. 18:2, 16:0 
1,2-di-phytanoyl-sn-glycero-3-phosphocholine (PC)  C48H96NO8P  846.27  16:0, 16:0 2. Materials and Methods 
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2.1.5.  Biological material 
2.1.5.1.  Bacterial strains and genomic DNA 
Helicobacter pylori 26695 genomic DNA and a clinical isolated strain of Campylobacter jejuni 
were kindly provided by Dr. Stefan Bereswill. The sequence of the frdCAB operon from this 
C. jejuni strain was determined (double-strand) and deposited (EMBL nucleotide sequence 
accession number AJ628040) using the primers Cat2Cj_seq1-20. Wolinella succinogenes wild 
type (WT) DSM 1740 (genome accession number EMBL BX571656) was employed to produce 
WT QFR  and  to  create  the  ∆hemL  mutant  strain.  For the production  of the heterologous 
enzymes, a W. succinogenes ∆frdCAB deletion mutant strain (Simon, et al., 1998) (∆frdCAB) 
was  used.  All  cloning  steps  were  performed  in  E.  coli  JM110  and  XL1-blue  MRF'  Kan 
supercompetent cells (Stratagene). 
2.1.5.2.  Oligonucleotide Primers 
The oligonucleotide primers that were used for preparative PCR, analytic PCR, sequencing, 
and  site-directed  mutagenesis  were  synthesized  by  ThermoHybaid  and  are  listed  in  the 
following  tables.  Table  2-IX  shows  the  homology  between  the  residues  previously 
exchanged in the W. succinogenes QFR and those that have been here exchanged in the C. 
jejuni and H. pylori QFRs by using the primers listed in Table 2-XIV. 
 
Table 2-VI: Oligonucleotide primers used for preparative and analytic PCR. The inserted restriction 
sites are indicated as underlined nucleotides. Start and stop codons are indicated as bold nucleotides. 
Name  Sequence 
C. jejuni_Fw  5'-CCA TCG ATC GTG AGC TTA TCG AAG GTT ATT TGG G-3' 
C. jejuni_Rv  5'-CCC CTA GGT TTA TTT CTT TGA GCG ACA AGT TGT C-3' 
H. pylori_Fw  5'-CCA TCG ATC AAC AAG AAG AGA TTA TAG AGG GT-3' 
H. pylori_Rv  5'- CCC CTA GGG CGG CTT TTA CCC ACT TTC AAC ATC C -3' 
pFrdcat2_Fw  5’-CCC CTA GGT AAA TCT CCT TGG AGC GGG GTC TCC C-3’ 
pFrdcat2_Rv  5’-CCA TCG ATC ATC TGT TTC CCC TGT GCA GTA TT-3’ 
HemL1_Fw  5'-CCG GAT CCG CAT CAC CCC CGA AGC CTT GGC TGT C-3' 
HemL1_Rv  5'-CCG AAT TCG GTT AAA CGC CCA AAG TGC CAC GCC C-3' 
KanM_Fw  5'-CCC CGG GCC CGG AAA GCC ACG TTG TGT CTC AAA ATC TC-3' 
KanM_Rv  5'-CCC CCC ATG GGG CGC TGA GGT CTG CCT CGT GAA GAA GG-3' 
HpG_probe_Rv  5’- CCT TAA CCC AGC TAG TCC GC –3’ 
2_Integr.check  5’-GAT TGC ACC CTC ACG CTC ATC C-3’ 
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Table 2-VII: Oligonucleotide primers used for sequencing. 
Name  Sequence 
Cat2_seq1  5’-CTC TTA CAG TTC CAA ACT ACC-3’ 
Cat2_seq11  5’-CCT TTA ACA GGG GAT TCT CTA G-3’ 
Cat2Cj_seq2  5’-GCT TCA GGG CTT TTT TTA GG-3’ 
Cat2Cj_seq3  5’-GGT TGT AAG TCA TTT TAT GTG GC-3’ 
Cat2Cj_seq4  5’-GTG AAG CGT TCT CAC TCT GC-3’ 
Cat2Cj_seq5  5’-TAT TGA TAG AAT GGA AGC AG-3’ 
Cat2Cj_seq6  5’-ATG GAG CAT ATT CGT AAA GG-3’ 
Cat2Cj_seq7  5’-GAC ACA AAT GTA GTA AAA GAC-3’ 
Cat2Cj_seq8  5’-AGA AGG CGA AAC TTT GCC AC-3’ 
Cat2Cj_seq9  5’-GGA TGC AGA TCT GAG TTT TG-3’ 
Cat2Cj_seq10  5’-CTA GAT ATT TAC AAG ATC CGC-3’ 
Cat2Cj_seq12  5’-GCG GAT CTT GTA AAT ATC TAG-3’ 
Cat2Cj_seq13  5’-CAA AAC TCA GAT CCG CAT CC-3’ 
Cat2Cj_seq14  5’-GTG GCA AAG TTT CGC CTT CTA C-3’ 
Cat2Cj_seq15  5’-GTC TTT TAC TAC ATT TGT ATC-3’ 
Cat2Cj_seq16  5’-CCT TTA CGA ATA TGC TCC ATC-3’ 
Cat2Cj_seq17  5’-CTG CTT CCA TTC TAT CAA TG-3’ 
Cat2Cj_seq18  5’-GCA GAG TGA GAA CGC TTC AC-3’ 
Cat2Cj_seq19  5’-GCC ACA TAA AAT GAC TTA CAA CC-3’ 
Cat2Cj_seq20  5’-CCT AAA AAA AGC CCT GAG GC-3’ 
Cat2Hp_seq2  5’-CGG GCT TGA TTT TAG CGC TC-3’ 
Cat2Hp_seq3  5’-CTT ATT GTT TGC CGT AGA ATT GC-3’ 
Cat2Hp_seq4  5’-CAA GCG AGC CTT GCG AAC GC-3’ 
Cat2Hp_seq5  5’-ATA AAT GCT ATG GGG CGG TG-3’ 
Cat2Hp_seq6  5’-GAT ATT GCT ATT TTA GGG CG-3’ 
Cat2Hp_seq7  5’-CAA CAC GCA AAA AGT TGA AG-3’ 
Cat2Hp_seq8  5’-CTG AGC AAG ACA TGC CCA CG-3’ 
Cat2Hp_seq9  5’-AAG CGC GGT GAG TAA GCC GC-3’ 
Cat2Hp_seq10  5’-TGC GGG TGT TGT ATC GCT TC-3’ 
 
 
Table 2-VIII: Oligonucleotide primers used for site-directed mutagenesis. The underlined-bold triplets 
indicate the mutagenized amino acids (see also Table 2-IX). 
Name  Sequence 
Cj E64Q_Fw  5’-CTG TGG TAC ATT TTT TAC AAT TAA AAT TTG TTT ACG ATA ATC CTG-3’ 
Cj E64Q_Rv  5’-CAG GAT TAT CGT AAA CAA ATT TTA ATT GTA AAA AAT GTA CCA CAG-3’ 
Cj V162K_Fw  5’-CGG CGA TAT GTC AGG AGA TAG GAA AGT AAG TCA TTT TAT GTG GC-3’ 
Cj V162K_Rv  5’-GCC ACA TAA AAT GAC TTA CTT TCC TAT CTC CTG ACA TAT CGC CG-3’ 
Cj V162R_Fw  5’-CGG CGA TAT GTC AGG AGA TAG GCG CGT AAG TCA TTT TAT GTG GC-3’ 
Cj V162R_Rv  5’-GCC ACA TAA AAT GAC TTA CGC GCC TAT CTC CTG ACA TAT CGC CG-3’ 2. Materials and Methods 
33 
Cj E179Q_Fw  5’-CTT TTA GTC TGT GTT CAA CTT CAT GGA AGT ATA GGG C-3’ 
Cj E179Q_Rv  5’-GCC CTA TAC TTC CAT GAA GTT GAA CAC AGA CTA AAA G-3’ 
Hp E66Q_Fw  5’-GTG GCG AAA TTT TTT CAA GGG AGC TTG TTT TTA AAA GCG G-3’ 
Hp E66Q_Rv  5’-CCG CTT TTA AAA ACA AGC TCC CTT GAA AAA ATT TCG CCA C-3’ 
Hp F163K_Fw  5’-GGC CTC ATG GTT CAA GCT ATC GTA AAG TAA CGC AAA ACT TTT GGC-3’ 
Hp F163K_Rv  5’-GCC AAA AGT TTT GCG TTA CTT TAC GAT AGC TTG AAC CAT GAG GCC-3’ 
Hp F163R_Fw  5’-GGC CTC ATG GTT CAA GCT ATC GTC GCG TAA CGC AAA ACT TTT GGC-3’ 
Hp F163R_Rv  5’-GCC AAA AGT TTT GCG TTA CGC GAC GAT AGC TTG AAC CAT GAG GCC-3’ 
Hp E180Q_Fw  5’-CTT ATT GTT TGC CGT ACA ATT GCA TGG CTC TAT TGG G-3’ 
Hp E180Q_Rv  5’-CCC AAT AGA GCC ATG CAA TTG TAC GGC AAA CAA TAA G-3’ 
 
 
Table 2-IX: Site-directed mutagenesis performed on the C. jejuni and H. pylori frdCAB operons. The 
residues exchanged in this thesis work are homologous to those indicated in the W. succinogenes QFR 
column. 
W. succinogenes QFR 
C. jejuni QFR 
substitution 
H. pylori QFR 
substitution 
FrdC-E66  FrdC-E64Q  FrdC-E66Q 
FrdC-M163  FrdC-V162L  FrdC-F163L 
FrdC-M163  FrdC-V162R  FrdC-F163R 
FrdC-E180  FrdC-E179Q  FrdC-E180Q 
 
2.1.5.3.  Plasmids 
The characteristics of the plasmids used and constructed in this thesis are summarized in the 
following table. 
 
Table 2-X: Plasmids used. 
Name  Characteristics  Reference 
pFrdcat2 
Derivative of pSC101. E. coli low copy number vector. Contains the 
chloramphenicol resistance (cat), a truncated kan resistance, lacZ’, 
SC101 replicon, W. succinogenes wild type frdCAB operon including 
promoter and terminator sequences. 
Simon, et al., 1998 
pCatCj4  Derivative of pFrdcat2. The W. succinogenes wild type frdCAB operon is 
replaced by the C. jejuni frdCAB operon. 
This work 
pCatHpG8  Derivative of pFrdcat2. The W. succinogenes wild type frdCAB operon is 
replaced by the H. pylori frdCAB operon. 
This work 
pBR322  Contains the tetracycline resistance, ampicillin resistance.  Bolivar, et al., 1977  
pBRH01  Derivative of pBR322, contains the W. succinogenes hemL gene.  This work 
pBR∆H01 
Derivative of pBR322, contains the W. succinogenes disrupted hemL 
gene. 
This work Section 2.1: Materials 
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2.1.5.4.  Enzymes 
Taq polymerase ‘Expand Long Template PCR System’ (Roche) was used for long-template 
preparative PCR, whereas Taq polymerase GoldStar (Eurogentec) was used for analytical 
short template PCR. Restriction and modification enzymes were obtained from Fermentas. 
2.1.6.  Media and growth conditions 
W. succinogenes was grown in minimal or rich medium (addition to the minimal medium of 
Brain  Heart  Infusion,  Difco)  with  formate, as  electron  donor,  and  fumarate  or  nitrate  as 
electron acceptors (Table 2-XI, Table 2-XII and Table 2-XIII) (Bronder, et al., 1982, Lorenzen, 
et  al.,  1993).  The  media  were  made  anaerobic  in  gastight  bottles  by  repeated  vacuum-
nitrogen  cycles.  Large-scale  protein  production  was  performed  in  60  liters  anaerobic 
medium  containing  the  required  additives  and  200  µl  antifoam.  Maintainance  of  W. 
succinogenes strains was accomplished in 10 ml culture gastight vials that were stored at 4°C 
up to 1-2 months. For the aminolevulinate-auxotrophic strain, 1 mM ALA or 0.2-0.4 mM 1-
13C-ALA  (Figure  2-1)  was  supplied.  W.  succinogenes  cultures  contained,  when  required, 
kanamycin and chloramphenicol at a concentration of 25 and 12.5 mg/l, respectively. These 
concentrations were doubled (50 and 25 mg/l) in E. coli Luria-Bertani cultures. 
 
 
Table 2-XI: Formate – fumarate 10x (A) and formate – nitrate pre-medium 20x (B). 
A  B 
Tris  0.5 M  Tris  1 M 
KOH  2 M  Sodium formate  1.6 M 
Fumaric acid  0.9 M  KNO3  0.8 M 
Sodium formate  1 M  K2HPO4  20 mM 
K2HPO4  200 mM  K2SO4  100 mM 
(NH4)2SO4  50 mM  Fumaric acid  100 mM 
NH4Cl  50 mM  Adjust pH  7.5 
CH3COONa x 3H2O  200 mM  Trace elements  2x 
Glutamic acid  10 mM     
Adjust pH  7.9-8.0     
Trace elements  1x     
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Figure  2-1:  Chemical  structure  of  the  1-
13C-5-aminolevulinate.  The  isotopically  labeled  carbon  (
13C)  is 
indicated in red. 
 
2.2.  Molecular Biology/Genetics 
2.2.1.  Standard methods 
Agarose  gels  for  DNA  gel  electrophoresis  were  prepared  using  LE  agarose.  Plasmid 
extractions from E. coli (maxi- and mini-prep) and DNA extraction from agarose gels were 
carried  out using Qiagen kits.  The DNA ligations  were performed  with T4  DNA Ligase 
overnight at 16°C. Genomic DNA preparation from W. succinogenes was performed using the 
Table 2-XII: Formate – fumarate (A) and formate – nitrate medium (B). 
A  B 
Pre-medium  1x  Pre-medium  1x 
Ca-Mg solution  1x  Ca-Mg solution  4x 
Brain Heart Infusion  13 g/l  Brain Heart Infusion  13 g/l 
Adjust pH  7.9-8  Adjust pH  7.5 
Degas and autoclave  Degas and autoclave 
  Add cys-glu solution prior to inoculation 
Table 2-XIII: Trace elements solution 500x (A); cysteine – glutamate (cys-glu) solution 100x (B); calcium 
– magnesium solution 1000x (C). 
A  B  C 
Na2EDTA x 2H2O  5.2 g/l  Glutamic acid  10 g/l  CaCl2 x 2H2O  7.4 g/l 
FeCl2 x 4H2O  1.5 g/l  L-cysteine x HCl  10 g/l  MgCl2 x 6H2O  51 g/l 
ZnCl2  0.07 g/l  Adjust pH  7.0     
MnCl2 x 2H2O  0.1 g/l  Degas and autoclave     
H3BO3  0.062 g/l         
CoCl2 x 6H2O  0.190 g/l         
CuCl2 x 2H2O  0.017 g/l         
NiCl2 x 6H2O  0.024 g/l         
Na2MoO4 x 2H2O  0.036 g/l         Section 2.2: Molecular Biology/Genetics 
36 
DNeasy  Tissue Kit  (Qiagen).  DNA  sequencing  was  performed  according  to  Sanger  et  al. 
(Sanger,  et  al.,  1977)  and  provided  by  SeqLab.  DNA  quantification  was  accomplished 
spectrophotometrically  and  by  agarose  gel  electrophoresis  with  the  help  of  a  calibrated 
molecular mass standard (1 kb DNA molecular mass standard, New England Biolabs). E. coli 
supercompetent  cells  were  transformed  as  indicated  in  the  kit  (Stratagene).  The  DNA 
manipulations not described here were performed using standard protocols, as described by 
Sambrook et al. (Sambrook, et al., 1989). Site-directed mutagenesis on the FrdC subunit was 
performed with the use of one of the oligonucleotide primer couples Cj E64Q, Cj V162K, Cj 
V162R, Cj E179Q for the mutation of the pCatCj4 construct, and Hp E66Q, Hp F163K, Hp 
F163R, Hp E180Q for the mutation of the pCatHpG8 construct. The method (QuickChange II 
site-directed  mutagenesis  kit,  Stratagene)  is  based  on  PCR-based  amplification  of  the 
mutated plasmids and digestion by the DpnI restriction enzyme, which digests the parental 
methylated and hemimethylated DNA strands. Subsequently, transformation of E. coli will 
repair the nick and clone the new plasmid with the desired mutation(s). 
2.2.2.  Transformation of W. succinogenes 
Transformation of W. succinogenes (Simon, et al., 1998) was carried out by electroporation in 
an anaerobic tent. A fresh 10 ml formate/nitrate rich medium was inoculated and incubated 
at 37°C until an OD578 of ~0.3 was reached. The cells were then spun down and resuspended 
in  10  ml  sterile  sucrose  (0.3  M).  After  a  second  centrifugation,  the  sucrose  solution  was 
decanted until ~50 µl were left. The cells were then resuspended, mixed with 5-10 µg of 
dialyzed (“V” Series Membranes, Millipore) plasmid and set on ice. Five minutes later, the 
mixture was placed in an electroporation cuvette and pulsed (800 ohm, 25 µFD, 1.25 kV, time 
constant). Immediately after the pulse, 1 ml of cold fresh medium without antibiotic was 
added. The culture was transferred into a new tube together with 9 ml of fresh medium and 
incubated  at  37°C  for  ~10  hours.  The  longer  incubation  and  the  larger  volume  of  fresh 
medium are modifications from the method established by Simon, et al., 1998. The cells were 
finally spun down and plated on Petri dishes with an agar formate/nitrate rich medium 
containing the required selective antibiotics. The growing colonies (usually in 2-3 days) were 
isolated and inoculated in a fresh formate-nitrate liquid medium without any antibiotic, and 
screened for the right genomic insertion by PCR. Oligonucleotide primers were designed so 
that  only  a  locus-specific  genome  insertion  could  give  a  signal  by  using  2_Integr.check 2. Materials and Methods 
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primer and a specific reverse primer (CatCj_seq19 or HpG_probe_Rv). PCR-positive clones 
were re-inoculated in a rich formate-fumarate medium and stored at 4°C. 
2.2.3.  Southern blotting 
Southern  blotting  was  performed  as  described  (Southern,  1975,  Simon,  et  al.,  1998).  The 
genomic DNA (2 µg) of W. succinogenes was digested with the restriction enzyme HindIII 
and run into an agarose gel. The gel was then placed on a nylon membrane (Biodyne B 
transfer  membrane,  Pall)  and  laid  on  a  porous  carrier  of  an  aspirating  vacuum-blotting 
device. The digested DNA was transferred to the nitrocellulose by adding i) SB buffer 1 
(depurination step); ii) SB buffer 2 (denaturation step); iii) SB buffer 3 (neutralization step); 
iv) SB SSC (1x) buffer. The DNA was then fixed to the membrane by incubation at 121°C for 
30  minutes.  Rinsing  of  the  membrane  with  SB  SSC  buffer  was  followed  by  a  pre-
hybridization at 68°C with the hybridization buffer for one hour. Previously, digoxigenin-
labeled probes were made for the upstream (QFR locus) and downstream region (cat locus) 
using the PCR DIG Probe Synthesis Kit and the primers CatCj_seq8 and CatCj_seq12 (800 bp 
fragment) for the C. jejuni frdCAB and H. pylori_Fw and HpG_probe_Rv (500 bp fragment) 
for the H. pylori frdCAB. The probe was added to the hybridization buffer, boiled for 10 min, 
shock-frozen in liquid N2 and finally thawed on ice. The membrane underwent hybridization 
in  an  oven  at  68°C  overnight  by  mixing  it  with  the  prepared  digoxigenin-labeled  probe 
inside a rolling tube. After hybridization, the membrane was washed twice with 2x SSC + 0.1 
% SDS at RT, and subsequently twice with 0.1x SSC + 0.1 % SDS at 68°C for 15 min The 
membrane  was  then  washed  with  the  SB  detection  wash  buffer  for  5  min  and  with  SB 
detection 2 buffer for 30 min The anti-DIG-AP was mixed with the SB detection 2 buffer and 
left binding to the membrane. The membrane was washed with SB detection 3 buffer and the 
CSPD solution was added. After washing off the CSPD solution with water and with the 
stripping  solution,  the  labeled  DNA  fragments  were  detected  with  a  radiography  film 
(Kodak). 
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2.3.  W. succinogenes Growth Curves and Membrane Preparation 
Growth of W. succinogenes strains was tested in triple-trial in rich and minimal media (50 or 
250 ml) and doubling times were calculated by measuring absorbance at 578 nm every one 
or two hours until the stationary phase was reached. Membranes of W. succinogenes were 
prepared  by  harvesting  the  cells  by  centrifugation  at  late-exponential  phase  and 
resuspending in a buffer containing 50 mM Tris (pH 7.8), 2 mM malonate, 1 mM EDTA. The 
cells were then resuspended using a grinder and physically disrupted by a French press at 
130  MPa.  Afterwards,  the  membranes  were isolated  by ultracentrifugation  (100’000  g,  45 
min, 4°C). 
 
2.4.  Large-Scale Protein Production and Purification 
2.4.1.  Heterologous QFR production and purification 
The expression of QFR for large-scale preparation consisted of a culture of W. succinogenes in 
60  liters  formate/fumarate anaerobic  rich medium  containing  12.5mg/l  chloramphenicol. 
After inoculation (with a 240 ml preculture), the culture was incubated for approximately 12-
15 hours at 37°C until late exponential phase. As described earlier, the cells were harvested 
by  centrifugation  (with  a  centrifuge  Avanti  J20  XPI),  homogenized,  disrupted,  and  the 
membranes were isolated by ultracentrifugation (see previous section). 
Table 2-XIV: Southern blotting buffers and instructions. 
Buffer name  Ingredients 
SB buffer 1  0.25 M HCl 
SB buffer 2  1.5 M NaCl, 0.5 M NaOH 
SB buffer 3  1 M Tris, 2 M NaCl, pH 5.0 
SB SSC (20x)  3 M NaCl, 0.3 M sodium citrate*2H2O, pH 7.0 
SB hybridisation  5x SSC, 1 % blocking reagent, 0.1 % n-lauryl sarkosin (Na), 0.02 % SDS 
SB detection 1  100 mM maleic acid, NaCl 150 mM, NaOH to pH 7.0 (autoclave) 
SB detection wash  SB detection 1 + 0.3 % Tween 20 
SB detection 2  SB det. 1 + Blocking Reagent (Roche), dissolve at 68°C, autoclave, store at 4°C 
SB detection 3  100 mM Tris, 100 mM NaCl, HCl to pH 9.5 
Stripping solution  0.2 M NaOH, 0.1 % SDS 2. Materials and Methods 
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2.4.1.1.  Membrane protein solubilization 
The pelleted membranes were resuspended in Tris-acetate (50 mM, pH 7.8), 1 mM DTT, and 
2  mM  malonate  buffer  with  Triton  X-100  at  a  detergent:membrane  protein  ratio  of  1:1 
(w/w)
c. After stirring for one hour in anaerobic conditions at room temperature (RT), the 
solubilized membrane proteins were isolated by a second step of ultracentrifugation (100’000 
g,  45  min,  4°C).  The  supernatant,  containing  the  solubilized  membrane  proteins,  was 
collected and kept on ice. 
2.4.1.2.  DEAE-sepharose anion exchange 
The solubilized membrane proteins were loaded into a DEAE-sepharose column (~400 ml 
bed volume), which was previously equilibrated with the Tris-malonate buffer plus 0.05 % 
Triton  X-100,  and  washed  with  two  bed  volumes  of  equilibration  buffer.  A  linear  NaCl 
gradient (0-300 mM) in this buffer was applied to the column and the eluate was collected in 
~10 ml fractions. QFR eluted at a NaCl concentration of about 100-120 mM. A first indication 
of the presence of QFR was obtained by observing the color of the eluted fractions. The 
amount of fumarate reductase activity present in each fraction was then precisely calculated 
via the “MB assay” (see below section 2.5.7.1). The salt concentration present in the protein 
sample  after  elution  was  halved  using  a  pressure  dialysis  concentrator  (Amicon)  with  a 
membrane  cut-off  of  100  kDa.  Subsequently,  the  protein  solution  was  re-loaded  into  a 
smaller (~60 ml capacity) DEAE-sepharose column in order to exchange the detergent from 
TritonX100  to  a  mixture  of  0.05  %  decyl-β-D-maltoside  (DM)  and  0.05  %  dodecyl-β-D-
maltoside (LM). The enzyme was eluted from this second anion exchange chromatography 
column with a NaCl-containing (200 mM) Tris-malonate buffer. The high salt concentration 
of the sample was diluted to 10-14 mM with the use of a second smaller pressure dialysis 
concentrator (Amicon) with a membrane cut-off of 100 kDa. 
2.4.1.3.  Preparative isoelectric focusing 
The isoelectric focusing gel was prepared by mixing 0.01% (w/v) LM, 0.1% (w/v) DM, 2 % 
ampholyte solution with a pH range 5-8 (servalyt, SERVA), and 8 g of Ultrodex (Amersham 
Pharmacia) in 200 ml water, poured onto the electrofocusing flatbed and dried at 60°C until 
                                                
c As a rule of thumb, the amount of membrane proteins was estimated to be one twentieth of the cell 
mass weight. Section 2.4: Large-Scale Protein Production and Purification 
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30 % water evaporation was reached. A maximum of 200 mg of highly concentrated protein 
(>20 mg/ml) was loaded onto the gel, which was situated on a thermostatic plate at 4°C. A 
power of 16 W was applied to the gel for at least 8 hours. After isoelectric focusing, the 
protein was extracted from the gel with a buffer containing 20 mM HEPES (pH 7.3), 1 mM 
EDTA, 0.01% (w/v) LM, 0.1% (w/v) DM and either 2 mM malonate or 20 mM fumarate in 
those samples subjected to crystallization trials and concentrated with Centrisart I micro-
concentrators (100 kDa cut-off) up to 20 mg/ml. In order to remove the ampholytes, the 
sample was subjected to a gel filtration step on PD-10 columns. The re-concentrated samples 
were either further purified by gel filtration or shock frozen with liquid N2 and stored at –
77°C.  
2.4.1.4.  Gel filtration 
In order to improve the purity and homogeneity of the sample, a further purification step 
was introduced by performing gel filtration at 4°C on a TSK-GEL G4000SW column 60 cm x 
21.5 mm (200 ml bed volume, TOSOH Bioscience) on an Äkta Purifier 10. After equilibration 
with at least one bed-volume of the previously used buffer, the protein was loaded into the 
column at a flow speed of 3 ml/min, and the QFR eluted at a volume equal to ¾ of the bed 
volume. Due to the capacity of this column (up to 20 mg of protein), multiple cycles were 
consecutively performed by washing with two bed volumes between one cycle and the next. 
Only the fractions (0.8 ml volume each) that appeared to contain pure QFR were collected. 
Subsequently,  the  pooled  fractions  underwent  concentration  by  Centrisart  I  (cut-off  100 
kDa),  shock  freezing  with  liquid  N2  and  storage  at  –77°C.  These  samples  were  used  for 
crystallization and analytical ultracentrifugation analysis. 
2.4.2.  Production of the W. succinogenes QFR containing
 13C-labeled heme 
propionates 
A mutant strain of W. succinogenes lacking the hemL gene (N2 strain, see work in section 
3.2.1) was pre-inoculated overnight  in  minimal  medium  supplemented with 0.4 mM 
13C-
labeled ALA. Using this pre-culture the 60 liters minimal medium containing 0.2 mM 
13C-
labeled ALA were subsequently re-inoculated at an inoculum to fresh medium volume ratio 
of 1:50. Cells were harvested by centrifugation at late exponential phase after 24 to 30 hours. 
QFR isolation (up to isoelectric focusing) was performed as described above. The samples 
subjected to FTIR spectroscopy analysis were washed and concentrated to 1.0-1.5 mM in 100 2. Materials and Methods 
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mM  potassium  phosphate  (KPi)  buffer  at  pH  7  containing  100  mM  KCl  as  supporting 
electrolyte  and  1  mM  DM  as  detergent.  The  final  sample  concentration  was  adjusted  in 
Vivaspin concentrators (500 µl capacity, 100 kDa cut-off). 
2.5.  Protein Characterization 
Detection of covalently bound FAD was carried out on SDS-polyacrylamide gels containing 
5-10 µg protein. After electrophoresis, the gel was treated for 10 min with 10 % acetic acid, 
washed with water, and irradiated with UV light (Unden, et al., 1980).  
The  concentration of  heme b in  the  sample was  determined by  looking  at  the  difference 
spectrum  “reduced-minus-oxidized”  redox  states  derived  from  spectra  of  the  enzyme 
treated  respectively  with  dithionite  or  K3Fe(CN)6  (∆abs563-575,  ε=  23.4  mM
-1  cm
-1  (Kröger  & 
Innerhofer,  1976a).  Alternatively,  determination  of  heme  b  concentration  was  calculated 
from the absorbance at 415 nm (Soret-band), using an extinction coefficient of 139.1 mM
-1 cm
-
1  each  heme.  An  Agilent  8453  spectrophotometer  was  used  for  spectrophotometric 
measurements.  
The  total  protein  concentration  was  measured  using  BSA  as  a  standard  with  the 
bicinchoninic  acid  assay  (BCA  assay,  Pierce)  (Smith,  et  al.,  1985)  in  a  multi-well  reader 
Power-wave-X spectrophotometer.  
SDS  polyacrylamide  gel  electrophoresis  (12.5%  w/v  acrylamide)  was  carried  out  as 
described (Laemmli, 1970), using Coomassie blue for staining and Prestained Protein Marker 
(6-175 kDa, New England Biolabs) as a molecular mass standard. 
2.5.1.  Oxidation-reduction (“redox”) titration of FAD and iron-sulfur 
clusters and detection by EPR spectroscopy 
The  experimental  work  of  FAD  and  iron-sulfur  cluster  titration  and  detection  by  EPR 
spectroscopy  was  carried  out  in  collaboration  with  Dr.  Fraser  MacMillan  and  Dr.  Klaus 
Zwicker. The titration of the redox states of the QFR's FAD and iron-sulfur clusters from W. 
succinogenes,  C.  jejuni  and  H.  pylori  was  performed  essentially  as  described  by  Dutton 
(Dutton, 1978). A solution of purified protein (60-75 µM) was stirred at 298K in an anaerobic 
reaction  vessel.  The  following  redox  mediators  were  added  to  the  protein  solutions: 
tetramethyl-phenylene-diamine,  phenazine-methosulfate,  methylene  blue,  menadione, 
resorufin,  indigotrisulfonate,  1,2-naphthoquinone,  2-hydroxy-1,4-naphthoquinone, Section 2.5: Protein Characterization 
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phenosafranine, benzyl viologen, and methyl viologen, resulting in a final concentration of 
35 µM each. The redox potential of the solution was monitored by a redox micro-electrode 
and adjusted to selected values by addition of small aliquots of a 50 mM sodium dithionite 
solution.  At  appropriate  redox  potentials,  80  µl  aliquots  of  protein  sample  were 
anaerobically  transferred  into  an  argon  flushed  EPR  tube,  frozen  at  ~120K  in  a  cold 
isopentane/methylcyclohexane mixture (5:1) and stored in liquid nitrogen. The degree of 
reduction of individual redox centers was monitored by cw-EPR spectroscopy under non-
powersaturating conditions, using a Bruker spectrometer E500 or ESP300 (Bruker) equipped 
with a continuous flow liquid helium cryostat (Oxford Instruments) set at 50K and 10K for 
the FAD and iron-sulfur clusters, respectively. The conditions adopted are listed in Table 
2-XV. Due to overlapping signals arising from FAD and mediators, the FAD titration data 
were normalized by subtracting the EPR intensities generated by titration of a protein-free 
solution of buffer and mediators. FAD redox midpoint potentials were calculated by fitting 
with a double Nernst equation (Equation 2-1, Hägerhall, et al., 1999, Sato-Watanabe, et al., 
1995). From the experimental conditions, an error/approximation of about ± 10 mV can be 
considered.  Radical  formation  of  FAD  was  quantified  by  calculating  the  ratio  of  the 
integrated  areas  of  the  maximum  intensity  peak  obtained  from  FAD  and  the  iron-sulfur 
cluster  S1  (fully  reduced).  The  titrations  of  the  iron-sulfur  clusters  were  fitted  with  the 
Nernst equation (Equation 2-2). 
 
 
Table 2-XV: EPR spectroscopy parameters used for the measurement of the QFR 
cofactor’s radical species. 
Radical species:  FAD  S1 and S3  S2 
Temperature (K)  50  10  10 
Microwave power (dB/mW)  20/2  20/2  3/100 
Amplitude (Gpp)  2  2  10 
Modulation frequency (kHz)  100  100  100 
 
 
( ) [ ] ( ) [ ] { }
1 89 . 16 89 . 16
max
2 1 10 10 1
− × − × − + + × =
h m m h E E E E I Abs  
 
Equation 2-1: Double Nernst equation for the calculation of the oxidation-reduction (redox) midpoint 
potential  values  of  the  FAD.  Parameters:  Abs,  absorbance;  Imax,  max  absorbance  intensity;  Eh,  redox 
potential (V); Em1, redox midpoint potential of the first electron reduction; Em2, redox midpoint potential of 
the second electron reduction. 
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( ) [ ] { }
1 89 . 16
max 10 1
− × − + × =
m h E E I Abs  
 
Equation 2-2: Nernst equation for the calculation of the redox midpoint potential values of the iron-
sulfur clusters. Abs, absorbance; Imax, max absorbance intensity; Eh, redox potential; Em, redox midpoint 
potential. 
 
2.5.2.  Electrochemistry and FTIR/VIS-spectroscopy 
For both FTIR and vis-spectroscopy, the QFR sample in phosphate buffer (100 mM, pH 7), 
containing 100 mM KCl and 1.0 mM LM was concentrated to approximately 1.0 mM by 
using a 100 kDa Microcon filtration cell. The experimental work of heme titration by vis-
spectroscopy (Lancaster, et al., 2000) and the FTIR-spectroscopy analysis (Haas, et al., 2005) 
was carried out in an ultra-thin-layer spectroelectrochemical cell by Alexander Haas (Haas, 
2004).  
The redox midpoint potentials of heme bH (high potential) and heme bL (low potential) were 
obtained using a double Nernst equation (Equation 2-3). The error in the determination of 
the midpoint potentials can be estimated to be ± 10 mV. 
 
 
( ) [ ] { } ( ) [ ] { }
1 72 . 41
max
1 72 . 41
max 10 1 10 1
− × − − × − + × + + × =
mH h mL h E E
H
E E
L I I Abs
 
Equation  2-3:  Double  Nernst  equation  for  the  calculation  of  the  heme  redox  midpoint  potentials. 
Absorbance intensities are always referred to a reference spectrum (see text). Abs, absorbance; Eh, redox 
potential; L, low potential (distal) heme; H, high potential (proximal) heme; Imax: max absorbance intensity; 
Em, redox midpoint potential. 
 
2.5.3.  Mass spectrometric analysis of hemes 
The heme b cofactors were extracted (Lubben & Morand, 1994) from the purified labeled and 
unlabeled QFR. A volume of 50 µl of QFR sample at a concentration of about 20 mg/ml was 
thoroughly mixed with 0.45 ml of an acetone/HCl mixture (19:1, v/v) in clean glass tubes 
(washed with acetone, or chromic mix etc.), kept at RT for 20 min, and centrifuged (5000 g, 2 
min). The supernatant was treated with 1 ml of ice-cold water and 0.3 ml of ethyl acetate. Section 2.5: Protein Characterization 
44 
After thoroughly vortexing and centrifuging, the supernatant underwent another cycle of 
extraction with 0.3 ml of ethyl acetate. After solvent evaporation in a speed-vacuum, the 
extracted hemes were re-dissolved in 50 µl acetonitrile. The measurements at the MALDI 
TOF mass spectrometer were carried out by Dr. Ute Bahr, in the department of Prof. Michael 
Karas, and described in Mileni, et al., 2005a. 
2.5.4.  Native quinone quantification 
The  native  quinone  quantification  was  performed  as  described  (Unden,  1988).  The 
menaquinone (MK6) and methyl-menaquinone (MMK6) were extracted by adding the protein 
(1 volume, aqueous solution) to a solvent mixture 1:1 of methanol and petroleum benzine (2 
volumes + 2 volumes), and vigorously shaking at 37°C for 15 min After adding acetone (2 
volumes), the shaking step was repeated. The two phases were then left for 10 min on ice 
and subsequently centrifuged (3000 g, 5-10 min). The organic solvent, which contained the 
dissolved  quinones  was  then  evaporated  and  replaced  by  a  mixture  of 
acetonitrile/isopropanol in a ratio of 6.5:3.5 and loaded into a HPLC column (LiChroCART 
250-10,  LiChrosorb  RP-18  column,  Merck)  for  separation  and  quantification  with  a  UV 
detector. The standard curve was derived from a commercially available menaquinone MK4 
(Vitamin K2).  
2.5.5.  Lipid analysis 
2.5.5.1.  2D thin layer chromatography (TLC) 
Approximately 3 µl of enzyme sample (15-20 mg/ml) after IEF or after gel filtration was 
applied  to  thin  layer  silica  plates  (Kieselgel  60,  Merck).  The  mobile  phase  of  the  first-
dimension migration was a mixture of 13 ml chloroform, 5 ml methanol and 0.8 ml water. 
The  mobile  phase  of  the  second-dimension  migration  was  a  mixture  of  chloroform, 
methanol, and 25 % ammonia (13:7:1 v/v/v). A non-specific staining was carried out at first 
with iodine vapor and the developed smears were marked with a pencil. Subsequently, the 
TLC  plates  underwent  specific  staining  by  spraying  either  with  a  solution  1.3  % 
molybdenum  oxide  in  4.2  M  sulfuric  acid,  for  staining  of  phosphorous-containing 
compounds; or with α-naphthol (0.05 g dissolved in 10 ml methanol-water 1:1) for glycolipid 
staining; or with ninhydrin (1 g dissolved in 100 ml acetone), for the staining of nitrogen-
containing compounds. Up to 5 µmol of synthetic lipids (sodium salts, Avanti Polar Lipids, 2. Materials and Methods 
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Table 2-V) were applied on the standard TLC plates. In the case of the standard calibration 
assay, the 2 dimensions were tested separately in two different plates. 
2.5.5.2.  MALDI TOF mass spectrometry 
 Analysis of lipids by mass spectrometry (MS) was attempted on IEF-purified QFR samples 
adopting  three  different  approaches  depending  on  the  level  of  lipid  isolation.  The 
measurements were performed by Dr. Ute Bahr and Prof. Michael Karas. 
2.5.5.2.1.  Whole protein analysis 
The  protein  sample  was  diluted  in a buffer  (pH  7.4)  containing 10 mM  Tris-HCl, 2 mM 
fumarate and 0.03 % LM. Up to 10 pmol of protein were loaded into the mass spectrometer, 
either directly after dilution or mixed with acetonitrile to a ratio of 1:1 (Distler, et al., 2004). 
2.5.5.2.2.  Methanol-chloroform extraction  
In  this  procedure  (Patton  &  Robins,  1998,  Folch,  et  al.,  1957)  one  volume  of  the  protein 
sample (10-20 mg/ml) was treated with 19 volumes of a chloroform/methanol (2:1 v/v) 
mixture, saturated with nitrogen, shaken vigorously and sonified. After adding 0.2 volumes 
of 0.9 % NaCl and shaking, the biphasic mixture was centrifuged (2000 g, 10 min). The upper 
phase (methanol/water) was discarded and the lower phase (chloroform) was transferred by 
a glass Pasteur pipette into a new tube, concentrated (speed-vacuum) and used for MS, or 
stored at –20°C. Every step was carried out with glass tools and in glass tubes. 
2.5.5.2.3.  Lipid isolation by TLC 
The hydrophobic substances isolated by TLC and appearing as smears in the TLC plate were 
removed by selectively scraping these silica patches and collecting the material in a glass 
tube. The lipids contained in the collected silica gel were separated by extraction with a 
chloroform/methanol  (2:1  v/v)  mixture.  This  sample  was  concentrated  by  evaporation 
(speed-vacuum)  and  used  for  MS  analysis.  Tandem  MS-MS  was  performed  on  the 
prominent peaks appearing in the 600-1700 Da range. Section 2.5: Protein Characterization 
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2.5.5.3.  High pressure liquid chromatography 
The  protein  sample  underwent  methanol-chloroform  extraction  as  described  above.  The 
automatic sampler loaded 15 µl of the extracted portion into a LaChrome HPLC coupled to a 
Sedex  75  ELS  detector.  The  HPLC  chromatography  column  (LiCroSphere  Si60)  could 
separate lipids with different polar head groups using a gradient of two solvent mixtures of 
chloroform, methanol and 32 % ammonium hydroxide (90:10:1 and 20:80:1, respectively). 
Typical  operating  pressures  ranged  from  80  to  95  bars  (1  ml/min  flow).  Prior  to  every 
experiment,  standard  calibration  was  accomplished  by  making  a  pair  of  runs  with  a 
chloroform-dissolved  standard  mixture  of  cardiolipin,  phosphatidylethanolamine, 
phosphatidylinositol, phosphatidic acid, phosphatidylcholine, phosphatidylserine and DM.  
2.5.6.  Analytical ultracentrifugation (AUC) 
The  QFRs  from  C.  jejuni,  H.  pylori  and  W.  succinogenes  that  were  used  in  analytical 
ultracentrifugation  experiments  were  prepared  as  described  above.  For  sedimentation 
velocity experiments, the samples were diluted to a final concentration of 0.35 mg/ml using 
a buffer containing 20 mM HEPES, 1 mM EDTA, 20 mM fumarate, 0.1% DM and 0.01% LM). 
The  AUC  experiments  were  carried  out  by  Dr.  Christos  Tziatzios  and  are  described  in 
Mileni, et al., 2005b. 
2.5.7.  Functional characterization 
2.5.7.1.  Enzymatic activities 
All spectrophotometer measurements were performed with an Agilent Spectrophotometer. 
The enzymatic velocity was calculated using the slope calculated by the Agilent software 
imposing  a  zero-order  reaction.  The  activity  units  are  defined  as  equivalent  to  µmols  of 
product produced per minute. 
2.5.7.1.1.  Quinol:fumarate reductase 
The samples containing isolated QFR were diluted to a concentration of 0.5-1.0 mg/ml in a 
nitrogen-saturated buffer containing 20mM HEPES, 1mM EDTA, 2 mM malonate, 0.01% LM 
and 0.1% DM, and subsequently incubated at 37°C for 30 minutes. Volumes of 4-8µl were 
added to the assay mixture. All enzymatic assays were performed in nitrogen saturated 25 2. Materials and Methods 
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mM potassium phosphate buffer at pH 7.3. Three different kinds of enzymatic assays were 
performed  using  photometric  recording  at  37°C  in  0.5-cm-path-length  degassed  quartz 
cuvettes: 
 
A.  “MB  assay”,  radical  methylene  blue  (0.2  mM,  ε578:  17.5  mM
-1  cm
-1)  reduction  by 
succinate (10 mM) (Kröger, et al., 1979, Kröger, et al., 1980) 
B.  “BV assay”, dithionite-reduced (radical) benzyl viologen (1 mM, ε546: 19.5 mM
-1 cm
-1) 
oxidation  by fumarate  (10  mM) (Kröger & Innerhofer,  1976b,  Unden  &  Kröger, 
1986) 
C.  “DMNH2 assay”, 2,3-dimethyl-1,4-naphthoquinol (DMNH2, 0.2 mM) oxidation by 
fumarate (1 mM) 
 
Figure 2-2: Graphical representation of 
the three different enzymatic assays on 
the QFR. The blue arrow represents the 
electron  direction  during  catalytic 
activity.  The  membrane  limits  are 
shown  as  gray  dotted  lines;  cyt, 
cytoplasm;  perip,  periplasm;  succ., 
succinate; fum., fumarate. 
 
 
 
 
 
 
Whereas the first two assays (A and B) are independent of the membrane-integral subunit C, 
the  third  (C)  represents a  total  activity  assay, and is  subunit  C-dependent. The  different 
kinds of enzymatic activity assays can also be classified as succinate-oxidizing (Figure 2-2-A) 
or  fumarate-reducing  (Figure  2-3-B  and  -C)  depending  on  the  direction  of  the  electrons 
within the complex.  
Reduction  of  DMN  was  performed  either  by  NaBH4  (“BH4-DMNH2  assay”)  (Lancaster, 
2003b, Unden, et al., 1980), or by a coupled reaction with DT-diaphorase and NADH (“DT-
DMNH2 assay”) (Grivennikova, et al., 1993). In the former method, the enzymatic reaction 
was monitored by measuring the DMNH2 (re-)oxidation as the absorbance difference of 270-
minus-290 nm (∆ε270-290: 15.0 mM
-1 cm
-1). Alternatively, the catalytic reaction can be measured 
with the “low-sensitivity-BH4 assay”, which consists of monitoring the fumarate reduction at 
the same wavelengths (270-290 nm) after adding an eccess of NaBH4 (ε270-290: 0.45 mM
-1 cm
-1). 
succ. / fum.  C 
perip 
cyt 
DMNH2 
B  A 
Fe/S 
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Although  this  last  procedure  was  33.3  times  less  sensitive  than  monitoring  the  DMNH2 
oxidation, the reaction course was linear over far longer periods of time. The “DT-DMNH2 
assay”was instead used for the calculation of QFR maximum velocities, Michaelis constants 
(KM) and inhibitor constants (Ki). Here, the enzymatic activity was indirectly determined by 
adding  to  the  assay  mixture  ~400  µM  NADH  (ε340:  6.29  mM
-1  cm
-1)  and  rat  liver  DT-
diaphorase (20 µg/ml), and by measuring NADH disappearance at 340 nm. 
2.5.7.1.2.  Hydrogenase 
D.  “hydrogenase assay”, DMN reduction by oxidation of H2 
The activity of the hydrogenase (HydCAB, EC 1.12.5.1) from W. succinogenes was measured 
using the same conditions as described for the “BH4-DMNH2 assay”, except that the electron 
donor substrate was added by saturating the buffer with H2 instead of adding NaBH4.  
2.5.7.1.3.  Electron transport activity (QFR and Fdh) 
This assay measured the respiratory chain activity that leads to the reduction of fumarate by 
the oxidation of formate (Unden & Kröger, 1986). The W. succinogenes WT and the strains 
expressing the frdCAB operons from C. jejuni and H. pylori were grown in one liter cultures 
until late exponential phase, and harvested. The membranes were prepared as described 
earlier (chapter 0) and resuspended in HEPES buffer (50 mM, pH 7.5). 
 
E.  “ETC assay”, formate (10 mM) oxidation by fumarate (2 mM) reduction (ε270-290: 0.45 
mM
-1  cm
-1)  The  fumarate  disappearance  was  recorded  identically  to  the  “BH4-
DMNH2 assay”, but using an extinction coefficient of ∆ε270-290: 0.45 mM
-1 cm
-1 
F.  “Fdh assay”, formate (10 mM) oxidation by DMN (ε270-290: 15.0 mM
-1 cm
-1) reduction 
 
“DT-DMNH2  assay”  was  used  to  measure  the  QFR  activities  directly  on  the  membrane 
preparations. The theoretical electron-transport activities of the formate-fumarate respiratory 
chain  were  also  calculated  following  the  two  independent  catalytic  activities  using  the 
Kröger-Klingenberg equation: 
 
VET = VFdh VQFR (VFdh + VQFR)
-1 
 
Equation 2-4: Kröger-Klingenberg equation (Kröger & Klingenberg, 1973). VET, electron transport activity; 
VFdh, Fdh activity; VQFR, QFR activity.  
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2.6.  3D-Crystal Structure Determination 
2.6.1.  Crystallization 
After purification, the enzyme at a concentration of 20 mg/ml or higher was in a buffer at 
pH 7.4 containing 20 mM HEPES, 1 mM EDTA and 20 mM fumarate, 0.1 % DM and0.01 % 
LM. The sample was then supplied with some additives: an oxidant (2 mM K3Fe(CN)6), the 
quinone substrate (2 mM vitamin K2), and a small amphiphile (2.4-4.8 % benzamidine or 3.0-
6.0 % heptane-1,2,3-triol). After mixing of such prepared enzyme with the reservoir solution, 
the crystallization mix underwent a centrifugation step (15’000 g, 2 min). The crystals were 
mainly  obtained  by  vapor  diffusion  (sitting  drops  and  hanging  drops).  Only  the  phase 
diagrams were obtained from micro-batch trials. Crystallization screenings were performed 
using a crystallization robot in Greiner sitting drop plates (CrystalQuick 96-well standard 
profile - round bottom), where the overall protein droplet volume was of 1 µl (500 nl enzyme 
sample + 500 nl reservoir). The screening reservoir solutions were purchased either from 
Hampton  Research,  or  Jena  Bioscience,  or  Sigma,  or  Molecular  Dimensions  Ltd.  When 
needed, larger amounts of reservoir solutions were self-prepared using bi-distilled water 
and filtered (0.2 µm cut-off). The hanging drop technique consisted of 1 µl of the reservoir 
mixed  with  1-1.5  µl  of  the  protein  solution  on  silanized  cover  slides  (2  % 
dichlorodimethylsilane in trichloroethane and washed in ethanol 100 %). Sitting-drop trials 
were also carried out in 24-well plates equipped with micro-bridges (round bottom, 12µl 
capacity) or boxes equipped with 1 or 2 bridges with 3-drop positions (50 µl capacity each). 
The bridges were glued to plastic boxes or 24-wells plates with ethyl acetate. When required, 
crystal nucleation was triggered by the microseeding or streaking techniques. For the micro-
batch crystallization, the reservoir was mixed with the protein sample under a layer of Al’s 
oil (paraffin oil and silicon oil, 1:1) in 72-well microbatch plates. Ultracentrifugation of the 
crystallization sample prior to incubation was carried out in an Optima MAX UC (~170’000 
g,  30  min,  4°C).  The  protein  detergents  LM  and  DM  were  exchanged  with  either  0.1  % 
LDAO, or 0.04 % UM, or 0.015 % Thesit, or 0.01 % LM, or 0.1 % DM, or 0.6 % OG. Small-scale 
detergent exchange was performed by Vivapure Q (quaternary ammonium) resin maxi (60-
80 mg capacity). This procedure did not have any effect on the enzymatic activity of the 
enzymes. The presented X-ray crystal structure was obtained using from a crystal of about 4 
x 1.5 x 0.1-0.2 mm size and grown with the following conditions (Table 2-XVI): 
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Table 2-XVI: Crystallization conditions that lead to the 3D-crystal structure determination of 
the C. jejuni QFR. 
Protein concentration:   28 mg/ml 
Purification grade  Gel purification 
Protein buffer  HEPES, EDTA, fumarate, LM, DM (see above) 
Oxidizing agent  1 mM K3Fe(CN)6 
Substrate  Vitamin K2 (MK4) 
Buffer, pH  0.1 M ADA/NaOH, pH 6.5 
Precipitant  12 % PEG 4000 
Salt  0.1 M LiSO4 x H2O 
Small amphiphile  Heptane-1,2,3-triol 
Seeding  No 
Drop volume  50 µl 
Reservoir volume  8 ml 
Temperature  18°C 
Incubation time  ~6 weeks 
 
2.6.2.  Data collection 
Data sets from the C. jejuni QFR crystals were collected at 4°C in the beamline ID14-EH1 of 
the ESRF synchrotron light source (Figure 2-3, www.esrf.fr, Grenoble, France) and in the 
beamline X11 of the DESY synchrotron light source (www.desy.de/html/home/, Hamburg, 
Germany). 
 
 
A 2. Materials and Methods 
51 
 
 
Figure 2-3: The beamline ID14-EH1 at the ESRF. The control room (A) and the hutch (B) are shown. 
 
 
For transportation, the crystals were harvested from the crystallization drop and placed in 
eppendorf tubes containing the soaking buffer (i.e. in a solution equivalent to the mother 
liquor). Just prior to x-ray exposure, the crystals were extracted from the soaking buffers, 
placed in glass capillary tubes partially filled with the soaking buffer and sealed with wax.  
 
 
 
Figure 2-4: Crystal transportation and mounting. Crystals (indicated by the arrow) were transferred from 
the crystallization plate (7.5-cm-diameter round box at the right-top of the picture) to eppendorf tubes 
containing  soak  buffer  (bottom)  and  transported  to  the  synchrotron  location.  The  crystals  were  then 
transferred into glass capillary tubes and sealed with wax (left-top). 
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The capillaries were then mounted on a goniometer with plasticine and aligned to the x-ray 
beam. Due to radiation damage, and thus diffraction decay, crystal translations equal to the 
beam size (0.08 mm) through the x-axis were generally executed every 10 images. The back 
up of data sets was carried out on DLT tapes and laptop PCs. 
The dataset that produced the crystal structure presented here was collected at the beamline 
ID14-EH1. The parameters under which the data set has been collected are summarized in 
Table 2-XVII. 
 
Table 2-XVII: Data set collection parameters at the beamline ID14-EH1. 
N° of images  195 
Oscillation angle  1° 
Exposure time (no attenuation)  6 seconds 
Number of passes per frame  2 
Detector distance  300.00 mm 
Max resolution  3.14 Å 
Vertical slit aperture  0.08 mm 
Horizontal slit aperture  0.08 mm 
Wavelength (fix)  0.934 Å (13.270 keV) 
 
 
2.6.3.  Data processing and refinement 
HKL package, which includes the software XdisplayF, Denzo, and Scalepack (Otwinowski & 
Minor, 1997), was used for viewing the diffraction patterns, indexing and processing the 
data  set.  The  phases  were  calculated  by  PD  Dr.  C.  Roy  D.  Lancaster  by  molecular 
replacement  using  the  W.  succinogenes  QFR  (PDB  entry  code  2BS2,  Lancaster,  C.R.D., 
unpublished) as a search model.  
The atomic model of the QFR from C. jejuni was built using the program O (Jones, et al., 
1991). Model refinement, including simulated annealing and grouped
d B-factor refinement, 
was performed using the “Crystallography & NMR system” (CNS) package (Brunger, et al., 
1998).  
 
 
                                                
d Single amino acids were divided in two groups, i.e. main chain and side chain.  
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3.  RESULTS 
3.1.  H. pylori and C. jejuni QFR Studies 
3.1.1.  Plasmid construction and insertion of the QFR operons from H. 
pylori and C. jejuni into the W. succinogenes genome 
The heterologous expression of frdCAB loci from C. jejuni or H. pylori in W. succinogenes is 
based on the restoration of an intact frdCAB operon in the genome of the deletion mutant W. 
succinogenes ∆frdCAB (see section 1.3.2). The strategy for plasmid construction consisted of 
ligating a vector derived from pFrdcat2 (Simon, et al., 1998) to the PCR-amplified frdCAB 
operon  from  H.  pylori  or  C.  jejuni.  The  frdCAB  operons  were  amplified  using  H.  pylori 
genomic DNA and whole C. jejuni cells (colony-PCR) and the oligonucleotide primers C. 
jejuni_Fw/Rv or H. pylori_Fw/Rv, respectively. The PCR products contained the entire frdC, 
-A and -B genes excluding the frdC start codon and the frdB stop codon. The vector was also 
amplified by PCR, using the synthesized pFrdcat2 Fw/Rv oligonucleotide primers and the 
pFrdcat2 (Simon, et al., 1998) as template. The amplified vector contains the chloramphenicol 
resistance gene (cat), the origin of replication site for E. coli, the promoter and terminator 
regions including start and stop codons of the homologous W. succinogenes QFR operon, and 
a region (named “H”) for homologous recombination in the genome of the ∆frdCAB deletion 
strain (Figure 3-1). 
 
 
 
 
 
 
 
 
 
 
Figure 3-1: Maps of the PCR-amplified DNA fragments used for cloning. Markers, restriction sites and 
coding regions are indicated. The terms “pro.” and “ter.” stand for promoter and terminator, respectively. 
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The primer pairs used for amplification contained suitable restriction sites at their 5´-ends 
(Table 2-VI): the restriction sites ClaI and AvrII were added after the start codon “ATG” and 
before the stop codon “TAA”, respectively, to clone the heterologous operons in frame with 
the expression vector. Therefore, due to the cloning procedure four amino acids (Ile-Asp at 
the amino terminus of FrdC, and Pro-Arg at the carboxy terminus of FrdB) were inserted 
into the WT enzymes. The C. jejuni and H. pylori frdCAB operons contained in the plasmids 
pCatCj4 and pCatHpG8 (Figure 3-2), respectively, were sequenced. Whereas the H. pylori 
QFR operon did not undergo any undesired mutation, it was found that the FrdCAB of the 
C. jejuni clinical isolate differs from the FrdCAB of the C. jejuni NCTC11168 (Parkhill, et al., 
2000) by 84 nucleotides (see appendix). Interestingly, nearly all of these operon mutations 
were silent, since there were only five amino acid changes after translation. The determined 
frdCAB sequence from pCatCj4 was deposited in the databank under accession no. AJ628040. 
 
 
 
 
 
 
 
 
 
 
 
Figure  3-2:  Map  of  the  constructed  plasmids  containing  the  H.  pylori  and  C.  jejuni  QFR  operons. 
Restriction sites, coding regions and relevant regions are indicated. 
 
 
The ∆frdCAB deletion mutant strain of W. succinogenes was transformed by electroporation 
with  the  constructed  plasmids  described  above.  The  homologous  non-reciprocal 
recombination occurring by a single crossing –over is graphically illustrated in Figure 3-3. A 
few hundred clones grew in the selection agar medium plates containing chloramphenicol at 
concentrations of 12.5 and 25.0 mg/l
e. Approximately 35 clones were analyzed by PCR using 
the primers 2_Integr.check and CatCj_seq19 or HpG_probe_Rv: three clones contained a C. 
jejuni QFR operon whereas ten clones contained a H. pylori QFR operon. In order to verify 
                                                
e The amount of antibiotic was increased to minimize false positive clones (see section 2.1.6). 
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the  insertion  of  the  appropriate  operon,  the  species-specificity  of  the  primers  was 
demonstrated, as PCR cross-reaction did not occur. In contrast to the starting W. succinogenes 
deletion mutant strain ∆frdCAB, these clones were all capable of growth on a rich medium 
with fumarate as a sole terminal electron acceptor. After determination of the doubling times 
by growth cultures, three clones were selected
f for expression and named WsHpGM31 and 
WsHpGM33, containing the H. pylori QFR operon, and WsCjM11, containing the C. jejuni 
QFR operon. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3: Illustration of the integration of the plasmid constructs into the genome of W. succinogenes. 
 
 
After  genomic  extraction  of  the  recombinant  clones,  plasmid  integration  into  the  correct 
genomic locus was further verified by Southern blotting analysis of the HindIII-digested 
genome, using two PCR-synthesized labeled probes complementary to the upstream region, 
                                                
f The isolated clones characterized by lower doubling times were discarded. 
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inside the QFR operon, and to the downstream region of recombination, at the cat locus 
(Figure  3-4):  the  two  different  labeled  probes  appear  to  bind  to  DNA  fragments  of  the 
expected size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3-4:  Maps  of  the  genomic  QFR  locus  after  integration.  WsHpGM31  and  WsCjM11  are  the 
recombinant  strains  of  W.  succinogenes  that  have  been  transformed  with  the  plasmid  pCatHpG8  and 
pCatCj4, respectively. R, restriction sites (HindIII), “H”, homology regions for recombination. 
 
 
Unfortunately, the upstream region of integration for the C. jejuni QFR-containing plasmid 
could  not  be  verified  as  the  Hind  III  restriction  sites  were  too  close  to  the  upstream 
integration site for an efficient pairing of the labeled probe. For this reason, only the results 
from  the  WsHpGM31  and  WsHpGM33  strains  are  shown  (Figure  3-5).  Cross-reactions 
between labeled probes was tested as a negative control, and again ensured correct species-
identification of the inserted heterologous QFR. Together with the expected bands at about 
5.0 kb (upstream integration) and 2.2 kb  (downstream  integration), two other prominent 
bands appeared at 4.2 kb
g. 
 
 
 
                                                
g This size corresponds to the DNA fragments containing the H. pylori QFR operon or the cat gene after 
digestion of the pCatCj4 plasmid with the restriction enzyme HindIII. 
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Figure 3-5: Southern blot analysis. L, molecular 
mass standard; A and C, WsHpGM31; B and D, 
WsHpGM33;  A  and  B,  hybridization  with  the 
upstream  (QFR)  labeled  probe;  C  and  D, 
hybridization with the downstream (cat) labeled 
probe;  E,  positive  control  made  with  the 
recombinant K4 QFR (Simon, et al., 1998). 
 
 
 
3.1.2.  Properties of W. succinogenes strains expressing the heterologous 
frdCAB operons 
The mutants W. succinogenes CjM11 and HpGM31/33 express the respective frdCAB operons 
from  C.  jejuni  and  H.  pylori  under  the  control  of  the  W.  succinogenes  frd  promoter  and 
terminator. These mutants contain a single copy of the frdCAB locus on the genome that 
replaces the genuine frdCAB operon of W. succinogenes WT cells. In contrast to the parental 
strain  W.  succinogenes  ∆frdCAB,  the  CjM11  and  HpGM31/33  strains  grow  by  fumarate 
respiration, albeit at slightly longer doubling times compared to the WT (Table 3-I). The cell 
yield for growth by fumarate respiration was found to be identical in the three strains (not 
shown). Light microscopy (400x) observation of the two strains grown in rich medium did 
not  reveal  any  difference  in  motility  or  cell  morphology  as  compared  to  the  WT  W. 
succinogenes.  Table  3-I  shows  the  specific  fumarate  reductase  activities  measured  in  cell 
fractions of the strains using various enzyme activity assays. 
In order to examine the possibility that this longer doubling time in the HpGM31/33 strains 
corresponded  to a lower  efficiency  of the respiratory  chain,  the  electron  transfer  activity 
between Fdh and QFR of cell membranes was measured and is presented in section 3.1.4.4.1. 
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Table 3-I: Doubling times and specific fumarate reductase activities of W. succinogenes strains. The cells 
were grown by fumarate respiration either in minimal or rich medium. The specific activities were based on 
cells grown in rich medium. 
 
DSMZ 
1740 
WsCjM11  WsHpGM31 
Doubling time (h)       
in rich medium  1.0  1.2  1.9 
in minimal medium  2.0  2.3  3.0 
Specific fumarate reductase activity (U mg
-1)       
Succinate ￿ methylene blue       
Cell homogenate  0.7  0.2  0.8 
Membrane fraction  1.4  0.4  1.1 
Soluble fraction  ≤0.03  ≤0.02  ≤0.02 
DMNH2 ￿ fumarate       
Cell homogenate  2.3  1.2  2.4 
Membrane fraction  3.2  2.1  3.4 
Soluble fraction  ≤0.05  ≤0.04  ≤0.05 
 
3.1.3.  Protein purification 
The two heterologous frdCAB operons inserted in W. succinogenes were expressed for large-
scale membrane protein preparation. As monitored with the “MB assay”, the specific activity 
of cell homogenates was about 0.2-0.3 U mg
-1 (total volume 233 ml, 72 g cells) for CjM11 and 
0.7-0.8 U mg
-1 (255 ml, 105 g cells) for HpGM31. The same assay performed on the cytosolic 
fraction after the first ultracentrifugation of the membranes was found to give negligible 
values (see Table 3-I). After anion exchange chromatography, about 14 to 18 fractions were 
pooled, usually consisting of fractions with an “MB assay” specific activity above ~4 U ml
-1. 
An  SDS-PAGE  of  the  fractions  confirmed  the  activity  results  (not  shown).  Further 
purification steps yielded a remarkable increase in the specific partial activity (“MB assay”) 
of the protein sample up to 12.3 U mg
-1 for H. pylori QFR and 7.3 U mg
-1 for C. jejuni QFR. 
However, a more relevant determination of the purification profile was accomplished by 
monitoring the specific activity of DMNH2 oxidation by fumarate (Table 3-II). 
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Figure  3-6:  The  QFR  purification  procedure:  anion  exchange  chromatography  (A),  and  preparative 
isoelectric focusing (B). The fumarate reductase (reddish band) was separated during elution from other 
membrane proteins (A). In the IEF gel, the theoretical pH established by the electric field is shown (B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-7: Chromatogram of the gel filtration purification. The curves show the absorbance course at 415 
nm (Soret band, red line) and 280 nm (black line). The bed volume of the chromatography column was 200 
ml. The minor ticks on the abscissa display the fraction volume, which corresponds to 0.8 ml. 
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Although  a  drastic  decrease  in  enzymatic  activity  of  the  H.  pylori  QFR  after  the  gel 
purification  (nearly  80  %) was  observed,  this purification  procedure  resulted in  a  purity 
factor of 8.1 and 5.1 for the C. jejuni and H. pylori QFR, respectively, with a final specific 
activity  of  9.7  U  mg
-1  for  C.  jejuni  and  12.2  U  mg
-1  for  H.  pylori  QFR  (see  Table  3-II). 
Nevertheless, as will be shown in chapter 3.1.4.2, the addition of certain lipids did have a 
striking effect on the enzymatic activity of the H. pylori QFR after gel filtration (Table 3-V). 
Alongside the purification profile based on enzymatic activity, protein purity was assessed 
by SDS-PAGE (Figure 3-8). Three bands represent the three subunits FrdA, B and C from the 
two QFRs with no major contamination and appropriate stoichiometric ratios, as inferred 
from  the  respective  band  intensities.  Based  on  the  amino  acid  sequences,  the  molecular 
weights of the H. pylori QFR subunits A, B, and C are 80.2 kDa, 27.6 kDa, and 28.8 kDa, 
respectively. The corresponding values for C. jejuni QFR subunits are 73.8 kDa, 27.5 kDa, 
30.3 kDa. As demonstrated by (Unden, et al., 1980), the QFR hydrophobic subunit C appears 
smallest in the SDS-PAGE experiment. Together with a general improvement in purity, the 
gel filtration step eliminated a contaminant protein of approximately 55-60 kDa. 
 
 
Table 3-II: Purification profile based on total specific activity (“DT-DMNH2 assay”). 
 
Total 
activity 
(U) 
Specific 
activity 
(U mg
-1) 
Protein 
yield 
(%) 
Purification 
factor 
Cell Homogenate  12.9 x 10
3  1.2  100  1.0 
Triton X-100 Homogenate  16.3 x 10
3  2.0  126  1.7 
Triton X-100 Extract  14.3 x 10
3  3.4  111  2.8 
Anion Exchange 
Chromatography 
4.2 x 10
3  7.3  33  6.1 
Isoelectric Focusing  1.6 x 10
3  9.3  12.4  7.8 
C
.
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Gel Filtration  0.78 x 10
3  9.7  6.0  8.1 
Cell Homogenate  40.9 x 10
3  2.4  100  1.0 
Triton X-100 Homogenate  43.8 x 10
3  3.8  107  1.6 
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Figure 3-8: SDS-PAGE of samples during purification. A-G, C. jejuni QFR samples; H-Q, H. pylori QFR 
samples. L, molecular mass standard (or “ladder”); A and H, cell homogenate; B and I, supernatant; C and 
M, Triton homogenate; D and N, Triton extract; E and O, anion exchange; F and P, isoelectric focusing; G 
and Q, gel filtration. 
 
3.1.4.  QFR enzymatic characterization 
3.1.4.1.  Cofactor analysis and redox midpoint potential determination 
FAD: Fluorescence associated with the A subunit band in an SDS polyacrylamide gel after 
electrophoresis illuminated with UV-light (Figure 3-9) demonstrated that the FAD prosthetic 
group is covalently bound to the respective A subunits of the H. pylori and C. jejuni enzymes. 
 
 
 
 
Figure  3-9:  FAD  fluorescence  under  UV-light 
exposure (A) after running an SDS-PAGE (B). L, 
molecular mass standard; 1-3, C. jejuni QFR; 4-5, 
W. succinogenes QFR; 6-8, H. pylori QFR. 
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Although redox characterization of flavin prosthetic groups can be accomplished by UV/VIS 
spectrophotometry, in this case the determination of the redox properties by this method 
was not feasible since its absorption spectrum was obscured by intense transitions from the 
heme b groups, which have far higher extinction coefficients. Therefore, the FAD (n=2) redox 
midpoint potential at pH 7.3 was determined by measuring the cw-EPR (X-band) signal of 
the flavin semiquinone (radical FAD
• ¯ state) as a function of the environmental potential. 
The  potential  was  adjusted by  performing a dithionite  titration  in  the presence  of redox 
mediators (see Materials and Methods). An FAD prosthetic group can exist in three redox 
active  states:  the  fully  oxidized  form,  which  is  diamagnetic  and  hence  EPR  silent;  the 
semiquinone (or one-electron reduced) form, which is paramagnetic and has a characteristic 
EPR spectrum; and the hydroquinone (or fully -two-electron- reduced) form, which is again 
diamagnetic and EPR silent. The peak intensity values at different potentials were plotted 
and the curve was fitted with a double Nernst function. Typical bell-shaped curves were 
obtained for this prosthetic group (Figure 3-10-B). In order to determine the two half-wave 
potentials, the signal yield of the FAD semiquinone state was required. Taking the fully 
reduced iron-sulfur cluster S1 as a reference, the signal yield values obtained for the FAD 
radicals were 9 %, 12 % and 7 % for W. succinogenes, C. jejuni and H. pylori QFR, respectively. 
These  ratios  did  not  change  when  the  titration  was  repeated  in  the  presence  of  10-fold 
vitamin K2 (MK4).  
 
 
 
 
 
 
 
 
 
 
Figure 3-10: Determination of the redox midpoint potential of the prosthetic group FAD by EPR. A 
typical EPR spectrum at 50K is shown (A). The intensity amplitudes were measured as indicated by the 
arrows. The double Nernst equation was used for fitting the data points (B). The three oxidation states and 
the structure of FAD are shown (left side). The magnetic field is measured in Gauss (G). The potential is 
always referred to the standard hydrogen electrode (SHE). 
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Iron-sulfur clusters: Redox midpoint potentials at pH 7.3 of the three iron-sulfur clusters 
S1, S2 and S3 (n=1) were also determined in the presence of mediators. A plot of the EPR 
signal against the potential was fitted with the standard Nernst function revealing a typical 
sigmoidal shape (Figure 3-11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11: Determination of the redox midpoint potential of the iron-sulfur clusters [2Fe-2S] (or S1), 
[4Fe-4S] (or S2) and [3Fe-4S] (or S3). EPR spectra at 10K (A, C, E) and fitting of the respective data points 
with the Nernst equation (B, D, F) are illustrated. Intensity amplitudes were measured as indicated by the 
arrows. The oxidation states and the structures of these coenzymes are shown (left side). 
 
[2Fe-2S]
2+/1+
3300 3450 3600
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Magnetic field (G)
A 
-0.2 -0.1 0.0 0.1
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Potential (V)
B 
-0.3 -0.1 0.0 0.1 0.3
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Potential (V)
3325 3350 3375 3400
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Magnetic field (G)
[3Fe-4S]
1+/0
E  F 
-0.5 -0.4 -0.3 -0.2
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Potential (V)
3000 3250 3500 3750
E
P
R
 
s
i
g
n
a
l
 
a
m
p
l
i
t
u
d
e
 
(
A
U
)
Magnetic field (G)
[4Fe-4S]
2+/1+ 
C  D Section 3.1: H. pylori and C. jejuni QFR Studies 
64 
Heme groups: Spectroscopic determination of the heme b content consisted of quantifying 
the absorption difference (∆Abs) at 565-minus-575 nm of the difference spectrum derived 
from the protein reduced-minus-oxidized redox states. These measurements have verified a 
heme to protein (monomer) stoichiometric ratio of 2:1. The redox midpoint potential of the 
heme  b  groups  were  determined  by  analyzing  electrochemically  induced  absorbance 
difference spectra by monitoring at the wavelengths of 428 nm (Soret-band) and 561 nm (α-
band). Two titrating groups, i.e. heme bH and heme bL, can be perfectly fitted with a double 
Nernst function in each of the curves. Within an error of 5%, the two hemes contributed 
equally  to  the  total  change  in  absorbance.  Taking  the  average  value  of  reductive  and 
oxidative titrations, the fitted curves yielded midpoint potentials of -129 mV and +1 mV for 
the low potential and high potential hemes of the C. jejuni QFR, and -106 mV and +8 mV for 
the low potential and high potential hemes of the H. pylori QFR. Monitoring the α-band and 
Soret-band yielded analogous titration curves and very similar redox midpoint potentials. 
As determined for the W. succinogenes QFR (Lancaster, et al., 2000), high potential values can 
be assigned to the proximal hemes, and the low potential values can be assigned to the distal 
hemes (Haas & Lancaster, 2004). As is known for W. succinogenes QFR (see e.g. Lancaster, et 
al., 2000), the interaction of the NaBH4-poised DMN with the enzymes
h showed that C. jejuni 
and  H.  pylori  QFRs  sustain  a  reduction  of  only  one  heme  out  of  two.  This  behavior  is 
interpreted as a release of one electron from the quinol via the distal heme, whose midpoint 
potential was –129/–106 mV, to the proximal heme, whose midpoint potential was +1/+8 
mV, confirming that an intramolecular electron transfer between the hemes is possible. 
 
 
 
 
 
 
 
 
 
Figure 3-12: Fitting of the titration curves for the determination of the heme redox midpoint potentials 
from the C. jejuni (A) and H. pylori (B) QFRs. The intersection points of the blue and pink lines with the 
fitting curves represent the heme redox midpoint potentials. 
 
                                                
h NaBH4 reduces the DMN to DMNH2 but not the enzyme. 
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3.1.4.2.  Analysis of native lipids co-purifying with the QFR 
3.1.4.2.1.  Lipid isolation by 2D thin layer chromatography 
An attempt was made to isolate and identify lipids co-purifying with the proteins on 2D TLC 
plates. Staining procedures allowed detection either of nitrogen, phosphorous, or glycolipid 
containing  compounds.  While  the  outcome  of  the  latter  staining  procedure  was  always 
negative,  except  for the  case  of  the  detergents  which  appear  as  black spots,  staining  for 
nitrogen and phosphorous allowed detection of several positive signals (Figure 3-13 A and 
B, respectively). 
 
 
 
 
 
 
Table 3-III: Redox midpoint potentials of all QFR cofactors from W. succinogenes (W.s.), 
C. jejuni (C.j.), and H. pylori (H.p.). The structures and the arrangement of the cofactors 
shown  on  the  left  side  of  the  table  are  based  on  the  W.  succinogenes  QFR  structure 
(Lancaster, et al., 1999). 
Cofactor 
W.s. QFR 
(mV) 
C.j. QFR 
(mV) 
H.p. QFR 
(mV) 
FAD  -125  -101  -70 
[2Fe-2S]  -112  -5  +26 
[4Fe-4S]  -340  -235  -260 
[3Fe-4S]  -61  +42  +33 
Proximal heme b  -9  +1  +8 
Distal heme b  -152  -129  -106 Section 3.1: H. pylori and C. jejuni QFR Studies 
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Figure 3-13: TLC trials of the C. jejuni (A) and H. pylori (B) QFRs after IEF. Spots appearing after iodine 
vapor  staining  are  pencil-encircled.  Nitrogen  staining  (A)  and  phosphorous  staining  (B)  are  shown. 
Symbols and abbreviations: +, staining-positive; -, staining-negative; det., detergents. 
 
 
All spots appeared to be positive in the phosphorous staining. Comparing the experiments 
shown above, although the migration of the spots was slightly different, the overall patterns, 
e.g. number of spots and staining results, were very similar. The only exception is spot n° 6, 
which  was  present  only  in  the  H.  pylori  QFR  and  turned  out  to  be  positive  for  both 
phosphorous and nitrogen staining. Spots no. 1, 3, and 5 were also positive for the nitrogen 
staining. The spots appearing black after applying the staining for glycolipids were classified 
as  “detergents”.  As  will  be  shown  below,  this  prediction  was  confirmed  with  the  MS 
analysis.  In  order  to  identify  the  lipidic  head-groups  of  the  migrated  spots,  most  of  the 
common lipids found in prokaryotic membranes were run in the TLC plate for standard 
calibration (Figure 3-14). However, because of the poor accuracy of migration, the precise 
identification of the isolated lipids/compounds was not possible. 
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Figure 3-14: TLC lipid standard. D1, first dimension; D2, second dimension; 1, DOPE; 2, 16:1 PC; 3, 18:1 
CA; 4, DOPG; 5, 16:1 PE; 6, DOPC; 7, DPPE; 8, DPPG; 9, DPPC; 10, Brain PS. As expected, lipids with the 
same head group have very similar retention factors. The two columns on the right represent phosphatidyl 
phosphoethanolamine  (PE)  and  phosphatidylglycerol  (PG)  treated  with  the  nitrogen  staining  (N)  and 
phosphorous staining (P). 
 
 
Thanks  to  the  standard  calibration,  it  was  possible  to  infer  that  only  the  compounds 
localized close to the detergent spots are possible lipidic compounds and to exclude those 
with very high retention factor.  
The  2D  TLC  was  also  performed  on  QFR  samples  after  gel  filtration  purification. 
Interestingly, in the H. pylori QFR sample almost every smear was either lost or too weak to 
be detected (Figure 3-15). 
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Figure 3-15: Portions of TLC trials of the C. jejuni (A) and H. pylori (B) QFRs after gel filtration. Det., 
detergents; the arrows are indicating detected smears. The dashed arrow indicates a weakly visible smear. 
 
 
3.1.4.2.2.  MALDI TOF mass spectrometry assessment for lipid identification 
The  MALDI  TOF  mass  spectrometry  method  was  chosen  for  the  identification  of  lipids 
bound  to  the  C.  jejuni  and  H.  pylori  QFR  purified  samples.  Three  approaches  were 
undertaken for the preparation of the analyzed samples (see Materials and Methods).  
1
st approach: whole protein analysis 
As a positive control for the instrument, approximately two molecules per monomer of a 
synthetic lipid (DPPC) were added to the protein solution and analyzed.  The presence of 
this phospholipid was confirmed with the appearance of two peaks at the correct masses of 
734.4 m/z (proton adduct) and 756.4 m/z (sodium adduct). Unfortunately, apart from the 
detergents DM and LM, which were identified as two peaks corresponding to 505.3 m/z and 
533.3 m/z (sodium adducts), respectively, it was not possible to assign any of the peaks 
obtained. In other words, none of the peaks found in the expected mass (m/z) range of 500-
1800 kDa were sufficiently strong to be investigated further. This negative result was also 
due to the persistence of a mild unpredictable contamination background. 
2
nd approach: analysis of the methanol-chloroform extract 
Similar to the previous approach, the identification of compounds was impossible. 
3
rd approach: analysis of the isolated compounds from 2D TLC 
The  identification  of  the  detergent  spots  in  the  TLC  plates  by  glycolipid  staining  was 
confirmed  by  mass  spectrometry  (Figure  3-16-A).  In  this  third  approach,  apart  from  the 
detergents, only spot n° 5 (in Figure 3-13) resulted in two strong peaks at 817.6 m/z and 
685.6 m/z (Figure 3-16-B). 
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Figure 3-16: MALDI TOF measurement of the extracted spots labeled “detergent” (A) and n° 5 (B). 
 
 
 
These specific target peaks underwent fragmentation by MALDI TOF tandem MS-MS, and, 
whereas the 685.6 m/z peak was readily recognized as polymeric dihydroxybenzoic acid 
(DHB) molecules (not shown), the second peak presented a fragmentation pattern that could 
not be interpreted (Figure 3-17). Moreover, many of the samples were contaminated with a 
polymeric  substance  having  a  molecular  weight  of  44  m/z,  most  likely  consisting  of 
polyethylene glycol. The origin of this contamination was not clear. Section 3.1: H. pylori and C. jejuni QFR Studies 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-17: Tandem MS-MS of the peak 817 m/z. 
 
 
 
3.1.4.2.3.  High-pressure liquid chromatography 
A further attempt to identify the lipidic species co-purifying with the H. pylori QFR consisted 
of an HPLC analysis of the purified sample after methanol-chloroform extraction. After a 
standard calibration, the peak retention times of the lipids added to the standard mixture 
(Table 3-IV) were annotated and compared to those obtained with the QFR sample extracts. 
 
 
Table  3-IV:  List  of  retention  times  obtained  from  the  standard  calibration  curve.  CA, 
cardiolipin; PE, phosphatidylethanolamine; PI, phosphatidylinositol; LM / DM, lauryl- and 
decyl-maltoside; PS, phosphatidylserine; PA, phosphatidic acid; PC, phosphatidylcholine. 
Lipid/Detergent 
 Polar Head 
Retention Time 
(min) 
CA  5.11 
PE  7.72 
PI  8.87 
LM / DM  9.68 
PS  ~10-11 (weak) 
PA  12.55 
PC  16.55 3. Results 
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Figure 3-18: HPLC chromatogram of the H. pylori QFR after extraction. The upright inset represents a 
magnification of the square highlighted in black. Retention times of the significant peaks are indicated. 
 
 
The strongest peak observed in the HPLC chromatogram (Figure 3-18) has a retention time 
of 10.0 min, and corresponds to maltoside detergents. A second prominent signal appears at 
a retention time of 5.20 min. Although this latter peak is somewhat broadened at its base, its 
retention  time  strongly  suggests  that  this  compound  is  cardiolipin.  The  presence  of 
cardiolipin  confirms  the  results  obtained  with  the  enzymatic  assays  (Table  3-V).  Indeed, 
addition of cardiolipin to the H. pylori QFR after gel filtration increased its enzymatic activity 
more than lipids  like PG and  PC,  which had less  effect on  the  H.  pylori  QFR enzymatic 
activity,  or  like  PE,  which  had  no  effect  at  all  (Table  3-V).  Furthermore,  addition  of 
cardiolipin  to  the  H.  pylori  QFR  crystallization  mixture  had  a  beneficial  effect  in 
crystallization trials (see crystallization section). The last peak detected is characterized by a 
very low intensity, and might correspond to phosphatidylethanolamine (7.84 min retention 
time). 
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Table  3-V:  Recovery  of  the  H.  pylori  QFR  enzymatic  activity  upon 
treatment  with  lipids  at  the  stoichiometric  ratio  of  5  molecules  per 
monomer. The results are shown in percentages and are referred to QFR 
sample after IEF purification. 
Added Lipid  Recovered Enzymatic Activity (%) 
None  20 
CA  154 
DPPE  22 
DPPG  70 
DOPC  147 
 
3.1.4.3.  Analytical ultracentrifugation 
The oligomeric state of QFR from all three organisms, C. jejuni, H. pylori and W. succinogenes, 
was studied  by sedimentation  velocity experiments  in combination with  Lamm  equation 
fitting. Figure 3-19 shows the analyses of sedimentation velocity experiments on the three 
QFR species, based on a continuous distribution model for s-values in the range between 0.5 
and 20 S. The partial specific volume,  v, of QFR in aqueous buffers, corrected for protein-
bound prosthetic groups, was calculated from its amino acid composition as 0.730 ml/g. The 
corresponding  v-value  for  the  mixed  decylmaltoside/dodecylmaltoside  micelles  was 
calculated assuming a weight ratio of the two detergents of 10/1. This led to v = 0.794 ml/g. 
All c(s)-distributions gave an excellent fit to the experimental data, exhibiting the presence of 
a well-defined sharp peak at approximately 8 S. In addition, the presence of small amounts 
of material with higher and lower sedimentation coefficients was suggested (Figure 3-19-B,-
C and-D). Since the relative area under a peak in the c(s)-distribution corresponds to the 
relative loading concentration of the respective species, it is concluded that the majority of 
the material is in the single peak at ~8 S. The area under this peak accounts for approx. 90 % 
of the total amount of protein in the sample for QFR from C. jejuni and from H. pylori, and 
for approximately 97 % for QFR from W. succinogenes.  
The  peak  at  ~8  S  is  clearly  resolved,  which  suggests  homogeneity  of  the  respective 
component.  The  experimental  A(r,t)  data  were  therefore  analyzed  using  solutions  of  the 
Lamm equation for a small number of discrete non-interacting species (Schuck, 2000). For 
QFR  from  the  first  two  bacteria,  terms  for  four  discrete  components  were  used  for  the 
calculation of sedimentation and diffusion coefficient of the ~8 S-peak, with starting s-values 
identical to those found by the c(s)-method. In the case of QFR from W. succinogenes the 
experimental  sedimentation  velocity  data  were  fitted  assuming  the  presence  of  a  single 3. Results 
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component. The fits were of very good quality. The results found for the main component of 
QFR from all three organisms were similar: the s- and D-values found for QFR from C. jejuni 
were 7.82 S and 2.15 ⋅ 10
-7 cm
2/s, respectively, those for QFR from H. pylori were 7.97 S and 
2.14 ⋅ 10
-7 cm
2/s, respectively, and those for QFR from W. succinogenes 7.50 S and 1.93 ⋅ 10
-7 
cm
2/s, respectively. The effective molar mass, Meff,c = Mc(1-v c⋅ρo)
i, of the protein/detergent 
complexes was calculated from their s- and D-values using the Svedberg equation (Cantor & 
Schimmel, 1980). It was obtained (83,000 ± 9,000) g/mol for the first complex, (85,000 ± 9,000) 
g/mol for the second and (88,000 ± 7,000) g/mol for the last one. It should be noted that the 
relatively large uncertainty of approx. 10 % in determining Meff,c has its origin mainly in the 
uncertainty of the D-value, which could be varied in the analysis by approx. 10% without 
significant increase of the rms error of the fit (Schuck, 1998). These results clearly indicate 
that  the  ~8  S-component  represents  the  same  state  of  association  of  QFR  from  either 
organism. 
 
 
Figure  3-19:  Sedimentation  velocity  analysis  on  QFR  from  C.  jejuni  (A,B),  H.  pylori  (C)  and  W. 
succinogenes (D). Experimental sedimentation velocity distributions (A) of the enzyme at different times 
(symbols) and best fit- distributions calculated using solutions of the Lamm equation based on the model of 
continuous  size-distribution  (solid  lines).  For  clarity  only  every  fourth  data  set  is  shown.  Best  fit- 
sedimentation coefficient distribution c(s) (B, C, D). 
                                                
i Where ρ is the density of the solvent; v is the partial specific volume Section 3.1: H. pylori and C. jejuni QFR Studies 
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3.1.4.4.  Functional characterization 
3.1.4.4.1.  Electron transfer activity 
The  specific  electron  transfer  activity  between  the  formate  dehydrogenase  and  fumarate 
reductase was tested on membranes of W. succinogenes expressing the QFR operon from W. 
succinogenes,  C.  jejuni  and  H.  pylori  by  the  establishment  of  an  electron  transfer  chain 
supported  by  native  menaquinone  (MK6  and  MMK6).  As  controls,  the  single  relative 
activities,  i.e.  formate  dehydrogenase  and  fumarate  reductase  activities,  were  measured. 
These results together with the absolute theoretical electron transport activities calculated 
using the Kröger-Klingenberg equation (Equation 2-4) are listed in Table 3-VI. 
 
Table 3-VI: Electron transfer activities (Sp. activity) and turnover numbers (TN or Kcat) performed on W. 
succinogenes re-suspended membranes containing the homologous QFR (A), the C. jejuni QFR (B) and the 
H. pylori QFR (C). 
A  B  C 
Activity assay  Sp. activity 
(U mg
-1) 
TN 
(min
-1) 
Sp. activity 
(U mg
-1) 
TN 
(min
-1) 
Sp. activity 
(U mg
-1) 
TN 
(min
-1) 
Formate to quinone  0.07  8  0.19  24  0.04  5 
Quinol to fumarate  3.24  421  1.40  182  3.52  458 
Formate to fumarate  0.48  154  1.43  458  0.23  74 
Theoretical electron 
transport 
63.7 x 10
-3  7.9  164.2 x 10
-3  21.2  38.6 x 10
-3  4.9 
 
 
3.1.4.4.2.  Enzymatic activity 
Total  and  partial  activities  of  the  isolated  QFRs  belonging  to  the  three  different  ε-
proteobacteria were calculated and are listed in Table 3-VII. These enzymatic assays involve 
either the whole complex (Unden, et al., 1980, Grivennikova & Vinogradov, 1982, Cecchini, et 
al., 1986, Westenberg, et al., 1990, Grivennikova, et al., 1993, Maklashina & Cecchini, 1999) or 
only  the  hydrophilic  subunits  (Kröger,  et  al.,  1980,  Unden  &  Kröger,  1986).  The  partial 
enzymatic assays can be usefully exploited when assessing enzyme stability or searching for 
some indications upon inhibitor-binding regions. Whereas the partial activity measured with 
the “BV assay” in the W. succinogenes and C. jejuni QFRs is far higher than the one measured 
with  the  “MB  assay”, this  phenomenon is  not  observed  in the H. pylori QFR.  Moreover, 
although these two different types of partial activities show that the W. succinogenes QFR is 3. Results 
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apparently more active, the “DT-DMNH2 assay” (Figure 3-20) proves that its total activity is 
similar to the two heterologous QFRs. For comparison reasons, the total enzymatic activities 
were  also  performed  with  the  “BH4-DMNH2  assay”:  despite  the  fact  that  the  calculated 
specific activity of this latter method was generally two-fold lower than the “DT-DMNH2 
assay”,  the  activity  proportions  amongst  the  three  QFR  species  did  not  change.  The 
calculated Michaelis constants (KM) for the quinone substrate (DMN) were found to be of the 
order  of  0.05-0.10  mM,  thus  similar  to  what  was  previously  determined  for  the  W. 
succinogenes QFR (Lancaster, et al., 2005). To assess the enzymatic stability, activity assays 
were performed after ten days of incubation at 4°C of the detergent solubilized QFRs, and 
showed a decrease up to 20%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-20: Typical “DT-DMNH2 assay” course. The red line represents a zero order fitting of the first 100 
seconds of the reaction time. The activity course is linear, and thus stable, for approximately 2/3 of the 
entire absorbance interval from 0.34 to 0.78 OD340. 
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Table 3-VII: Enzymatic activity, Michaelis constant, and inhibitor constant values of the isolated QFR 
from W. succinogenes (A), C. jejuni (B), and H. pylori (C) after IEF. The Michaelis constant (KM) values 
for  menaquinone  and  fumarate,  max  velocities  (Vmax),  and  inhibition  constants  (Ki)  values  for  the 
indicated inhibitors were calculated based on the “DT-DMNH2 assay”. 
A  B  C 
  Sp. act. 
(U mg
-1) 
TN 
(sec
-1) 
Sp. act. 
(U mg
-1) 
TN 
(sec
-1) 
Sp. act. 
(U mg
-1) 
TN 
(sec
-1) 
“MB assay”  22.5  50  7.3  9  12.3  29 
“BV assay”  154  340  41  91  15  35 
Vmax  14.7  32  9.3  21  12.2  28 
Quinone KM (mM)  0.08  0.06  0.05 
Fumarate KM (mM)  0.35
j  0.1  0.1 
Oxantel Ki (mM)  -  0.38  0.42 
Thiabendazole Ki (mM)  -  0.96  1.35 
Omeprazole Ki (mM)  -  1.96  - 
 
 
3.1.4.4.3.  Effects of inhibitors  
Effects  of  inhibitors  like  oxantel,  thiabendazole  and  omeprazole  on  QFR  were  finely 
measured using the quinol-regenerating coupled reaction with DT-diaphorase, so that long 
and stable enzyme kinetics could be measured (Figure 3-20). With this method, the inhibitor 
was added 20-30 seconds after the catalytic reaction was started, so that the pre-inhibition 
activity value could be used as an internal control for each trial. The enzymatic assay in the 
presence of the inhibitor was carried out with a minimum of six different substrate (DMN) 
concentrations.  The  rate  of  DMNH2  regeneration  by  DT-diaphorase  was  measured,  and 
proved to be faster than the QFR enzymatic activity at any time and condition. As a further 
experimental control, the DT-diaphorase enzymatic activity was measured in the presence of 
the  inhibitors,  so  that  any  unforeseen  inhibition  effect  was  prevented.  The  inhibition 
constant (Ki) values of these compounds are listed in Table 3-VII. The Lineweaver-Burk plots 
(Figure  3-21)  show  that  whereas  oxantel  has  an  un-competitive  effect  on  both  enzymes, 
                                                
j From Lancaster & Simon, 2002. 3. Results 
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thiabendazole affects QFR activity as a competitive inhibitor in the H. pylori QFR and as a 
non-competitive  inhibitor  in  the  C.  jejuni  enzyme.  Omeprazole  show  only  a  competitive 
effect in the C. jejuni QFR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-21: Lineweaver-Burk plots of C. jejuni QFR (A) and H. pylori QFR (B) activity. The red empty 
circles (•) and the solid line (linear regression) represent QFR activity without inhibitors. The blue empty 
squares (•) and the dashed line represent QFR activity in presence of 300µM oxantel. The black crosses (￿) 
and the dashed line represent QFR activity in presence of 2mM thiabendazole. The green empty squares (￿) 
and the dashed line represent QFR activity in presence of 2mM omeprazole. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-22: Chemical structure of tested inhibitors: oxantel (A), thiabendazole (B) and omeprazole (C). 
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The effects of these three inhibitors, whose chemical structures are shown in Figure 3-22, 
were also tested on partial activities (“BV assay” and “MB assay”) of the C. jejuni and H. 
pylori QFR. Based on results obtained with the former enzymatic assay, oxantel was the only 
inhibitor affecting the hydrophilic subunits of the two enzymes (IC50 ~ 0.2-0.3 mM). The “MB 
assay” was rather sensitive to the addition of DMSO (the inhibitor solvent) and, except for 
the oxantel, where inhibition was rather unequivocal (IC50 ~ 0.1 mM), thiabendazole and 
omeprazole showed questionable effects. 
Others  inhibitors  such  as  metronidazole,  nizatidine,  morantel,  and  TTFA  had  very  high 
extinction coefficients at the wavelength used for NADH or DMN detection, and hence they 
could not be characterized with the available enzymatic assays. 
3.1.5.  Crystallization and data collection 
Firstly, crystallization attempts using conditions equal to those producing well-diffracting 
W. succinogenes QFR crystals were made. However, these conditions were not optimal for the 
H. pylori and C. jejuni QFRs, therefore, extensive crystallization screening of these enzyme 
samples  after  IEF  or  gel  filtration  purification  has  been  carried  out.  Phase  diagrams  are 
important  to  monitor  the  precipitation  tendency  of  the  protein  during  crystallization 
attempts. The phase diagrams for H. pylori QFR (not shown) and C. jejuni QFR (Figure 3-23) 
after IEF were plotted based on results obtained from micro-batch crystallization at 18°C 
using the conditions indicated in the figure legend. As observed in Figure 3-23, the tolerance
k 
to polyethylene glycol (precipitant) observed for the C. jejuni QFR was up to 7 %. Strikingly, 
the tolerance to the same precipitant for the H. pylori QFR was far higher, reaching even 10 
%. Moreover, up to 7-8 % precipitant, the crystallization drop was perfectly clear and no 
phase changes were observed. Between 8 % and 10 % of precipitant the H. pylori QFR formed 
crystalline  precipitate  or  gelatinous  phases.  Thus,  though  the  protein  did  not  form  any 
proper crystal, it demonstrated to be very stable in this crystallization conditions. 
 
 
 
 
 
                                                
k Intolerance is defined as formation of an amorphous precipitate where the protein assumes a dark-
brownish color. 3. Results 
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Figure 3-23: Phase diagram of the C. jejuni QFR. The diagram color code for the phases is clarified with the 
support of the pictures (see pictures frame). The reservoir consisted of 0.1 M LiSO4, 0.1 ADA (pH 6.5), 2 % 
isopropanol, and different concentrations of PEG 4000. 
 
 
Preliminary three-dimensional (3D) crystallization attempts of the C. jejuni QFR and H. pylori 
QFR after IEF generally produced large ultra-thin layer crystals (Figure 3-25-D), and little-
squared layer crystals (Figure 3-25-A), respectively. The H. pylori QFR clearly resulted to be 
less prone to crystallize, as the best achievement obtained was rod shaped crystals with size 
of ~0.2 mm (Figure 3-25-B) that diffracted up to 8 Å. However, results obtained in many 
crystallization  conditions  showed  that  both  QFR  samples  maintained  even  after  several 
weeks or months a vivid orange color, sign that the heterologous QFR preparations were 
highly stable and did not undergo denaturation. Whereas the size and the shape of crystals 
of the C. jejuni QFR strikingly improved after gel filtration, the H. pylori QFR crystals were 
replaced from orange jelly/amorphous phases (Figure 3-25-C). 
To  remove  any  undesired  micro-precipitation  and  protein  aggregates  from  the  protein-
reservoir crystallization mixture, an ultracentrifugation cycle (Horsefield, et al., 2003) was 
performed on the H. pylori QFR sample prior to incubation, but did not lead to particular 
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improvements. Crystallization of the same protein in the presence of lipids (CA 18:1, DPPE, 
DOPC, DPPG) at the stoichiometric ratio of five lipid molecules per monomer of QFR, has 
also been attempted. As it was seen for the enzymatic activity, this protein seems to be far 
more stable and less prone to the formation of the gelly phases when lipids were added. 
Most importantly, the addition of cardiolipin has improved the crystallization properties of 
the H. pylori QFR (Figure 3-24). Crystallization trials with this enzyme at the last stage of 
purification (gel filtration) were not able to produce any crystal, whereas after addition of 
CA 18:1 some tiny crystals were appearing in the drop. The protein-lipid co-crystallization 
experiments are however at a preliminary stage, and further studies are necessary.  
 
 
 
Figure  3-24:  Co-crystallization  of  the  H.  pylori  QFR  with  cardiolipin  (B),  and  comparison  to  a 
crystallization  trial  without  cardiolipin  (A).  The  crystallization  setup,  photographed  at  two  different 
magnifications (1 and 2), consists of 1 µl drop volume with conditions similar to those indicated in Table 
2-XVI. 
 
 
Efforts  aimed  at  the  3D  crystallization  of  the  two  heterologously  produced  QFRs  have 
included a large variety of crystallization methods and conditions (e.g. seeding, streaking, 
change of incubation temperature, screening of other additives, freezing in liquid N2, etc.). 
The use of cryo-compatible reservoirs (hence containing cryo-protectant) or crystal soaking 
in paraffin, silicon oil or Al’s oil was helpful in the procedure of freezing but fruitless in 
terms of resolution improvement. Furthermore, the crystallization of the two enzymes did 
not show any improvement when the detergents LM and DM present in the QFR sample 
have been exchanged with other detergents like LDAO, Thesit, LM, DM, OG, UM. During 3. Results 
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the crystal development of the C. jejuni QFR, several crystal forms were obtained: diamond-
like  (Figure  3-25-E),  triangular  (-F),  needle-like (-G),  arch-like  (-H),  “rugby  ball”-like (-I), 
broom-like (-L), trapezoidal (-M, -N), crystals agglomerates (mainly at the interface between 
different phases) (-O), small layers (-P), large layers (-Q, -R). This latter crystal form resulted 
to be a high-resolution diffracting crystal (see Material and Methods for conditions), albeit 
some  other  crystal  forms  were  larger  in  size  (e.g.  trapezoidal  shape).  The  Figure  3-25-S 
shows the previous crystal (picture -R) mounted in the glass capillary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3-25:  Crystals  of  C.  jejuni  (D-S)  and  H.  pylori  QFRs  (A-C).  The  respective  crystallization 
conditions have been displayed in Table 3-VIII. 
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Table 3-VIII: Crystallization conditions which have been used for the achievement of the C. jejuni and 
H. pylori QFR crystals shown in Figure 3-25. The protein buffer was containing of 0.1 % DM, 0.01 % LM, 
20mM fumarate, 1mM EDTA, 20mM HEPES at pH 7.3. The protein concentration was 20mg/ml unless 
indicated. In order to maintain the protein oxidized, 1mM K3Fe(CN)6) was added to every crystallization 
mixture. Crystallization setups were incubated at 18°C. 
Pic. 
Prot. 
Prep. 
Add.  Add.  S.A.  Precip.  Salt 
Buffer (mM) 
pH 
Remarks 
A 
HpQFR 
IEF 
vitK2 
1 mM 
DMF 
5.5 % 
BA 
1.2 % 
PEG3350 
10 % 
NaCl 
150 mM 
NaCit. 20mM 
pH 5.6  seeding 
B 
HpQFR 
IEF 
vitK2 
1 mM 
DMF 
5.5 % 
BA 
1.2 % 
PEG3350 
10 % 
NaCl 
150 mM 
NaCit. 20mM 
pH 5.6 
seeding 
C 
HpQFR 
GF  
vitK2 
1 mM 
isop. 
2 % 
BA 
1.2 % 
PEG4000 
14 % 
LiSO4 
0.1 M 
ADA 0.1 M 
PH 6.5 
- 
D  
CjQFR 
IEF 
vitK2 
 1 mM 
DMF 
5.0 % 
BA 
1.2 % 
PEG3350 
10 %, 
NaCl 
150mM 
NaCit. 20mM 
pH 5.6 
- 
E 
CjQFR 
GF 
vitK2 
1 mM 
isop. 
2 % 
BA 
2.4 % 
PEG4000 
10 % 
LiSO4 
80 mM 
ADA 0.1 M 
PH 6.5 
+ oxantel 
1mM 
F 
CjQFR 
GF 
vitK2 
1 mM 
- 
BA 
2.4 % 
PEG8000 
10 % 
- 
MgAc. 
0.2 M 
- 
G 
CjQFR 
GF 
vitK2 
1 mM 
DMF 
5.5 % 
BA 
1.2 % 
PEG3350 
10% 
NaCl 
150 mM 
NaCit. 20mM 
pH5.6  - 
H 
CjQFR 
GF 
vitK2 
1 mM 
-  - 
PEG4000 
12 % 
LiSO4 
100 mM 
ADA 0.1 M 
PH 6.5 
silicon oil 
I 
CjQFR 
GF 
vitK2 
1 mM 
- 
HT 
2 % 
PEG4000 
15 % 
AmmSO4 
0.2 M 
NaCit. 0.1 M 
PH 5.6 
- 
L 
CjQFR 
GF 
vitK2 
2 mM 
OG 
0.3% 
HT 
1.5 % 
PEG4000 
16 % 
LiSO4 
0.2 M 
TRIS-HCl  
0.1 M pH 8.5 
prot. conc. 
28.5 mg/ml 
M 
CjQFR 
GF 
vitK2 
1 mM 
isop. 
2 % 
BA 
2.4 % 
PEG4000 
12 % 
LiSO4 
100 mM 
ADA 0.1 M 
PH 6.0 
- 
N 
CjQFR 
GF 
vitK2 
2 mM 
isop. 
2 % 
BA 
2.4 % 
PEG4000 
10 % 
LiSO4 
80 mM 
ADA 0.1 M 
PH 6.5 
+ oxantel 
1mM 
O 
CjQFR 
IEF 
vitK2 
2 mM 
DMF 
5.0 % 
BA 
2.4% 
PEG3350 
10 % 
NaCl 
150 mM  
NaCit. 20mM 
pH5.6 
- 
P 
CjQFR 
GF 
vitK2 
1 mM 
OG 
0.6% 
- 
PEG4000 
16 % 
LiSO4 
0.2 M    
TRIS-HCl  
0.1 M pH 8.5 
+ oxantel 
1 mM 
Q 
CjQFR 
GF 
vitK2 
2 mM 
- 
HT 
2 % 
PEG4000 
12 % 
LiSO4 
100 mM 
NaCit. 0.1 M 
pH5.6 
prot. conc. 
28.5 mg/ml 
R, S 
CjQFR 
GF 
vitK2 
2 mM 
- 
HT 
2 % 
PEG4000 
12 % 
LiSO4 
100 mM 
ADA 0.1 M 
PH 6.5 
prot. conc. 
28.5 mg/ml 3. Results 
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3.1.5.1.  3D-crystal structure of the C. jejuni QFR 
Data collection was accomplished as described in Materials and Methods. Data processing 
has established that the unit cell symmetry of the crystal form used for solving the C. jejuni 
QFR structure belong to the space group P21 (primitive monoclinic). The unit cell parameters 
as well as data processing statistics are listed in Table 3-X. 
The three-dimensional crystal structure of the QFR from C. jejuni in the fully oxidized state 
(Figure 3-27) has been solved by molecular replacement using as a search model the W. 
succinogenes  QFR,  solved  at  1.8  Å  resolution  (PDB  entry  code  2BS2,  Lancaster,  C.R.D., 
unpublished).  In  order  to  reduce  to  minimum  the  bias  deriving  from  the  search  model, 
which was solved at much higher resolution, a composite omit map has been calculated and 
used for model building. The recombinant C. jejuni QFR that was heterologously produced 
and crystallized is composed of 1166 amino acids, and is divided in the three subunits FrdA, 
FrdB, and FrdC, with 663, 243, and 262 amino acids, respectively. In the structure presented 
here, the electron density for 1051 amino acids is defined. The main chain of other 45 amino 
acids have been included in the structure
l, however the low quality of the electron density 
hindered  any  possibility  to  model  their  side  chains.  Unfortunately,  other  regions  of  the 
protein were not identifiable in the electron density maps, and the respective amino acids 
had  to  be  deleted  from  the  structure  produced.  The  list  of  unassigned  amino  acids  or 
residues  and  the  refinement  statistics  are  summarized  in  Table  3-IX  and  Table  3-X, 
respectively. 
 
Table 3-IX: Unussigned amino acids and side chains. List of amino acids that have not been assigned 
and  hence  deleted  from  the  modeled  structure.  List  of  amino  acid  side  chains  that  could  not  be 
assigned and whose occupancies (Q) have been set to zero. 
  Missing residues  Missing side chains 
Subunit A  (41 aa): 271-274, 277-279, 295-
297, 330-340, 349-351, 353-
359, 361-368, 662-663  
(29 aa): 121-123, 128-132, 267, 276, 285, 289-290, 
301, 307, 342, 346-348, 500-501, 516-517, 602, 
609-611, 633-634 
Subunit B  none  none 
Subunit C  (31 aa): 62-75, 246-262  (16 aa): 3-4, 111, 152, 199, 202-203, 205-207, 209, 
212, 227-228, 231-232   
 
 
                                                
l The occupancy of these 45 amino acid side chains has been set to zero in the PDB file. Section 3.1: H. pylori and C. jejuni QFR Studies 
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Table  3-X:  Crystallographic  table:  data  processing  and  refinement  statistics  of  the  C.  jejuni  QFR 
structure.  In  brackets  are  showed  the  respective  outer  shell  values;  R.M.S.D.,  root  mean  square 
deviations; the Rfree was calculated with 1.6 % of the total reflections; nobs/npar, ratio of the number of 
observed unique reflections used in the working set over the number of parameters necessary to define 
the model. 
Data collection  Refinement 
Space group   P21  Rcryst (%)  24.4 (33.4) 
Rfree (%)  25.8 (39.3) 
Average B-factor (Å
2)  62.1 
Unit cell size (Å)   a: 117.176 
b: 130.653 
c: 132.941  nobs/npar  2.15 
Unit cell angle β β β β (°)   107.969  R.M.S.D. from ideal values 
Mosaicity   0.090  Bond lengths (Å)  0.0089 
Resolution range (Å)  70.0-3.24 (3.36-3.24)  Bond angles (°)  1.461 
Measured reflections  241,397 (23,433)  Structure validation 
Redundancy  3.9 (3.8)  Subunit  FrdA  FrdB  FrdC 
Unique reflections   61,387 (6,090)  Amino acids n°  622  243  231 
Completeness (%)   99.2 (98.8) 
Rsym (%)   8.2 (34.3) 
Most favored 
regions (%) 
82.8  83.0  81.9 
I/σ σ σ σ(I)  5.2 (2.2)  Additional 
allowed (%) 
14.5  15.1  15.3 
    Generously 
allowed (%) 
2.1  0.5  2.3 
    Disallowed (%)  0.6  1.4  0.6 
 
 
The asymmetric unit contains two heterotrimeric molecules of the quinol:fumarate reductase 
complex formed by the three subunits A, B, and C associated in an identical fashion and 
arranged as a homodimer with a high degree of buried surfaces. The crystal packing found 
in this structure (Figure 3-26-A) has likely been influenced by the presence of an unusual 
loop involving the last 15 assigned residues of the FrdC subunit and probably the following 
17 amino acids of the same subunit (FrdC-246 to -262) that are not identified in the structure, 
which  depart  from  subunit  C  of  one  asymmetric  unit  and  reaches  the  subunit  A  of  the 
adjacent asymmetric unit (Figure 3-26-B). 
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Figure 3-26: Crystal packing (top) of the C. jejuni QFR structure and a snapshot (bottom) of one crystal 
contact as indicated by the blue box. The red cube in the top figure represent the crystallographic unit cell. Section 3.1: H. pylori and C. jejuni QFR Studies 
86 
Figure 3-27 shows the overall crystal structure of the C. jejuni QFR. Attached to subunit C, 
which is formed by five membrane-spanning helices and contains the site of menaquinol 
oxidation (Reaction 1-6), is subunit B, which is oriented towards the cytoplasmic side of the 
membrane  and  contains  in  the  following  order  the  [3Fe-4S],  [4Fe-4S],  and  [2Fe-2S]  iron-
sulfur clusters. Attached to subunit B, and not in contact with subunit C, is subunit A, which 
is  the  largest  subunit  and  which  incorporates  the  covalently  bound  flavin  adenine 
dinucleotide (FAD) prosthetic group and the site of fumarate reduction (Reaction 1-5). A 
relevant  domain  amongst  those  composing  subunit  A  is  the  capping  domain,  which 
undergoes a large movement upon binding of the substrate in order to close the active site to 
solvent (Lancaster, et al., 2001). It likely due to its high mobility that this latter domain and 
the nearby regions are characterized by poor electron density. 
 
 
 
Figure  3-27:  The  crystal  structure  of  the  C.  jejuni  QFR.  The  subunit  A  (in  yellow)  contains  the  FAD 
prostheic group (red sticks); the subunit B (in purple) contains from top to bottom the S1, S3, and S2 iron-
sulfur  clusters  (the  yellow  and  green  spheres  correspond  to  sulfur  and  iron  atoms,  respectively);  the 
transmembrane subunit C (in pink) contains from top to bottom the proximal and the distal hemes (blue 
sticks). 
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Figure  3-28  shows  the  location  of  all  cofactor  centers  of  this  enzyme  in  the  structure. 
Distances  between  centers  located  within  one  heterotrimer  lie  well  within  the  so-called 
“Moser-Dutton limit” for physiological electron transfer of 14 Å (Page, et al., 1999). Since the 
distances  between  hemes  belonging  to two  different homomers  in the dimer exceed this 
limit, no relevant electron transfer is to be expected between the two monomers. 
 
 
 
Figure 3-28: Arrangement of the prosthetic groups in the fumarate reductase from C. jejuni.  At the right 
of the figure the names of the cofactors are provided. Numbers refer to edge-to-edge distances, which were 
measured as defined by Page, et al., 1999. Color codes of the atoms are as follows: yellow, sulfur; green, 
iron; cyan, carbon; red, oxygen; blue, nitrogen. The adenosine dinucleotide group is drawn in light grey. 
 
 
The goodness of the composite omit maps in the regions of the iron-sulfur clusters S1 and S2 
with their cysteine ligands and some surrounding amino acids are shown in Figure 3-29-B. 
In addition, the electron density and the structure of the FAD group and its ligand FrdA-H43 Section 3.1: H. pylori and C. jejuni QFR Studies 
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(Figure  3-29-A)  are  confirming  the  8α-[Nε-histidyl]-linkage  to  the  isoalloxazine  ring,  as 
determined previously by Kenney & Kroger, 1977 and Lancaster, et al., 1999.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-29: Electron density and model of the FAD prosthetic group (A) and the S1 and S2 iron-sulfur 
clusters (B, cross-eye stereo view). The |2Fo|- |Fc|composite omit maps (Hodel, et al., 1992) are contoured 
at 0.8 standard deviations (σ) above the mean density of the maps. 
 
A 
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Figure  3-30:  Electron  density  and  model  of  the  distal  heme  (A),  and  the  region  between  the  hemes 
containing the FrdCE180 residue (B, cross-eye stereo view). The composite omip maps are contoured at 0.8 
σ. RC and RD correspond to the ring C and ring D propionates, respectively. 
 
 
Interestingly,  the  feature  observed  in  the  W.  succinogenes  QFR  structure  concerning  the 
structural  positions  of  the  hemeD  ring  C  propionate  and  the  residue  FrdC-E180  are  here 
B 
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conserved in the structure (Figure 3-30-A and -B). The conserved orientation of these two 
latter components is coherent with the view that also the QFRs from the ε-proteobacterium 
C. jejuni, like the one from W. succinogenes, could make use of the coupled transmembrane 
proton and electron transfer as suggested by the E-pathway hypothesis. However, as it is 
discussed  below  in  section  4.1.5.1,  the  structure  here  presented  is  characterized  by  low 
resolution, low structure factor intensities, and rather high B-factor values, which do not 
permit a definitive discussion at the present stage. 
 
3.2.   
13C-Labeling of QFR Heme Propionates 
3.2.1.  Cloning and characterization of the ∆ ∆ ∆ ∆hemL mutant 
The  following  cloning  procedure  was  carried  out  to  construct  a  plasmid  suitable  for 
homologous reciprocal recombination with the genome of the WT W. succinogenes in order to 
carry out a one-step gene disruption of the hemL gene. The gene glutamate-1-semialdehyde 
2,1-aminomutase (hemL), including 570 bp from the upstream region and 360 bp from the 
downstream region, was amplified by PCR using as template the genomic DNA from the 
WT  strain.  The  amplification  was  carried  out  using  the  two  synthesized  oligonucleotide 
primers HemL1_Fw and HemL1_Rv (see Table 2-VI). In order to insert the fragment into the 
vector pBR322 by ligation, the restriction sites EcoRI (in the HemL1_Rv primer) and BamHI 
(in the HemL1_Fw primer) were introduced at the 5’-ends of these primers. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-31: Plasmid maps of the pBR322 and the recombinant pBRH1. Restriction sites, plasmid size, 
genes, and markers are indicated. 3. Results 
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The  new  recombinant  plasmid  (pBRH01)  was  then  digested  with  NcoI  and  Bsp120I, 
generating  a  deletion  of  740bp  into  the  1.3  kbp  hemL  gene.  A  1.21  kbp  DNA  fragment 
containing the kanamycin resistance cassette (kan) was amplified by PCR using two newly 
synthesized primers (KanM_Fw and KanM_Rv), flanked by two inserted Bsp120I and NcoI 
restriction sites inserted at the 5’-ends. This latter amplified DNA fragment was digested 
with  Bsp120I  and  NcoI  restriction  enzymes  and  ligated  with  the  hemL-deleted  plasmid 
pBRH1, maintaining the same direction of the hemL promoter. 
 
 
Figure  3-32:  Plasmid  map  of  the 
recombinant  pBR∆ ∆ ∆ ∆H1.  Restriction  sites, 
plasmid  size,  genes,  and  markers  are 
indicated.  The  construction  procedure  is 
described in the text. 
 
 
 
 
 
 
Analytical digestion on this new plasmid, named pBR∆H01, was performed with the four 
restriction enzymes used for cloning and BssSI to ensure the correct insertions and directions 
in the  construct.  As  expected, double  digestion  with BamHI and EcoRI  showed  that  the 
DNA fragment containing the ∆hemL gene was about 500 bp larger respect to the fragment 
produced by the previous pBRH01, which was used as a control. Only the BamHI/EcoRI 
excised plasmidic fragment was used for integration. W. succinogenes WT strain was hence 
transformed by electroporation, and the recombinant cells were collected from rich medium 
agar plates containing kanamycin (25 mg/l) and 1 mM ALA. 
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Figure 3-33: One-step gene disruption of the hemL gene from the W. succinogenes genome. The double 
crossing-over (black crosses) is occurring at the homology regions (obliquely striped areas). 
 
 
A few hundred colonies were obtained in the selective agar rich medium and screened by 
PCR in order to verify the homologous recombination event. The primers synthesized for the 
hemL amplification have been used to perform the PCR on the isolated colonies. The clones 
that  underwent a  genome recombination in the  correct  locus  yielded  an  amplified DNA 
fragment that was unequivocally 500 bp larger than the WT, which was used as a control. 
The presence of only the target amplified DNA band ruled out the  possibility of a non-
homologous recombination, which would be characterized by two DNA fragments of both 
sizes, instead. Out of twelve colonies screened, ten (N1 to N10) showed the correct hemL 
deletion. The growth yield and doubling times of these ten mutants were determined by 
following growth curves in minimal medium containing 1 mM ALA. The best candidate 
(mutant strain N2) was then selected for large-scale protein production. The deletion strains 
were also inoculated in rich and minimal media containing different concentrations of ALA. 
In  rich  medium,  growth  was  obtained  in  every  circumstance,  though  final  cell  density 
decreased  towards  lower  concentration  of  ALA.  In  minimal  medium,  growth  was 
experienced only in media containing ALA at a concentration equal to or above 0.2 mM. Due 
to the high cost of the labeled compound, the large-scale growth medium was supplemented 
with  a  concentration  of  0.2  mM  ALA.  At  this  concentration,  it  was  found  that  several 
cultures failed to start growing, thus the cell growth was irreproducible, especially upon up-
scaling to larger culture volumes. This problem was overcome by increasing the ratio of 
inoculums to fresh medium from 1:200 to 1:50. At this latter ratio, the growth was fully 
recovered and comparable to higher concentrations of ALA. Furthermore, observation of the 
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cells in the late exponential phase with a light microscope (400x) did not show any optical 
difference between mutant and WT cells. 
3.2.2.  Enzymatic production and characterization 
The large-scale preparation yielded about 64 grams of cells, hence about half of the usual 
yield for the WT strain in rich medium. Processing of the cells and isolation of the 
13C-labeled 
QFR was performed in a procedure identical to that described already (see Materials and 
Methods).  The  purification  profile  based  on  the  “MB  assay”  activity  exhibits  a  usual 
enzymatic behavior of the QFR. SDS-PAGE analysis of the IEF purified QFR presents three 
characteristic bands of the subunits A, B, C, and very weak contaminant bands, comparable 
to typical WT QFR preparations. 
 
 
Table 3-XI: Purification profile based on partial specific activity (“MB assay”) of the
  13C-labeled QFR 
from W. succinogenes. 
 
Total 
activity 
(U) 
Specific 
activity  
(U mg
-1) 
Enzyme 
yield  
(%) 
Purification 
factor 
Cell homogenate  5150  0.6  100  1.0 
TritonX100 homogenate  5660  1.3  110  2.2 
TritonX100 extract  5700  2.8  111  4.7 
Anion exchange 
chromatography 
2394  12.0  46  20 
Isoelectric focusing  1744  17.4  34  29 
 
 
 
 
 
 
 
 
 
 
Figure  3-34:  SDS-PAGE  of  samples  during  purification.  L,  molecular  mass  standard;  1  and  2  cell 
homogenate;  3,  supernatant;  4,  Triton  homogenate;  5,  Triton  extract;  6,  anion  exchange;  7,  isoelectric 
focusing. 
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The heme b concentration was also calculated spectrophotometrically at the Soret-band and 
proved a molar “heme to protein” ratio of about 2:1. Both enzymatic assays, “MB assay” and 
“BH4-DMNH2 assay” (~6 U mg
-1), performed on the purified protein produced results that 
are  comparable  to  the  unlabeled  WT  QFR  enzymatic  activity.  Mass  spectrometric 
measurements  by  MALDI  TOF  of  the  hemes  extracted  from  the  labeled  and  unlabeled 
samples (Figure 3-35) yield clear signals at 616 atomic mass units (m/z) for unlabeled hemes 
and  618  atomic  mass  units  (m/z)  for  labeled  hemes.  The  examination  of  all  the  peaks 
obtained from the labeled sample show that only a negligible percentage of the propionates 
were not isotopically labeled. 
 
 
 
Figure 3-35: MALDI TOF analysis of the extracted hemes. Data for the unlabeled and 
13C-labeled hemes 
are shown in red and black, respectively. The molecular masses (m/z) are indicated above the individual 
peaks. 
 
 
Quinones give characteristic signals at certain wavelengths during redox changes around –
70 mV (potential referred to the standard hydrogen electrode, SHE) that may be interfering 
with the FTIR spectra analysis. In order to exclude any significant difference concerning the 
quinones  between  unlabeled  and  labeled  QFR  preparations,  bound  native  quinone-like 
species  (methyl-menaquinone  and  menaquinone)  were  extracted  from  the  same  protein 
samples  used  for  FTIR spectroscopy  experiments  and  their  concentration  was  measured. 
Separation  and  quantification  were  carried  out  by  HPLC,  giving  a  quinone-to-monomer 
ratio of 0.21 and 0.26 for the unlabeled and labeled sample, respectively. 
 3. Results 
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3.2.2.1.  Midpoint potentials of 
13C-labeled hemes at pH 7 
The midpoint potentials of the 
13C-labeled heme b groups of QFR were determined at pH 7 
by monitoring the absorption changes in the visible spectral range at the positions of the 
Soret-  and  α-bands  of  the  hemes  during  a  potential  change.  The  observed  midpoint 
potentials for the high- and low-potential hemes were +4 mV and –137 mV, respectively 
(Figure  3-36).  Thus,  the  values  are  approximately  10  to  15  mV  higher  than  the  average 
midpoints measured in the unlabeled WT (Lancaster, et al., 2000). For the latter, the statistical 
basis was broader since more independent data were collected, and an experimental error of 
±10 mV was estimated from the data scattering at pH 7. For the 
13C-labeled enzyme, the 
value obtained for the high-potential proximal heme bP lies within the error, and the value 
for the low potential distal heme bD exceeds it by +5 mV. Thus, the influence of the 
13C-label 
on the heme midpoint potentials, if any, is minor. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-36: Heme b titration curve of the 
13C-labeled QFR WT at pH 7. The data points were fitted with a 
two-step  Nernst  equation. The  black  vertical  bars  indicate  the  reference  potentials  (RED:  reduced,  IM: 
intermediate and OX: oxidized) chosen for the FTIR experiment, the red bars indicate the positions of the 
high and low midpoint potentials of the heme b groups. 
 
 
3.2.3.  FTIR-spectroscopy analysis 
3.2.3.1.  Reversible FTIR difference spectra of the “full potential” step 
Figure 3-37 shows the reversible electrochemically-induced FTIR difference spectra of the 
unlabeled and labeled QFR WT enzyme at pH 7.0, respectively, for the “full potential” step, 
+4 mV 
-137 mV 
Potential (V) 
∆ Abs Section 3.2: 
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i.e., with an initial reference potential at which all cofactors were fully reduced and a final 
potential  at  which  all  were  fully  oxidized  (and  vice  versa).  The  FTIR  difference  spectra 
obtained for the QFR containing the 
13C-labeled heme propionates are very similar to those 
for the unlabeled WT, which were discussed in ref. (Haas, et al., 2005). This indicates that the 
possible heme propionate contributions in the full potential step are of small amplitude. 
Thus, it was advisable to compute double-difference spectra in order to better resolve any 
smaller signals (see chapter 3.2.3.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3-37:  Electrochemically-induced  FTIR  difference  spectra  of  unlabeled  and 
13C-labeled  QFR. 
Reversible  full  potential  steps  “oxidized-minus-reduced”  (solid  line)  and  “reduced-minus-oxidized” 
(dotted line) FTIR difference spectra of the unlabeled QFR WT (in black), and 
13C-labeled enzyme (in olive) 
at pH 7. The reference electrode potentials (vs. SHE’) for the shown FTIR difference spectra were +0.21 V 
(full oxidative potential) and -0.37 V (full reductive potential). 
 
 
3.2.3.2.  Separation of redox-induced IR signals from hemes bD and bP 
Since the midpoint potentials of the two QFR heme groups differ by almost 150 mV, it was 
feasible  to  separate  the  corresponding  signals  and  address  the  low-  and  high-potential 
hemes individually by setting the appropriate reference potentials in the experiment. The 
best  separation  was  achieved  at  an  “intermediate”  potential,  which  corresponds  to  the 
average of the two midpoints at –81 mV. At this intermediate potential, about 95 % of the 
high-potential hemes are reduced, and 95 % of the low-potential hemes are oxidized. Thus, 
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the separation of the two heme midpoint potentials is wide enough to guarantee negligible 
contributions  (max.  5  %)  of  the  respective  other  heme  in  the  two  partial  potential  steps 
“reduced-minus-intermediate”  and  “intermediate-minus-oxidized”  (and  vice  versa).  The 
corresponding spectra are shown in Figure 3-38-A and-B. Because of the small amplitude of 
investigated signals that and due to the occurrence of noticeable baseline instabilities in the 
respective experiments, the spectra corresponding to the partial potential steps had to be 
baseline-corrected. In other words, the respective pairs of difference spectra, e.g. “reduced-
minus-intermediate”  and  “intermediate-minus-reduced”,  were  summed  to  determine  the 
baseline drift. This did not seem to have a disturbing impact on the quality of the data, since 
independently baseline-corrected difference-spectra are practically identical. In addition, the 
inset  of  Figure  3-38-A  shows  how  well  the  full  potential  step,  i.e.  the  electrochemically 
induced redox reaction, can be subdivided in two halves. This addition of difference spectra 
can equally be performed for the labeled enzyme. 
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Figure  3-38:  Electrochemically  induced  FTIR  difference  spectra  of  unlabeled  QFR  at  pH  7  with 
intermediate  step.  Reversible  “oxidized-minus-intermediate”  (solid  blue  line),  and  reversible 
“intermediate-minus-reduced” (solid red line) FTIR difference spectra. The reference electrode potentials 
for  the  shown  FTIR  difference  spectra  were  +0.21  V  (full  oxidative  potential),  –0.08  V  (intermediate 
potential), and –0.37 V (full reductive potential). The inset shows a comparison of the difference spectra of 
the measured full potential step (in black, same data as in Figure 3-37) with computed “full potential step” 
difference spectra (in magenta), which are based on the sum of the respective pairs of spectra. 
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Figure  3-39:  Electrochemically  induced  FTIR  difference  spectra  of 
13C-labeled  QFR  at  pH  7  with 
intermediate  step.  Reversible  “oxidized-minus-intermediate”  (solid  blue  line),  and  reversible 
“intermediate-minus-reduced” (solid red line) FTIR difference spectra. The reference electrode potentials 
for  the  shown  FTIR  difference  spectra  were  +0.21  V  (full  oxidative  potential),  –0.07  V  (intermediate 
potential), and –0.37 V (full reductive potential). 
 
 
3.2.3.3.  FTIR difference spectra of the “partial potential” steps 
The  FTIR  difference  spectra  of  the  two  potential  steps,  which  include  the  intermediate 
potential, reflect the redox transitions of the two heme groups bD and bP and contributions 
from other cofactors and prosthetic groups, which are inevitable. Although the difference 
spectra reveal clear deviations, the positions and proportions of the main spectral features 
are similar for both partial potential steps, and comparable for the unlabeled and 
13C-labeled 
QFR enzyme (see Figure 3-38 and Figure 3-39). The differences between the two steps in the 
amide I range of the spectra could arise from distinct sets of amino acid residues that may be 
altered in the course of one or the other individual potential step. Moreover, they could 
indicate redox-induced structural changes of the polypeptide backbone of QFR, which are 
either related to the redox transition of the high- or the low-potential heme.  3. Results 
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The sharp peak at 1545 cm
-1, which was observed in the full potential step has tentatively 
been assigned to heme porphyrin ν(CbCb) and/or νas(CaCm) vibrations (Figure 4-2, Haas, et al., 
2005). An analogous signal was present in both partial potential steps (with lower intensity 
than in the full potential step), which is in line with the performed assignment. The PO 
modes from the potassium phosphate buffer below 1200 cm
-1 reflect proton exchange of the 
enzyme  and  the  mediators  with  the  buffer  (Hellwig,  et  al.,  1996)  (Hellwig,  et  al.,  1999) 
(Baymann, et al., 1999). The spectra for the two partial potential steps showed that this effect 
was more pronounced in the low-potential partial step (Figure 3-38 and Figure 3-39) since 
the amplitude of the respective bands was stronger in this step. 
3.2.3.4.  Tentative signals of protonated heme propionate(s) of heme bD 
The range of Asp or Glu ν(COOH) modes above approximately 1710 cm
-1 (Venyaminov & 
Kalnin, 1990) is of particular interest with respect to a possible coupling of proton transfer 
via acidic groups to the redox transition of the high- and low-potential heme.  
 
 
 
Figure 3-40: Schematic view of the three relevant heme propionate vibrations. On the left, the carbonyl 
stretching vibration of the protonated carboxyl group (which absorbs between approximately 1700 cm
-1 and 
1665 cm
-1) is shown; in the middle, the antisymmetric vibration of the deprotonated form (between 1620 cm
-
1 and 1540 cm
-1); and on the right, the corresponding symmetric vibration (between 1420 cm
-1 and 1300 cm
-1). 
The  arrows  indicate  the  stretching  of  the  individual  bonds.  All  of  these  vibrations  are  sensitive  to 
13C 
isotope exchange and a maximal downshift of 30 to 40 wavenumbers upon isotopic labeling of the heme 
propionate group is expected (Behr, et al., 1998). 
 
 
At  1718  cm
-1,  a  signal  in  the  full  potential  step  of  the  unlabeled  QFR  WT  enzyme  has 
tentatively been assigned  to a FAD ν(C4=O)  vibration in  the  oxidized state (Haas, et al., 
2005). The difference spectra of the 
13C-labeled and unlabeled QFR associated with the low-
potential step and thus with heme bD differ considerably above 1710 cm
-1 (Figure 3-41). In the 
unlabeled WT, two separated positive contributions associated with the intermediate state 
are centered at 1740 cm
-1 and 1726 cm
-1.  In opposition, the 
13C-labeled enzyme reveals one Section 3.2: 
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broad contribution in the intermediate state around 1728 cm
-1. Hence, it has to be concluded 
that  at  least  one  propionate  of  bD  contributes  in  this  high  frequency  range,  and  that  the 
vibration was downshifted by 15 to 20 wavenumbers upon 
13C-labeling (Figure 3-41). 
 
 
Figure  3-41:  Detail  of  FTIR  difference 
spectra of unlabeled and 
13C-labeled QFR at 
pH 7. FTIR difference spectra of the partial 
potential step “intermediate-minus-reduced” 
for the unlabeled QFR (black line) and for the 
13C-labeled  QFR  (olive  line).  The  reference 
electrode potentials are the same as indicated 
above. 
 
 
 
 
 
 
 
 
3.2.3.5. Tentative signals of deprotonated heme propionate(s) of heme bD 
The “single-difference” spectra of labeled and unlabeled QFR are very similar, as can be seen 
by comparing the corresponding spectra in Figure 3-38; therefore, it is necessary to look at 
“double-difference” spectra (Figure 3-42). The computed double-difference spectra are rather 
noisy, which is almost inevitable since independent experiments always differ slightly from 
each other; in addition, the spectra have to be scaled for comparison. The double-difference 
spectra  allow  the  assignment  of  the  observed  contributions  to  the  low-potential  redox 
transition related to the distal heme.  
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Figure 3-42: FTIR double-difference spectra of “unlabeled-minus-
13C-labeled” QFR at pH 7. The upper 
traces  show  the  data  for  the  potential  step  “oxidized-minus-intermediate”  (red  line);  the  lower  for 
“intermediate-minus-reduced” (black line). The magenta circles point out the frequency ranges in which the 
contributions of the heme propionates are observed. The obliquely striped areas correspond to regions of 
elevated noise level (in the amide I region, 1700 cm
-1 to 1600 cm
-1, due to the strong H2O and amide I 
absorbance, and below 1200 cm
-1 due to the absorbance of KPi-buffer modes), which are difficult to handle 
in double-difference spectra and should thus be excluded from the analysis. 
 
 
As can be seen in Figure 3-42 for the low potential step, the positions of the obtained FTIR 
double-difference bands of “unlabeled-minus-
13C-labeled” QFR in the IR-spectrum coincide 
very well with the expected ranges (Behr, et al., 1998). The series of difference-signals at 1553, 
1528,  and  1501  cm
-1  can  be  attributed  to  anti-symmetric  vibrations  of  at  least  one 
deprotonated heme propionate of bD, and the signal around 1388 cm
-1 to the corresponding 
symmetric  modes,  respectively  (Figure  3-40).    Only  residual  contributions  of  very  small 
amplitude  (as  mentioned  above,  an  overlap  of  5  %  at  the  intermediate  potential  was 
estimated for the contributions of the two hemes) plus noise are seen at the corresponding 
wavenumbers in the “oxidized-minus-intermediate” potential step. Additional discrepancies 
between  the  double-difference  spectra  of  the  full  and  the  “reduced-minus-intermediate” 
potential  step  might  arise  due  to  conformational  changes  or  environmental  differences, 
which could affect the heme propionate vibrations, and which are specifically related to the 
intermediate potential, as this state does not contribute to the full potential step.  
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4.  DISCUSSION 
4.1.  Quinol:Fumarate Reductase from H. pylori and C. jejuni: 
Production and Characterization 
4.1.1.  A novel host for heterologous expression 
The results demonstrate for the first time that the ε-proteobacterium W. succinogenes is a 
well-suited host for heterologous membrane protein production. Beside the fact that H. pylori 
and  C.  jejuni  must  be  handled  with  high  safety  standards  (e.g.  in  a  high  safety  level 
laboratory),  culturing  of  these  bacteria  is  a  rather  demanding  task  (Marais,  et  al.,  1999b) 
(Kelly, 2001). Due to the difficulty and risks of producing these enzymes from their natural, 
pathogenic sources, these protein complexes have been heterologously produced in the non-
pathogenic  host  W.  succinogenes.  A  well-established  transformation  method,  the  strong 
homologous frdCAB operon promoter and terminator, efficient selective markers such as like 
kanamycin  and  chloramphenicol  with  their  own  bacterial  promoters  are  previously 
established genetic tools (Simon, et al., 1998) that have been useful for expressing genes or 
operons  in  this  novel  host.  Further  advantages  of  using  W.  succinogenes  are  its  known 
genome  sequence  (Baar,  et  al.,  2003),  especially  for  homologous  gene  amplification  and 
homologous recombination, and its rapid growth to high cell densities in minimal media, 
which enables fast and cost-effective production of cell quantities sufficient for large-scale 
protein purification. Considering that the purification factor values of the QFR from H. pylori 
and  C.  jejuni  preparations  are  not  markedly  large  notwithstanding  the  high  purity,  it  is 
inferred that the level of protein production in the expression host is extremely high. Taken 
together, the results presented above and discussed below demonstrate W. succinogenes to be 
a useful and efficient expression system. 
4.1.2.  A functional heterologous replacement of the QFR in W. 
succinogenes 
The  pCatCj4  and pCatHpG8  plasmids contain  the  frdCAB  operons  from  C. jejuni  and  H. 
pylori  QFR,  respectively.  Locus-specific  PCR  and  Southern  blotting  analysis  permitted  to 
confirm that the recombinant HpGM and CjM strains possess the plasmid pCatHpG8 and 
pCatCj4,  respectively,  integrated  into  the  genomic  QFR-locus  of  the  deletion  mutant 
∆frdCAB of W. succinogenes (Simon, et al., 1998). Indeed, although integration at the upstream Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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recombination region of the C. jejuni QFR operon could not be tested by Southern blotting 
analysis, the obtained results from the Southern blotting at the downstream recombination 
region and  the  locus-specific PCR (which  is associated  with the upstream  recombination 
region) can undoubtedly rule out any misinterpretation. The appearance of prominent bands 
of the size of about 4.2 kb in the Southern blot radiography film (Figure 3-5) are most likely 
demonstrating that the antibiotic resistance was due to plasmid replication inside the host 
and not (only) to plasmid integration. This phenomenon might account for the difficulties 
encountered  in  the  antibiotic  selection  method,  which  was  too  often  affected  by  the 
appearance of  too  many false-positive clones. However,  this last  obstacle  has  apparently 
been overcome by increasing the volume of fresh medium added after electroporation and 
the subsequent incubation time (see Materials and Methods). 
Prior to genome integration of the plasmids pCatCj4 or pCatHpG8, the deletion mutant W. 
succinogenes  ∆frdCAB  was  unable  to  grow  on  a  medium  containing  fumarate  as  a  sole 
electron acceptor. The recombinant strains of W. succinogenes CjM and HpGM were able to 
overexpress the respective frdCAB operons from C. jejuni and H. pylori. Growth curves of 
these strains cultivated on minimal and rich media containing fumarate as a sole terminal 
electron acceptor revealed that fumarate respiration was recovered. Moreover, even though 
strains  carrying  the  H.  pylori  QFR  (WsHpGM31/33)  were  slightly  slower  in  growth,  the 
doubling time and cell mass yield of these two transgenic strains are rather similar to the W. 
succinogenes WT (Table 3-I).  
These  observations  demonstrate  that  the  W.  succinogenes  ∆frdCAB  strain  could  efficiently 
restore fumarate respiration using the fully functional H. pylori or C. jejuni QFR membrane 
protein  complex.  Hence,  it  is  possible  to  infer  that,  after  a  correct  transcription  and 
translation of the heterologous operon, the protein complex could be correctly folded and 
delivered into the plasma membrane. Furthermore, all of the six cofactors, i.e. two heme b 
groups, three iron-sulfur clusters (S1, S2, S3), and an FAD prosthetic group were correctly 
assembled  into  the  enzyme.  Even  though  these  three  ε-proteobacteria  species  are  all 
phylogenetically rather close, their QFR amino acid sequence homology is not very high (the 
membrane anchors show only about 50 % identity, Table 4-I). Strikingly, the respective QFRs 
can  be  efficiently  interchangeable,  implying  also  an  efficient  interplay  between  the 
heterologous enzymes and the contingent associated (homologous) chaperons. 
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Table 4-I: Amino acidic sequence identities between the QFR from W. succinogenes 
DSM 1740 strain, the C. jejuni clinical isolate strain, and the H. pylori 26695 strain. 
Values are given in percentages (%). The alignments have been performed using the 
scoring matrix BLOSUM 62 (by the SECentral software package). 
  FrdC  FrdA  FrdB 
C. jejuni vs. W. succinogenes  49  69  66 
H. pylori vs. W. succinogenes  55  63  68 
C. jejuni vs. H. pylori  45  57  64 
 
 
In  order  to  investigate  the  longer  doubling  time  observed  for  the  W.  succinogenes  strain 
expressing the H. pylori QFR operon, the electron transport activity between Fdh and QFR 
membrane protein complexes on W. succinogenes cell membranes containing the QFR from 
either W.  succinogenes  (DSM  1740, WT  strain), or  C.  jejuni (WsCjM11  strain), or  H. pylori 
(WsHpGM31 strain) have been measured and compared. A very important observation is 
that  the  Fdh activity  was, as  expected  (Kröger &  Innerhofer,  1976b,  Kröger, et  al.,  1980), 
several times slower than the QFR activity, and even slower than the formate to fumarate 
(Fdh-QFR) activity. This latter finding is perhaps due to the fact that the Fdh enzymatic 
activity had to be measured after several days; therefore the samples were shock-frozen and 
thawed, and  thus  part  of  the  activity  was  lost due  to  deterioration of  the  enzymes.  The 
drawback of this issue does not prevent to compare the activities among the three strains, as 
they were all treated exactly in the same manner. Given that the reaction catalyzed by the 
Fdh  was  by  far  the  rate  limiting  reaction,  both  the  directly  measured  and  indirectly 
calculated (theoretical, see Equation 2-4) electron transfer activities were strongly influenced. 
Accordingly, the theoretical electron transport activities were from 6 to 8 times smaller than 
the  values  measured  directly  as  formate  to  fumarate  activity.  In  this  view,  a  direct 
comparison  between  electron  transport  activities  occurring  in  the  three  different  strains 
would lead to a wrong interpretation of the values. Instead, the bias imposed by the very 
low Fdh activity should be eliminated. If the ratio between the individual Fdh-QFR activity 
and the Fdh activity is calculated, it is obtained that whereas the WsCjM11 strain and the 
DSM 1740 strain had similar values (7.7 and 7.4, respectively), the WsHpGM31 strain had a 
significantly lower value (5.9). Similarly, the ratio between the Fdh activities in different 
species and their respective Fdh-QFR activities were corresponding to 2.9/3.0, between the 
DSM 1740 and WsCjM11 strains; to 6.2/4.8 between the WsCjM11 and WsHpGM31 strains; 
and 2.1/1.7 between the DSM 1740 and WsHpGM31 strains. Thus, it is possible to conclude Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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that the only disproportion between the Fdh and the Fdh-QFR activities is tangible in the 
WsHpGM31 strain. In other words, the electron transport activity appears to be less efficient 
only in the strain containing the H. pylori QFR, and this is perfectly in accordance with the 
observed difference in cellular doubling times. Although a supramolecular organization of 
the aerobic respiratory systems in the mitochondrial inner-membrane (super-complexes or 
‘respirasome’) is already known and described (Schägger & Pfeiffer, 2000), the formation of 
similar  super-complexes  in  the  anaerobic  respiratory  systems  of  bacteria  (like  fumarate 
respiration)  has  never  been  demonstrated.  Thus,  even  though  this  eventuality  cannot  be 
completely ruled out, the effect noticed in the WsHpGM31 is not justifiable with a super-
complex formation. 
Carefully looking at the specific QFR activities (Table 3-I) and electron transport activities 
(Table 3-VI) in cell homogenates and membrane fractions, it is noticeable that the expression 
level of H. pylori QFR was higher than the C. jejuni QFR and slightly higher than the W. 
succinogenes  QFR.  On  an  inversely  proportional  logic,  the  respective  Fdh  activities  were 
lower in the strains with higher QFR activity. It may be speculated that this phenomenon is 
not accidental, but the expression level of the QFR operon may affect the cellular production 
of Fdh in the membrane (and possibly even of membrane proteins in general), and even 
interfere with the production or distribution of menaquinol throughout the membrane. Since 
all the strains had the same QFR promoter/terminator, the higher production of H. pylori 
QFR could be explained by a longer half-life of the messenger RNA (mRNA), or a per se 
higher resistance of the protein to degradation. However, since WT W. succinogenes cells 
were also characterized by a high QFR production, one would assume that in this case the 
presence of QFR was finely tuned with the metabolic needs and setup of the cell. 
4.1.3.  The first large-scale preparation of a pure and homogeneous QFR 
from C. jejuni and H. pylori 
This novel heterologous expression system allowed to establish a large-scale preparation set 
up for the production of an active QFR from the pathogenic species C. jejuni and H. pylori. 
Previous enzymatic isolation from these two species was characterized by low yields of a 
QFR  of  comparatively  low  purity  and  stability  (Birkholz,  et  al.,  1994,  Ge,  et  al.,  1997, 
Lancaster  &  Simon,  2002).  On  the  contrary,  protein  characterization  and  crystallization 
require  large  amounts  of  a  highly  pure  and  stable  enzyme.  The  relative  simplicity  of 
working with W. succinogenes and its high yield of expression enabled to achieve, after full 4. Discussion 
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purification, up to 100 mg of C. jejuni QFR and 150 mg of H. pylori QFR. The SDS-PAGE 
(Figure  3-8)  and  the  gel  filtration  chromatogram  (Figure  3-7)  prove  that  these  enzyme 
preparations  are  characterized  by  a  high  purity  and  a  high  homogeneity.  Besides,  these 
enzyme  preparations  have  already  proven  to  be  suitable  for  protein  3D  crystallization, 
further evidence of high enzyme stability. The purified QFR samples appear in the SDS-
PAGE gel as three subunit bands with very minor contaminations and with roughly correct 
stoichiometric ratios
m. The quality of the enzyme purification procedure can also be assessed 
by examination of the purification table (Table 3-II). As the enzymatic activity measured by 
“MB assay” in the cytosolic fraction after ultracentrifugation of the solubilized membranes 
was negligible, it can be inferred that the QFRs were stably attached to the membrane and 
the  enzyme  integrity  was  maintained  during  mechanical  disruption  of  the  cells. 
Interestingly, when the H. pylori QFR sample was subjected to gel filtration, the total QFR 
enzymatic activity measured with the “DMNH2 assay” decreased dramatically. This may 
reflect, for instance, the loss of tightly bound phospholipids, which may affect the catalytic 
efficiency of subunit C. This last hypothesis arises from two main observations: the protein 
appears as a unique and homogeneous peak in the gel filtration chromatogram, proving that 
the enzyme is still assembled as a complex; and the partial activity measured with the “MB 
assay”  ensure  that  the  hydrophilic  subunits  are  not  affected  by  gel  filtration.  Further 
discussions on the role of lipids in the QFR from H. pylori are given below. 
4.1.4.  A full protein characterization of the produced enzymes 
To prove that the hemes have been correctly inserted into the transmembrane subunit C at 
the correct stoichiometric ratio, the heme content has been measured spectroscopically and 
compared  with  the  polypeptide  concentration  (BCA  assay).  As  expected  from  a  dihemic 
protein  complex,  the  protein-to-heme  ratio  was  confirmed  to  be  equal  to  1:2.  Another 
confirmation  was  given  by  the  fact  that,  during  the  heme  titration,  the  distal  and  the 
proximal hemes contributed equally to the total change in absorbance. 
The fluorescence associated with QFR subunit A on an SDS-PAGE gel illuminated with UV 
light (Figure 3-9) ascertained that the prosthetic group FAD of the both produced QFRs is 
covalently  linked  to  this  subunit,  in  analogy  to  W.  succinogenes  QFR.  This  data  is  also 
                                                
m  The thickness of the bands from the SDS-PAGE can be roughly estimated and reflects the molar 
mass. Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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confirmed in the C. jejuni QFR thanks to the determination of its 3D-crystal structure (Figure 
3-29). 
4.1.4.1.  Redox midpoint potentials of QFR cofactors and correlation to 
enzymatic activities 
The redox midpoint potentials of the QFR cofactors from the species W. succinogenes, C. jejuni 
and H. pylori, have been measured and are presented graphically in the figure below (Figure 
4-1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1: Redox midpoint potentials of the QFR cofactors from C. jejuni (black), H. pylori (red) and W. 
succinogenes (blue). Abbreviations: MK, menaquinone/menaquinol redox couple; HD, distal heme; HP, 
proximal heme; S3, iron-sulfur cluster S3; S2, iron-sulfur cluster S2; S1, iron-sulfur cluster S1; FAD, flavin 
adenosine  dinucleotide  prosthetic  group;  S/F,  succinate/fumarate  redox  couple.  The  substrates 
menaquinone and fumarate, and all the cofactors are represented graphically. 
 
 
Similar measurements were carried out previously in the W. succinogenes QFR (Unden, et al., 
1984). However, although the data obtained for the Fe-S centers in this last reference are in 
reasonable agreement with the data obtained in this work, the calculated redox midpoint 
potential of the W. succinogenes FAD was rather questionable. Thus, the signal assigned to 
the  flavin  semiquinone  by  Unden  et  al.  could  only  be  detected  and  measured  as 
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‘characteristic shoulders’ at both sides of a major peak arising from the redox mediators. 
Most importantly, instead of the bell-shaped titration curve, the signal persisted and even 
increased at low potentials, giving a maximal yield of 19%
n and half-maximal amplitude at –
120 mV. A similarly shaped titration curve was obtained by poising the enzyme with the 
succinate/fumarate couple, in this case giving a redox midpoint potential 0f –20 mV (41% 
yield). In contrast to these quoted experiments, the titrations of the FAD prosthetic group of 
all  the  three  QFRs  that  were  performed  here  resulted  in  clear  bell-shaped  curves  (n=2), 
which  could  then  be  correctly  fitted  with  a  double  Nernst  equation  for  redox  midpoint 
potential determination. Since molecules of native quinone are known to co-purify together 
substoichiometrically with the membrane proteins in general (Luna-Chavez, et al., 2000, Xia, 
et al., 1997, Simon, et al., 2000b, Gast, et al., 1985) and with ε-proteobacterial QFR specifically 
(Mileni, et al., 2005a) at a ratio of about 0.2 molecules per monomer (see chapter 3.2.2) and 
since  the  EPR  signal  signature  from  FAD
•  ¯  is  quite  similar  to  that  generated  by  a 
naphthosemiquinone, any possible misinterpretation of the obtained signals was avoided by 
re-performing  the  redox titration  in  the  presence  of a 10-fold  molar  concentration of  the 
menaquinone MK4
o. Since the yield of radical obtained did not change, it was concluded that 
the signal assignment to FAD is correct.  
As it is possible to notice from the EPR signal yield of the measured flavins (around 10%), 
the radical stability constant of these prosthetic groups was very low. The low stability of the 
semiquinone species has also been annotated for most of the other flavin-containing enzyme 
like the E. coli fumarate reductase and succinate dehydrogenase (Heering, et al., 1997, Leger, 
et al., 2001), the Shewanella frigidimarina flavocytochrome c3 (Turner, et al., 1999), the Nocardia 
corallina alkene mono-oxygenase (AMO) complex (Gallagher, et al., 1999), etc. Although this 
view is in contrast with the model which describes separate one-electron transfer processes 
as determinants of the course of catalytic electron transfer (Heering, et al., 1997), most of the 
results available in the literature, which were obtained also by using other techniques such 
as protein film voltammetry (PFV) or UV/VIS spectroscopy, favor a model where the two 
one-electron transfer processes through this center occur almost concertedly and are defined 
as  cooperative  (Leger,  et  al.,  2001).  This  conception  agrees  well  with  the  mechanism  of 
fumarate reduction by a hydride transfer, thus the transfer of one proton, and two electrons 
from the FAD prosthetic group. 
                                                
n The plateau represented 19% of radical signal compared to the enzyme concentration. 
o The native menaquinone is MK6, thus, only two isoprenoid chains longer than the one supplied. Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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Apart  from  the  iron-sulfur  clusters  of  the  W.  succinogenes  QFR,  whose  redox  midpoint 
potentials are about 100 mV lower, only relatively small differences are noticed
p between the 
cofactors of the QFRs from H. pylori and C. jejuni. More precisely, the FAD, the S1 cluster and 
the distal heme of the H. pylori QFR were higher than those of the C. jejuni QFR of about 25 
mV. However, the overall midpoint potential difference between the first (at the distal heme) 
and the last reduction stage (at the FAD) of the electron transfer  (∆E
HD
FAD), and hence the free 
energy difference
q (overall ∆G), were very similar: ∆E
HD
FAD: 27 mV, 28 mV, and 36 mV, for the 
W. succinogenes, C. jejuni, and H. pylori QFR, respectively.  
However,  it  must  be  borne  in  mind  that  the  experimentally  calculated  redox  midpoint 
potentials are relative to an oxidizing environment at pH 7.0 or pH 7.3. Since these bacteria 
inhabit quite different niches, which are all different from the aforementioned experimental 
in vitro conditions, the indicated differences may reflect differences in their physiological 
behaviors in vivo. For instance, the H. pylori’s habitat has an extremely low pH, albeit the 
cytoplasmic pH is close to neutrality (Tomb, et al., 1997). Hence, the midpoint potential of the 
cofactors, and especially those in proximity of the periplasm, would be most likely increased 
because they are affected by a lower pH (this behavior is called redox-Bohr effect). It is in 
fact calculated that an increase of 1 pH unit leads to a theoretical Em decrease of 60 mV
r. 
Therefore, the ∆E value of 36 mV obtained in vitro could be only apparently larger as the real 
(in vivo) midpoint potential of the H. pylori QFR distal heme could be somewhat higher since 
it could be influenced by the lower pH. On the other hand, as this bacterium can also adopt a 
positive-inside membrane potential by concentrating cations on the cytoplasmic side of the 
membrane (Marais, et al., 1999a), the electron transfer from the periplasm to the cytoplasm in 
vivo would anyway be electrostatically more favorable. 
The  W.  succinogenes  species  inhabits  bovine  rumen,  which  provides  a  very  low 
environmental redox potential (Waghorn, 1991, Marounek, et al., 1982) and a pH close to 
neutrality (Annamalai, et  al.,  2004). The low  values  of the midpoint  potentials of  the  W. 
succinogenes  QFR  cofactors,  and  especially  of  the  iron-sulfur  clusters,  might  hence  be 
ascribed  to  this  highly  reducing  environment.  Thus,  the  functionality  of  the  cofactors  is 
evidently optimal when their redox midpoint potentials are tuned and balanced with the 
environmental potential found in  the  rumen.  Otherwise,  re-oxidation of the cofactors,  or 
                                                
p The error in the determination of the midpoint potentials can be estimated to be ± 10 mV. 
q The correlation between ∆G and ∆E is given by the equation: ∆G = -zF∆E 
r This value is relative to a redox reaction where one electron is involved. Thus, the value has to be 
halved when two electrons are taking part in the redox reaction. 4. Discussion 
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more in general the enzymatic electron transfer would be more difficult or even energetically 
unfavorable in such a low potential environment.  
Over the experimental conditions adopted for the “DMNH2 assay”, the enzymatic activity of 
the W. succinogenes QFR may gain an advantage due to the lower potential of the cofactors 
(especially the iron-sulfur clusters). Indeed, given that the rate-limiting step of this catalytic 
reaction was the delivery of the electrons between the iron-sulfur clusters and the fumarate 
(Unden, et al., 1984, see Figure 1-4), such lower potentials at this stages would probably 
accelerate the electron transfer, therefore resulting in a higher turnover rate compared to the 
other QFR species. On the other hand, the enzymatic activity of the H. pylori QFR (VMAX: 12.2 
U mg
-1) was faster than the C. jejuni QFR (VMAX: 9.3 U mg
-1) probably because of the steeper 
course of its cofactor’s redox midpoint potentials (Figure 4-1, ∆E: 36 mV). 
In any case, because of the unpredictable changes caused by the environmental conditions in 
vivo,  this  effort  to  interpret  the  obtained  redox  midpoint  potential  values  is  rather 
speculative. Moreover, it must necessarily be considered that the redox midpoint potentials 
have been measured in a situation where the induced artificial reduction by dithionite of one 
cofactor species with a certain midpoint potential is occurring only when all other species 
with  higher  midpoint  potentials  are  already  reduced.  For  instance,  the  determined  low 
potential  for  the  [4Fe-4S]  iron-sulfur  clusters  may  be  an  artifact  due  to  anti-cooperative 
electrostatic  interactions  between  adjacent  redox  centers  (Cammack,  1995,  Salerno,  1991). 
Hence, like any titration of this kind, the values presented herein are not representing a real 
physiological situation where the reduction of one species is occurring when the adjacent (or 
preceding) ones are in the oxidized form. 
4.1.4.2.  Identification of lipids bound to the QFR 
Several biochemical and structural analysis have already shown that respiratory membrane 
proteins,  including  SQORs, contain phospholipids  (for recent  reviews see ref.  (Lee,  2004, 
Palsdottir  &  Hunte,  2004).  For  instance,  the  phospholipids  oleoyl-palmitoyl-
phosphatidylethanolamine and cardiolipin have been assigned to electron densities found in 
the  E.  coli  SQR  structure  (PDB  code  1NEK,  Yankovskaya,  et  al.,  2003).  Similarly,  the  W. 
succinogenes QFR (PDBs 1QLA and 1E7P) and E. coli QFR (PDBs 1KF6, 1KFY, 1LOV) have 
been  found  to  bind  hydrophobic  compounds  (assigned  as  LM,  glycols,  etc.)  which  may 
mimic, during crystallization, the presence of lipid molecules. Because of the blurred density 
and high B-factors, modeling of lipids or detergents into electronic densities is always very Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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difficult, and the identification of the correct compound is often questionable, these findings 
are strongly supporting for the presence of lipid molecules within SQOR proteins.  
It is believed  that  lipids  may  sustain  the  conformational  stability  and rigidity of  protein 
complexes and therefore improve their crystallization properties. In the past it was already 
shown that addition of a small amount of synthetic non-native phospholipid (DOPC) to a 
purified protein complex resulted in a dramatic improvement in crystallization efficiency 
(Zhang, et al., 2003). 
The two-dimensional thin layer chromatography performed in the H. pylori and C. jejuni 
QFR supports the hypothesis that a number of hydrophobic compounds interact and co-
purify  with  these  membrane  protein  complexes.  Identification  of  all  or  some  of  these 
compounds, eventually lipids, would be helpful to understand the molecular set up of the 
membrane-associated portions of the enzyme, and most importantly this would be a step 
forward  for  finding  the  best  crystallization  conditions.  As  inferred  from  the  TLC  plate 
staining results, all of these compounds are phosphorous-containing molecules, indication 
that some of them could very likely be phospholipids. Curiously, it could be noticed that 
whereas the TLC spot-patterns of the C. jejuni QFR sample before and after the gel filtration 
were the similar, the H. pylori QFR sample had lost, after the gel filtration, almost any spot 
with  retention factor  similar  to those  of  the phospholipids, as  measured in the standard 
calibration  TLC  plate.  On  the  whole,  even  though  staining  procedures  and  standard 
calibrations were adopted, it was not possible to identify any lipid type
s. Nonetheless, these 
results strongly suggest that during gel filtration of the H. pylori QFR, marked lipid depletion 
was occurring, and this was de facto confirmed by the deterioration of crystallization success. 
MALDI TOF mass spectrometry has already been shown to be a successful method for lipid 
determination (Distler, et al., 2004) in purified membrane proteins. The H. pylori QFR sample 
after  isoelectric  focusing  has  been  analyzed  with  this  technique  in  order  to  reveal  the 
molecular structure of the compounds detected by TLC. Although identification of synthetic 
lipids added to the protein solution (as a sort of positive control) was relatively easy, native 
lipids or other co-purified compounds were not detected with this strategy. An explanation 
for the failure of this attempt is probably given by the fact that the bound native lipids were 
present in a substoichiometric amount, and hence less than two molecules per monomer
t. 
This  amount  of  lipids  was  likely  too  low  to  be  detected.  Furthermore,  together  with  a 
possible  difficulty  in  detaching  of  the  bound  lipid  molecules  from  the  natural  protein-
                                                
s Defined by the type of polar head. 
t For the positive control, two molecules of synthetic lipid per monomer were added. 4. Discussion 
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binding site, the detection of lipids may suffer from the presence of such a large amount of 
protein which has a much larger molecular weight.  
Lipid  depletion  probably  also  occurred  at  an  early  stage  of  the  purification  (i.e.  anion 
exchange chromatography). The identification by MALDI TOF mass spectrometry of the low 
lipid amount that can be co-purified was challenged by the presence of contaminants. Even 
after elimination of the polypeptide milieu by methanol-chloroform extraction or after TLC 
isolation, it was neither possible to avoid contaminations nor to identify any compound. A 
solution to the problem may be obtained with the development of an extraction procedure 
that  does  not  lead  to  accumulation  of  contaminants  in  the  sample,  so  that  a  higher 
concentration of lipids in the extracts would increase the chances of gaining more signal 
intensity. 
High-pressure liquid chromatography permitted the identification of the cardiolipin polar 
head contained in the H. pylori QFR sample. Another peak corresponding to the retention 
time of phosphatidylethanolamine was observed, though its concentration was extremely 
low.  From  integration  of  the  peaks  of  the  HPLC  chromatogram,  it  was  clear  that  the 
concentration  of  the  detergents  in  the  sample  was,  as  expected,  almost  two  orders  of 
magnitude higher than the concentration of cardiolipin. Because of their partial depletion 
during  purification,  other  lipidic  compounds  may  not  be  seen,  especially  those  having 
longer retention times, since the corresponding signal peak would be even more broadened. 
Nevertheless, the presence of very low concentrations of lipids might be ascribed to other 
contaminating proteins and not to the QFR.  
However, specific functional studies on the H. pylori QFR based on enzymatic activity have 
proven  that  cardiolipin  has  a  beneficial  effect,  whereas  this  was  not  the  case  for 
phosphatidylethanolamine.  Similarly,  the  stability  of  the  lipid-supplied  protein  sample 
observed  in  the  crystallization  trials  is  consistent  with  this  view:  only  after  addition  of 
cardiolipin the H. pylori QFR sample was far more suitable for crystallization (Figure 3-24) 
and far less prone to forming gel phases or amorphous precipitates. 
Whether cardiolipin was the only lipid present in this enzyme or it coexisted with other 
lipidic species is not yet known, although experimental evidences demonstrated that this 
was a lipid of crucial importance for enzymatic activity, stability, and crystallization. Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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4.1.4.3.  Ultracentrifugation experiments identify a homogeneous and 
homodimeric form of the QFR in other two ε ε ε ε-proteobacteria 
From  the  available  crystal  structure  of  the  W.  succinogenes  QFR  it  was  found  that  this 
membrane protein complex crystallized as a homodimer. In more details, a QFR monomer 
surface  corresponding  approximately  to  3665  Å
2  (8  %)  is  buried  upon  dimer  formation 
(Lancaster, et al., 1999). As it was described earlier in this thesis, also the crystal structure of 
the C. jejuni QFR showed a formation of a homodimer with a largely buried surface area. In 
order  to  unequivocally  determine  whether  the  dimer  formation  of  these  ε-proteobacteria 
corresponds to the real physiological conformation of the complex or simply represents a 
crystallization artifact, the detergent solubilized complexes from W. succinogenes, C. jejuni 
and H. pylori were analyzed by analytical ultracentrifugation. 
According to the procedure described in (Tziatzios, et al., 2003), the oligomeric state of QFR 
was determined by evaluating the main peak in the c(s)-distribution. Assuming that QFR 
from C. jejuni is in a monomeric state with M1=132,400 g/mol, the calculated amount of 
protein-bound detergent, was 1.75 g per g of protein, using the  v- and Meff,c-values given 
above. The corresponding amounts for QFR from H. pylori and from W. succinogenes were 
found to be 1.82 and 2.0 g/g, respectively. Such high amounts of detergent bound by the 
enzyme are certainly not reasonable (Gennis, 1989, Moeller & Le Maire, 1993). In addition it 
has to be considered that, according to the structural properties of the enzyme (Unden, et al., 
1980,  Lancaster, et al., 1999), only one of the three protein subunits (subunit C with Mr = 30 
kDa) corresponding to less than one quarter of the molecular mass is membrane-embedded. 
Thus, the amounts of the bound detergent given above, which refer to the whole molecule, 
should be multiplied by a factor of approx. 4, to correspond to that part of the dimeric QFR 
which  is  integrated  into  the  membrane.  Consequently  the  assumption  that  QFR  is  in  a 
monomeric  state  cannot  be  correct.  Under  the  assumption  that  the  main  fraction  of  the 
enzyme is a dimer, the protein-bound detergent was calculated to be 0.21, 0.25 and 0.34 g/g 
of protein for QFR from the three organisms. These values are relatively low; nevertheless 
they are consistent with the range of values observed for other membrane proteins (Gennis, 
1989, Moeller & Le Maire, 1993). On the other hand, a trimeric or higher oligomeric state of 
QFR can be ruled out, since, even in absence of bound detergent, the calculated Meff,c-value 
was  much  higher  than  the  figure  calculated  from  s  and  D.  It  is  concluded  that  the 
homooligomeric state of the detergent solubilized QFRs from C. jejuni, from H. pylori and 
from W. succinogenes is dimeric. 4. Discussion 
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4.1.5.  Enzyme preparations producing X-ray diffracting 3D-crystals 
Homogeneity  and  purity  of  a  membrane  protein  preparation  can  also  be  tested  by 
“crystallizability”:  the  expression  and  purification  procedures  presented  here  are  able  to 
produce reproducible and highly stable 3D-crystals. The QFR from C. jejuni can produce 
crystals up to a size of the order of millimeters, which diffract up to about 3.0 Å. So far, the 
QFR from H. pylori produced rather smaller crystals that diffract up to 8 Å. The production 
procedure  established  in  this  work  makes  itself  conspicuous  for  the  optimum  output  in 
terms of yield (quantity) and quality. This is not only advantageous for screening of new 
crystallization conditions and co-crystallization attempts of this enzymes as well as eventual 
mutant enzymes, but greatly increases the reproducibility, and therefore enforces reliability 
when comparing crystallization results. 
4.1.5.1.  The 3D-crystal structure of the C. jejuni QFR 
The 3D-crystal structure of the QFR from the C. jejuni species has been solved at 3.24 Å 
resolution.  The  crystallographic  statistics  (Table  3-X)  obtained  for  data  processing  and 
refinement are very good for a structure solved at this resolution, but it mostly depends 
from the fact  that  the  calculated  phases  derive  from a  structure  that  has  a  much higher 
resolution, and hence the quality of the initial phases was much better than expected for the 
observed resolution of the data.  
Thanks to clear definition and sharpness of the electron density maps, the model structure 
was unambiguously assigned for most parts of the protein. However, some very important 
regions, such as the quinone binding site in the subunit C and the capping domain in the 
subunit A, are very blurred and model building was prevented. The weak intensities of the 
reflections (I/σ(Ι)), the high B-factors, and especially the structural heterogeneity in certain 
areas of the protein have caused weaknesses in the electron density maps and consequently 
resulted in heavy uncertainties on interpretation. In fact, the slightly high percentages of 
amino  acids  falling  into  the  generously  allowed  and  disallowed  regions  of  the 
Ramachandran  plot  are  an  explicit  sign  of  these  weaknesses.  At  the  present  state,  an 
interpretation of fine structural details that are crucial for an understanding of the functional 
aspects in this enzyme cannot be pursued. Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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On the whole, it has been found that the structure of the C. jejuni QFR has a high level of 
structural homology to that of the W. succinogenes QFR
u. Although slight differences between 
the two species cannot be ruled out at the present stage of analysis, the positions and the 
orientations of the cofactors, as well as many other features, appear to be conserved. This 
finding was somewhat surprising as the primary structure identity of the QFRs from W. 
succinogenes and C. jejuni ranges from 50% to 70% amongst the three subunits (Table 4-I).  
4.1.6.  Functional characterization 
Although QFR activity from C. jejuni and H. pylori bacterial lysates was detected in several 
works (Olbe, et al., 2003, Chen, et al., 2002, Pitson, et al., 1999, Chen, et al., 1999, Smith, et al., 
1999,  Ge,  et  al.,  1997,  Hoffman,  et  al.,  1996,  Mendz,  et  al.,  1995,  Mendz  &  Hazell,  1993, 
Grivennikova  &  Vinogradov,  1982),  these  enzymatic  activity  measurements  of  the 
homologously produced QFR performed on cell homogenates or scarcely purified samples 
(Birkholz, et al., 1994), were characterized by a very low enzymatic activity and stability 
(reviewed by Lancaster & Simon, 2002). 
In  this  work,  an  extensive  enzymatic  characterization  has  been  carried  out  through  the 
activity measurement with different enzymatic assays (Table 3-VII) on pure, highly stable 
enzymes. 
The first apparent peculiarity of the W. succinogenes QFR is that its partial activities were 
marked by much higher values compared to the other two species. Besides, this enzyme and 
the one from C. jejuni show that the “BV assay” enzymatic activity, where the electrons are 
delivered from the reduced BV to fumarate, was far higher than the “MB assay” activity, 
where the electrons are delivered from succinate to methylene blue (opposite direction than 
the physiological fumarate reduction). Differently, the H. pylori QFR does not have the same 
properties,  being  activity  values  obtained  with  the  “BV  assay”  and  “MB  assay”  rather 
similar. However it should be taken into consideration that, in contrast to the other two 
species, the H. pylori genome (Tomb, et al., 1997) contains a QFR operon, but not a SQR 
operon. Furthermore, it should also be considered that the ability of H. pylori to establish a 
positive inside membrane potential (Matin, et al., 1996) may, in physiological conditions, 
influence this ratio. 
Nevertheless, this kind of assays cannot be accurately compared amongst the species due to 
the fact that, since BV and MB are not natural substrates and do not bind to specific catalytic 
                                                
u A detailed description of the structure can be retrieved in Lancaster, et al., 1999 or Lancaster, 2003. 4. Discussion 
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sites,  these  two compounds  may  have  different  binding site  accessibility  in  the  different 
enzymes. Hence one may conclude, for instance, that the W. succinogenes QFR has higher 
activities because it simply displays higher accessibility to the BV and MB.  
Instead, a more reliable way of comparing the enzymes is to consider the total enzymatic 
activity measured with the “DMNH2 assay”. In this view, the three enzymes do not show 
remarkable differences, being the QFR enzymatic activities (Vmax) from C. jejuni, H. pylori, and 
W. succinogenes equal to 9.3 U mg
-1, 12.3 U mg
-1, and 14.7 U mg
-1, respectively. As pointed out 
earlier, these activity values were achieved using the “DT-DMNH2 assay”, a method that 
increases  their  values  by  a  factor  of  two  if  compared  to  the  “BH4-DMN  assay”.  Very 
interestingly, the values obtained with the “DT-DMNH2 assay” are perfectly similar to the 
values obtained with the alternative procedure “low-sensitivity-BH4-DMN assay”, thus by 
monitoring the fumarate reduction in the presence of excess NaBH4. Likely, the increasing 
amount of oxidized DMN in the assay mixture during catalysis slows down the reaction, 
thereby explaining the shorter linearity and the lower Vmax values obtained with the “BH4-
DMN assay”. 
Overall, previous determinations of W. succinogenes QFR activities corresponding to 28.8 U 
mg
-1, 7.4 U mg
-1, and 180 U mg
-1 with the “MB assay”, “BH4-DMNH2 assay” (Lancaster, et al., 
2000), and “BV assay” (Unden & Kröger, 1986), respectively, agree perfectly with the results 
shown here. Nevertheless, KM values for fumarate in the C. jejuni QFR and H. pylori QFR 
(Table  3-VII)  are  much  smaller  than  previous  measurements  (1.9  mM  and  0.83  mM, 
respectively) reviewed in ref. Lancaster & Simon, 2002. The KM values obtained here (in the 
order of one tenth of mM) appear more reasonable for efficient catalysis of QFRs. 
4.1.6.1.  An accurate inhibitor characterization 
In the past years, a number of compounds have already been suggested as inhibitors of QFR 
from C. jejuni and H. pylori species (Chen, et al., 2002, Mendz, et al., 1995, Smith, et al., 1999, 
Olbe, et al., 2003, Hoffman, et al., 1996, Chen, et al., 1999, Grivennikova & Vinogradov, 1982). 
Although some of these, such as metronidazole, nizatidine, morantel and TTFA, could not be 
assayed with the available assay methods due to the (prohibitive) high absorbance at the 
monitored wavelength, the QFR inhibitors omeprazole, oxantel, and thiabendazole could be 
tested and characterized. In contrast to the previous measurements, where Ki values were 
estimated in non-purified samples and/or by NMR spectroscopy, in this work we assign 
precise Ki values based on UV/VIS-spectroscopy activity measurement of the pure enzyme. Section 4.1: Quinol:Fumarate Reductase from H. pylori and C. jejuni: Production and Characterization 
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The  Ki  values  listed  in  Table  3-VII  reveal  that  the  order  of  inhibition  effect  was 
oxantel>thiabendazole>omeprazole, albeit this latter inhibitor had no effect in H. pylori QFR. 
With the use of Lineweaver-Burk plots, we could also assign the type of inhibition exerted 
by these three compounds. Omeprazole, which has no effect on the H. pylori QFR, has a 
competitive inhibitory effect on the C. jejuni QFR, thus it binds to the quinol-binding site. 
Curiously, the thiabendazole exerts a non-competitive (or allosteric) inhibition effect in the 
C. jejuni QFR, while in the H. pylori QFR the type of inhibition is competitive. In the “BV 
assay”,  this  compound  does  not  affect  either  of  the  two  enzymes,  thus  this  inhibitor  is 
supposed to bind to the hydrophobic transmembrane subunit C of the QFR, seemingly close 
to the quinone-binding  site.  Oxantel  was formerly analyzed on  H.  pylori broken  cells by 
monitoring fumarate concentration with NMR spectroscopy (Mendz, et al., 1995) and it was 
predicted  to  bind  competitively  at  the  fumarate  binding  site  with  an  inhibition  constant 
equal to about 60 µM. The results obtained here about the QFR inhibition by oxantel show 
that it exerts an un-competitive inhibition (with respect to the quinone substrate), thus the 
inhibitor binds to a site other than the active site (for quinone), but only when the substrate 
is bound. Inhibition by oxantel is also observed in the partial activity assays, proving that it 
is binding or affecting the hydrophilic subunits of the enzyme. In other words, although it is 
considered to bind at the fumarate binding site (Mendz, et al., 1995), i.e. rather far from the 
quinone site, it is assumed that the binding of the oxantel is able to decrease its affinity for 
the  quinone,  plausibly  by  imposing  a  structural  change  that  is  perceived  by  the  quinol 
oxidation site. Alternatively, multiple binding sites (i.e. one located in the subunit C and a 
second  in  the  hydrophilic  domain)  would  also  explain  the  observed  effects.  Whilst  the 
binding location found in these results does not contradict the previous characterization, 
experiments performed on the isolated enzyme show a markedly lower inhibition effect. 
Earlier studies on the C. jejuni QFRs activity in the presence of oxantel and thiabendazole 
have shown a much lower inhibition (IC50 of 6 and 70 mM, respectively) (Smith, et al., 1999).  
In conclusion, despite the fact that these compounds had perceivable inhibitory effects, they 
are rather modest inhibitors, and are probably not useful even as drug leads. As pointed out 
earlier, the QFR from H. pylori, S. typhimurium, and likely also C. jejuni can be considered as 
potential  targets  for  the  eradication  of  these  species,  as  current  therapies  often  produce 
severe side effects, they are aspecific, and occasionally ineffective due to acquired antibiotic 
resistances  (Ge,  2002,  Marais,  et  al.,  1999b).    The  screening  for  new  and  highly  effective 
inhibitors is now made possible with the use of the isolated active enzymes. 
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4.2. 
13C-Labeling of QFR Heme Propionates 
4.2.1.  Construction of the ∆ ∆ ∆ ∆hemL deletion strain 
In  anaerobic  bacteria,  the  glutamate-1-semialdehyde-2,1-amino-mutase  (encoded  by  the 
hemL gene) is responsible for the synthesis of 5-aminolevulinate, a precursor of the heme 
biosynthesis (Michal, 1999). The deletion of the hemL gene in the WT W. succinogenes resulted 
in an auxotrophic strain that was therefore able to grow in minimal medium only with the 
addition of exogenous ALA. Further characterization of the mutant genome was performed 
by PCR, which showed an unequivocal replacement of the hemL gene with the kanamycin 
resistance  gene.  These  two  data  clearly  show  that  the  mutant  strains  do  not  possess  a 
functional glutamate-1-semialdehyde-2,1-amino-mutase, and are forced to make use of the 
exogenous ALA.  
The  low  cell  density  reached  in  the  large  culture  was  partly  due  to  the  use  of  minimal 
medium, and partly because of the low concentration of the (labeled) ALA. Since it was 
observed  that  longer  degassing  time  of  the  medium  often  reduced  the  growth 
irreproducibility,  this  problem  might  be  due  to  hypersensitivity  of  the  mutant  cells  to 
oxygen.  Due  to  the  fact  that  this  problem  was  overcome  by  increasing  the  amount  of 
inoculated cells, a speculative explanation to the hypersensitivity phenomenon could be that 
the  cells  may  require  readily  available  heme  groups  and  functional  heme  proteins  to 
scavenge  oxygen  or  reactive  oxygen  species  (ROS)  present  in  the  medium  prior  to  start 
growing. If this holds true, the oxygen scavenger may originate from an archaic remains of 
aerobic respiratory chain found in the genome of W. succinogenes (Baar, et al., 2003), and 
could be represented by the cytochrome cbb3 and bd terminal oxidases. 
4.2.2.  A 
13C-labeled QFR suitable for FTIR spectroscopy analysis and 
comparison 
MALDI  TOF  analysis  ascertained  that  the  full  labeling  (nearly  100%)  of  the  heme 
propionates indeed occurred, thus confirming the results of the genetic work and providing 
a solid  basis for  the  discussion  of  the  spectroscopic results. The  mutant strain N2 of W. 
succinogenes  was  therefore  able  to  produce  a  QFR  specifically 
13C-labeled  at  the  carboxyl 
carbon atoms of the heme propionates (Figure 4-2). 
 Section 4.2: 
13C-Labeling of QFR Heme Propionates 
120 
 
 
Figure  4-2:  The  chemical  structure  of  a  heme  b  group  and  indication  of  the  isotopically  labeled 
propionates  (magenta).  The  porphyrin  ring  consists  of  four  pyrrole  units  named  from  A  to  D  (green 
letters). The respective carbons that connect the pyrrole units are named by Greek letters from α to δ. 
 
 
Enzymatic activities of the purified 
13C-labeled QFR were very similar to the unlabeled QFR, 
ensuring that the former enzyme is correctly folded and functional. Since both hemes are 
involved  in  the  total  enzymatic  activity  (Lancaster,  et  al.,  2000),  the  full  functionality 
indicates that the QFR contains all cofactors, including the labeled hemes. Further proof was 
given spectrophotometrically, as the heme-to-protein ratio resulted to be 2:1 (as expected for 
a di-hemic QFR), and as the characteristic “two steps” in the heme redox titration curve had 
equal intensity. The high specific activity together with the SDS-PAGE pattern of the isolated 
labeled QFR after isoelectric focusing allow to conclude that the enzyme functionality and 
purity was comparable to the usual WT QFR preparation.  
To further exclude any major difference in the physicochemical properties between the two 
proteins, the redox midpoint potentials of the labeled QFR hemes have been measured by 
visible spectroscopy. Any differences were found to be insignificant within the context of 
this study. 
Hydrophobic substrates such  as menaquinone,  which tightly  bind to  the  transmembrane 
region of the protein, are found to co-purify in substoichiometric ratios of about 0.1 or 0.2 
molecules  of  menaquinone  per  enzyme  monomer.  To  rule  out  the  possibility  of  major 
quinone-occupancy  differences,  determination  of  bound  quinone  was  performed  in  the 
labeled and unlabeled preparations, and resulted in quinone contents of 0.23 ± 0.025 per 4. Discussion 
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monomer. Considering only the signal generated from one propionate per monomer, less 
than 5% of  the  double difference  FTIR signal would  be  ascribed to  differences  in native 
menaquinone concentration. The expected signal shifts in the frequencies around 1400 cm
-1 
and 1550 cm
-1 upon potential changes would thus be undoubtedly due to heme propionate(s) 
protonation/deprotonation events. 
4.2.3.  FTIR Spectroscopy analysis of the labeled and unlabeled enzymes 
The obtained FTIR spectroscopic results based on 
13C-labeling of the QFR heme propionates 
clearly  indicate  an  involvement of  at  least one of  the  two  propionate  groups  of  the  low 
potential  distal  heme  bD  of  QFR  in  the  electrochemically  induced  redox  reaction.  This  is 
reflected  in  contributions  of  the  protonated  and  deprotonated  forms  of  the  respective 
group(s) to the computed “unlabeled-minus-labeled” QFR double-difference spectra. 
4.2.3.1.  Tentative vibrations of protonated heme propionates 
Above  1700  cm
-1,  similar  and  rather  broad  contributions  were  observed  in  the  FTIR 
difference spectra for the full potential, and for the “reduced-minus-intermediate” potential 
step,  which might be assigned to vibrations  of  protonated heme propionate(s) of bD  and 
which  are  shifted  to  lower  wavenumbers  where  they  are  heavily  obscured  by  other 
vibrations  (i.e.,  the  amide  I  and  the  strong  water  absorbance,  which  are  both  centered 
around  1650  cm
-1)  upon 
13C-labeling.  Based  on  observations  from  multiple  independent 
experiments on the unlabeled QFR WT enzyme, the signal around 1718 cm
-1 appears to be 
more susceptible for amplitude variations. Although frequencies above 1710 cm
-1 would be 
very high for a ν(COOH) heme propionate vibration (Behr, et al., 1998), the results obtained 
in this study indicate a frequency for a propionate carboxyl group vibration which is in the 
range of Glu or Asp ν(COOH) modes. Yet, this is conceivable if the local environment of the 
specific  propionate  is  very  hydrophobic  so  that  it  is  not  hydrogen-bonded,  enabling  the 
observed high frequency for the ν(COOH) mode. If experimental errors such as insufficient 
equilibration or pH effects can be excluded, the apparent differences between the specifically 
labeled and unlabeled QFR in this range are very likely related to the 
13C-labeling of the 
heme propionates. In principle, such a scenario is covered by the particular position and 
environment of the ring C propionate of bD as it is oriented parallel to the membrane plane 
inside  the  hydrophobic  subunit  and  not  along  the  membrane  normal  as  the  other Section 4.2: 
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propionates. Thus, it is feasible that the observed difference signals above 1710 cm
-1 contain 
ring C heme propionate contributions, which indicates a redox-coupled protonation change 
and/or an environmental change of a propionate group of bD. Yet, it remains difficult to 
explain the entire spectral features in terms of heme propionate vibrations, and additional 
effects arising from scaling errors cannot be excluded presently. 
4.2.3.2.  Tentative anti- and symmetric vibrations of deprotonated heme 
propionates 
The distinct series of positive and negative double-difference bands in the frequency range 
between  1560 cm
-1 and 1500  cm
-1  are  more  reliable to discuss,  and  they  are  indicative of 
antisymmetric  νas(COO
-)  vibrations  of  deprotonated  heme  propionates  and/or 
environmental  changes  (e.g.,  due  to  a  redox-coupled  conformational  change  of  the 
propionate group resulting in a different coordination of the oxygen atoms) of the respective 
groups. The band pattern cannot be ascribed to a simple downshift of a single deprotonated 
heme  propionate  mode  upon 
13C-labeling,  and  hence  the  observed  pattern  points  out 
combined redox effects. As inferred from the crystal structure of QFR and rationalized by 
previous electrostatic calculations (Haas & Lancaster, 2004), the ring D propionate of the 
distal heme bD is engaged in a salt bridge with the positively charged FrdC-R162. Thus, the 
only reasonable candidate for a (de)protonation event and/or environmental changes is the 
ring C propionate of the low-potential distal heme bD, and an environmental change of the 
ring D propionate,  which might reflect  a  variation in  the  strength of  the  salt  bridge, for 
instance.  Corresponding  mandatory  signals  for  the  symmetric  νs(COO
-)  vibrations  are 
present in the double-difference spectra in the frequency range between 1410 cm
-1 and 1360 
cm
-1, although they are less pronounced. At least for the acidic side chains of Asp and Glu, 
this is in line with smaller extinction coefficients for symmetric νs(COO
-) modes compared to 
the antisymmetric ones (Mileni, et al., 2005a). 
4.2.3.3.  Differences between the full and partial potential steps at the distal 
heme 
It is inferred that the spectral features in the double-difference spectra of the full and the 
low-potential  step  arise  from  the  (low-potential)  heme  bD  propionates.  The  observed 
discrepancies  that  are  visible  for  the  two  steps  could  be  due  to  the  different  reference 
potentials “intermediate” and “oxidized”,  respectively.  At the intermediate  potential,  the 4. Discussion 
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(high-potential)  proximal  heme  bP  is  reduced,  and  heme  bD  is  oxidized.  At  the  oxidizing 
potential,  both  hemes  are  fully  oxidized.  Hence,  it  is  feasible  that  the  redox  state  of  the 
proximal  heme  influences  the  redox  transition  of  the  distal  heme  bD.  In  the  electrostatic 
calculations  presented  by  Haas  et  al.  (Haas  &  Lancaster,  2004),  the  two  oxidized  hemes 
destabilize  each  other  by  0.6  ∆pK  units,  whereas  the  interactions  with  and  among  the 
reduced heme species are negligible. Thus, it is conceivable that the different redox state of 
the proximal heme bP has a noticeable influence (minor frequency shifts and/or intensity 
variations, as can be seen in Figure 4-3) on the vibrations of the ionized propionates of the 
oxidized distal heme bD. The absence of significant contributions from the propionates of the 
high-potential proximal heme bP is in line with the results from both the structure and the 
electrostatic  calculations  that  both  propionates  are  involved  in  stable  salt  bridges  and 
consequently not available for redox-driven proton transfer (Haas & Lancaster, 2004). For 
the distal heme bD, it is inferred that the ring C propionate is the dominating source for the 
observed double-difference bands, as any effect at the ring D propionate of bD would be 
restricted to an environmental change due to the salt bridge, which was identified in the 
crystal structures and MCCE calculations. The interpretation of the obtained experimental 
data associated with the distal heme bD, and particularly with the ring C propionate, in terms 
of a (de)protonation event possibly accompanied by an environmental effect, which could 
well be a conformational change, agrees very well with the suggested role of this propionate 
in the proposed “E-pathway” hypothesis of coupled transmembrane electron and proton 
transfer (Lancaster, 2002b). 
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Figure 4-3: A representation of the E-pathway hypothesis. The transmembrane subunit FrdC, depicted in 
pink,  contains  the  proximal  heme  (heme  bP)  and  the  distal  heme  (heme  bD).  The  electron  and  proton 
transfers  are  indicated  as  black  arrows.  The  abbreviations  “fum.”  and  “succ.”  stand  for  fumarate  and 
succinate,  respectively.  The  proposed  key  components  of  the  pathway  are  highlighted:  the  side  chain 
residue E180 (black dotted circle) and the ring C propionate of the distal heme (red circle). At the right side 
the FTIR double-difference spectra relative to the proximal (bP) and distal (bD) hemes are shown. 
 
 
 
 
4.3.  Concluding remarks and perspectives 
A broad range of methods and techniques were employed in order to reach the different 
goals of this thesis. In the first part, a heterologous gene expression in W. succinogenes for 
large-scale membrane protein production has been developed. Future genetic work will aim 
at the optimization of vector-based expression of genes encoding other metalloproteins from 
pathogenic ε-proteobacteria that may become realistic anti-microbial targets. The QFRs from 4. Discussion 
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the  pathogenic  bacteria  H.  pylori  and  C.  jejuni  have  been  produced  and  purified. 
Consequently, large amounts of stable and active purified protein permitted to extensively 
characterize these two enzymes, and to solve the 3D-crystal structure of the C. jejuni QFR at 
3.24 Å. This work provides the basis for further functional and structural studies of these 
membrane protein complexes that can be especially used to achieve new inhibitors and new 
drugs for eradication of H. pylori and C. jejuni. Since the inhibitors here characterized have 
different effects on these QFRs (e.g. the omeprazole does not exert any inhibitory effect on 
the H. pylori QFR), the inhibitor development (e.g. inhibitor screening by enzymatic assay, 
structure-based  drug  design,  etc.)  is  far  more  reliable  when  using  the  target  enzymes 
themselves, and not surrogate enzymes like the W. succinogenes QFR, whose high-resolution 
structure is already available.  
However,  a  crystal  structure  of  the  C.  jejuni  QFR  that  diffracts  at  higher  resolution  is 
necessary for further structure-based mechanistic or inhibitor studies. Therefore, the first 
perspective  is  to  achieve  a  better  crystal  structure  with  higher  resolution  and  without 
discontinuities in the electron density maps, especially in the crucial regions, like the active 
sites.  For  instance,  co-crystallization  of  the  protein  with  oxantel  or  other  fumarate-
competitive inhibitors might help to tighten the capping domain, which would improve the 
electron density in this region as well as increase the overall structure resolution. Similarly, 
the  achievement  of  QFR  crystal  structures  containing  efficient  inhibitors  such  as 
menaquinone-analogues, i.e. binding at the Q-site, could aid improving the structure but 
also unveiling important structural insights into the enzyme mechanism. 
Furthermore, site-directed mutagenesis on the C. jejuni and H. pylori QFRs is now a straight 
forward tool to selectively investigate the function of specific residues in these enzymes. For 
example, the  glutamate  residues FrdC-E66 and  FrdC-E180 from  the  W.  succinogenes QFR 
were replaced with glutamines in order to prove their ability to provide a basis for proton 
transfer during catalysis. Experiments performed on the respective variant enzymes enabled 
to  propose  that  the  former  residue  (E66)  is  an  essential  constituent  of  the  menaquinol 
oxidation site by accepting protons from quinol during oxidation, whereas the latter residue 
(E180) is one of the key components of the proposed E-pathway (Haas, et al., 2005). Amino 
acid substitutions at the homologous residues of the H. pylori and C. jejuni QFRs are required 
so  that  the  previous  functional  characterizations  can  be  verified  and  confirmed. 
Furthermore, due to the position of the FrdC-M163 in the structure of the W. succinogenes 
QFR, substitution of this residue with either an arginine or a lysine has been carried out in 
order  to  promote  the  formation  of  a  salt  bridge  with  the  ring  C  heme  propionate  and Section 4.3: Concluding Remarks 
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therefore to prevent proton transfer through this proposed key component of the E-pathway. 
Although the FrdC-M163 mutants in the W. succinogenes QFR were unstable and could not 
be produced (Juhnke & Lancaster, unpublished), homologous mutations on the C. jejuni and 
H. pylori QFRs may result in more stable mutants that can be characterized. At present, the 
plasmids containing the eight mentioned mutations (four in the C. jejuni QFR and four in the 
H.  pylori  QFR,  Table  2-IX)  have  been  produced,  sequenced,  and  are  hence  ready  to  be 
inserted into the genome of the W. succinogenes ∆frdCAB strain by transformation. 
 
The W. succinogenes mutant strain N2 was able to produce large amounts of QFR which was 
specifically 
13C-labeled at the carboxyl carbon atoms of the heme propionates. The purified 
labeled  enzyme  have  been  successfully  characterized  by  electrochemically-induced  FTIR 
difference spectroscopy and compared to the unlabeled enzyme. The absence of significant 
signal differences relative to the propionates of the (high-potential) proximal heme b is in 
line with the results from both the structure (7) and the electrostatic calculations that both 
propionates are involved in stable salt bridges and consequently not available for redox-
driven proton transfer. Concerning the (low-potential) distal heme b, it is inferred that the 
ring C propionate is the dominating source for the observed double-difference bands. The 
interpretation  of  the  obtained  experimental  data  associated  with  the  distal  heme  b,  and 
particularly  with  the  ring  C  propionate,  in  terms  of  a  (de)protonation  event  possibly 
accompanied  by  an  environmental  effect,  which  could  well  be  a  conformational  change, 
agrees very well with the suggested role of this propionate in the proposed “E-pathway” 
hypothesis of coupled transmembrane electron and proton transfer. 
In future works the W. succinogenes mutant N2 can be employed for efficiently producing 
QFR, or other proteins, which have 
13C- or 
15N-labeled hemes at one or more positions by 
supplying the medium with isotopically labeled ALA. FTIR or NMR spectroscopy may then 
be employed to analyze the labeled proteins for further studies. 
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Appendix A 
Nucleotidic alignment of the C. jejuni frdCAB operons from the NCTC11168 strain and the 
clinically isolated (C.I.) strain. 
 
Cj NCTC11168      1 atgcgtgagcttatcgaaggttatttgggtaagagcattgagggcaaaaa 
Cj C.I.           1 atgcgtgagcttatcgaaggttatttgggtaagagcattgagggcaaaaa 
 
Cj NCTC11168     51 aagtaaaatgcctgcgaaattagactttatccaaagtgcttcagggcttt 
Cj C.I.          51 aagtaaaatgcctgcgaaattagactttatccaaagtgcctcagggcttt 
 
Cj NCTC11168    101 ttttaggtctttttatgtgggtgcatatgctttttgtttctacaatttta 
Cj C.I.         101 ttttaggtctttttatgtgggtgcatatgctttttgtttctacaatttta 
 
Cj NCTC11168    151 gtcagtgaggatttttttaattctgtagtgcattttttagaattaaaatt 
Cj C.I.         151 gtcagtgaggatttttttaattctgtggtacattttttagaattaaaatt 
 
Cj NCTC11168    201 tgtttacgataatcctgttatgagttatcttacttcatttttagccgcct 
Cj C.I.         201 tgtttacgataatcctgttatgagttatcttacttcatttttagccgcct 
 
Cj NCTC11168    251 gtgttttagtggtttttttcgttcatgctttacttgcaatgagaaaattt 
Cj C.I.         251 gtgttttagtggtttttttcgtccatgctttacttgcaatgagaaaattt 
 
Cj NCTC11168    301 cctattaattaccgtcagtatcaaatactaagaacacacagtaaaaaaat 
Cj C.I.         301 cctattaattaccgtcagtatcaaatactaagaacacacagtaaaaaaat 
 
Cj NCTC11168    351 gaatcacagcgatacttcgttatggtgggttcaagcttttacaggtttta 
Cj C.I.         351 gaatcacagcgatacttcgttatggtgggttcaagcttttacaggtttta 
 
Cj NCTC11168    401 ttatgtttttcttaggttctgctcatcttatttttattgtaaccaatgca 
Cj C.I.         401 ttatgtttttcttaggttctgctcatcttatttttattgtaaccaatgca 
 
Cj NCTC11168    451 gataaaatcagcggcgatatgtcaggagatagggttgtaagtcattttat 
Cj C.I.         451 gataaaatcagcggcgatatgtcaggagatagggttgtaagtcattttat 
 
Cj NCTC11168    501 gtggcttttttatgctgttcttttagtctgtgttgaacttcatggaagta 
Cj C.I.         501 gtggcttttttatgctgttcttttagtctgtgttgaacttcatggaagta 
 
Cj NCTC11168    551 tagggctttatagactttgtgttaaatggggttggtttgaaggaaaaaat 
Cj C.I.         551 tagggctttatagactttgtgttaaatggggttggtttgaaggaaaaaat 
 
Cj NCTC11168    601 gtaaaagaaagtcgcaaaaagcttaaaactgctaaatggataatcagtat 
Cj C.I.         601 gtaaaagaaagtcgtaaaaagcttaaaactgctaaatggataatcagtat 
 
Cj NCTC11168    651 tttcttcctagttttaggtgtgttaagtcttgcagcatttataaaaatag 
Cj C.I.         651 tttcttcctagttttaggtgtgttaagtcttgtagcatttataaaaatag 
 
Cj NCTC11168    701 gttatgaaaactaccaaaatcaaacccaaactactgcgatgataaaaaac 
Cj C.I.         701 gttatgaaaattaccaaaatcaaacccaaactactgcgatgataaaaaac 
 
Cj NCTC11168    751 tacaatggagcaaattatgaatatacaatatagtgatgctttagtaatag 
Cj C.I.         751 tacaatggagcaaattatgaatatacaatatagtgatgctttagtaatag 
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Cj NCTC11168    801 gcggaggattagcaggtcttagagcggctattgaagtagcaaagagtggc 
Cj C.I.         801 gcggaggattagcaggtcttagagcggctattgaagtagcaaagagtggc 
 
Cj NCTC11168    851 caaagtgtaacacttttaagtatttgtccagtgaagcgttctcactctgc 
Cj C.I.         851 caaagtgtaacacttttaagtatttgtccagtgaagcgttctcactctgc 
 
Cj NCTC11168    901 agcggtgcaaggaggtatgcaggcaagtttagcaaatggggcaaaaggtg 
Cj C.I.         901 agcggtgcaaggaggtatgcaggcaagtttagcaaatggggcgaaaggtg 
 
Cj NCTC11168    951 agggtgataatgaagatcttcactttgcagatacagtaaaaggaagtgat 
Cj C.I.         951 agggtgataatgaagatcttcacttcgcagatacagtaaaaggaagtgat 
 
Cj NCTC11168   1001 tggggctgtgatcaagaagtagcaagaatgtttgctcaaactgcgccaaa 
Cj C.I.        1001 tggggctgtgatcaagaagtagcaagaatgtttgctcaaactgcaccaaa 
 
Cj NCTC11168   1051 agcagtgcgtgagcttgcggcttggggtgtgccttggactagagttacta 
Cj C.I.        1051 agcagtgcgtgaacttgcggcttggggtgtgccttggactagggttacta 
 
Cj NCTC11168   1101 aaggtccaagaactgttgtaatcaatgcacaaaaaactgtgattgaagaa 
Cj C.I.        1101 aaggtccaagaactgttgtaatcaatgcgcaaaaaactgtgattgaagaa 
 
Cj NCTC11168   1151 aaagaagaagcgcacgggcttattaatgctagagattttggtggaactaa 
Cj C.I.        1151 aaagaagaagcgcatggacttatcaatgcaagggattttggtggaacaaa 
 
Cj NCTC11168   1201 aaaatggagaacttgctatatcgcagatgcaacagggcattgtatgcttt 
Cj C.I.        1201 aaaatggagaacttgttatattgcagatgcaacaggccattgtatgcttt 
 
Cj NCTC11168   1251 atggtgtagcaaatgaagctattaaacatcaagtaaaaattattgataga 
Cj C.I.        1251 atggtgtagcaaatgaagccattaaacatcaagtaaaaatcattgataga 
 
Cj NCTC11168   1301 atggaagcagtaagaattatccatgatggtaaaaaatgcttaggtgtgat 
Cj C.I.        1301 atggaagcagtaagaattatccacgatggtaaaaaatgtttaggtgtgat 
 
Cj NCTC11168   1351 cgctagagatttaactaatggacaactcattgcttatattgcaagaggaa 
Cj C.I.        1351 tgctagagatttaaccaacggacaattaatcgcttatattgcgagaggaa 
 
Cj NCTC11168   1401 ccatgatagcaacagggggctatggtagaatttataaacaaactacaaat 
Cj C.I.        1401 ctatgatagcaacagggggttatggtagaatttataaacaaactacaaat 
 
Cj NCTC11168   1451 gcggtaatttgtgaaggaacaggtgcagccatcgctcttgaaacagggct 
Cj C.I.        1451 gcagtaatttgtgaaggaacaggtgcggctatcgctcttgaaacgggact 
 
Cj NCTC11168   1501 ttgcagactttcaaatatggaagcagtgcaatttcatccaactcctattg 
Cj C.I.        1501 ttgcagactttcaaacatggaagcagtgcaatttcacccaactcctattg 
 
Cj NCTC11168   1551 tgccaagcggtattttgcttactgagggctgtcgtggtgatggtggaatt 
Cj C.I.        1551 tgccaagcggtattttgcttaccgaaggttgtcgtggtgatggcggaatt 
 
Cj NCTC11168   1601 ttacgcgatgtggatggatatcgttttatgcctgattatgaaccagagaa 
Cj C.I.        1601 ttgcgtgatgtggatggatatcgttttatgcctgattatgaaccagagaa 
 
Cj NCTC11168   1651 aaaagaacttgcaagccgtgatgtggtaagtcgtagaatgatggaacata 
Cj C.I.        1651 aaaagaacttgcaagccgtgatgtggtaagtcgtagaatgatggagcata 
 
Cj NCTC11168   1701 ttcgtaaaggcaaaggtgtaaaaagcccttatggggatcatttatggctt 
Cj C.I.        1701 ttcgtaaaggtaagggtgtaaaaagtccttatggagatcatttatggctt 
 
Cj NCTC11168   1751 gatatttctatacttggaagagctcatgtggaaaaaaatctccgcgatgt 
Cj C.I.        1751 gatatttctatactaggtcgtgcgcatgtggaaaaaaatcttcgtgatgt 
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Cj NCTC11168   1801 acaagatatttgtaaaacttttaatggtattgatccagcagatgagggtc 
Cj C.I.        1801 gcaagatatttgtaaaacttttaatggtattgatccggcagatgaaggtc 
 
Cj NCTC11168   1851 caaaaggttgggcgccagttcttccaatgcagcattattctatgggtgga 
Cj C.I.        1851 caaaaggttgggcgccagttcttccaatgcaacattattctatgggtgga 
 
Cj NCTC11168   1901 attagaactaaaccaacgggtgaaagtcaatggttaaacggactttttgc 
Cj C.I.        1901 attagaactaaaccaacaggtgaaagtcaatggttaaacggactttttgc 
 
Cj NCTC11168   1951 ttgtggagaagcagcttgctgggatatgcacggatttaatcgtttaggtg 
Cj C.I.        1951 ttgtggagaagcagcttgctgggatatgcatggatttaatcgtttaggtg 
 
Cj NCTC11168   2001 ggaattcatgtgctgaaactgttgtagcaggtatgatagtgggagattat 
Cj C.I.        2001 gaaattcatgtgctgaaactgttgtagcaggcatgatagtgggagcttat 
 
Cj NCTC11168   2051 tttgcagattattgtaaaaataatggtgaagtaattgacacaaatgtagt 
Cj C.I.        2051 tttgcagattattgtaaaaataatggtgaagtaattgatacaaatgtagt 
 
Cj NCTC11168   2101 aaaagacttcttaactaaagagtatcaatatttaaaatctttagtagata 
Cj C.I.        2101 aaaagacttcttaactaaagagtatcaatatttaaaatctttagtagata 
 
Cj NCTC11168   2151 aagaaggtaaacataatgtttttgaaatcaaaaacagaatgaaagaaatc 
Cj C.I.        2151 aagaaggtaaatataatgtttttgaaatcaaaaacagaatgaaagaaatc 
 
Cj NCTC11168   2201 atgtgggataaggtggccatctttagaacaggtgaaggtttgaaagaagc 
Cj C.I.        2201 atgtgggataaggtggccatctttagaacaggtgaaggtttgaaagaagc 
 
Cj NCTC11168   2251 agtagatgaacttgaaaaactttataaagattctcaagacgttaaagtac 
Cj C.I.        2251 agtagatgaacttgaaaaactttataaagattctcaagacgttaaagtac 
 
Cj NCTC11168   2301 attgtaaagaacttgattgtgcaaatccagagcttgaagaagcgtataga 
Cj C.I.        2301 attgtaaagaacttgattgtgcaaatccagagcttgaagaagcgtataga 
 
Cj NCTC11168   2351 gtgccaagaatgttaaaaatagcactttgcgtagcttatggagcgctttt 
Cj C.I.        2351 gtgccaagaatgttaaaaatagcactttgtgtagcttatggagcactttt 
 
Cj NCTC11168   2401 aagaacagaaagtcgtggggcgcattatagggaagattatccaaaaagag 
Cj C.I.        2401 aagaacagaaagtcgtggggcgcattatagggaagattatccaaaaagag 
 
Cj NCTC11168   2451 atgatttaaattggatgaaaagaaccaatactttttgggtagaaggcgaa 
Cj C.I.        2451 atgatttaaattggatgaaaagaactaatactttttgggtagaaggcgaa 
 
Cj NCTC11168   2501 accttaccacgcatagaatacgaagagcttgatattatgaaaatggaaat 
Cj C.I.        2501 actttgccacgcatagaatacgaagagcttgatattatgaaaatggaaat 
 
Cj NCTC11168   2551 tccaccagcattccgtggatacggtgctaaaggaaatattatagaaaatc 
Cj C.I.        2551 tccaccagcattccgtggatacggtgctaaaggaaatattatagaaaatc 
 
Cj NCTC11168   2601 ctttaagtgaaaaacgccaagctgaagtggatgctatccgtgaaaaaatg 
Cj C.I.        2601 ctttaagtgaaaaacgccaagctgaagtggatgctatccgtgaaaaaatg 
 
Cj NCTC11168   2651 gaagctgaaggcaaaggtcgttatgaaattcaaaacgccttaatgcctta 
Cj C.I.        2651 gaagctgaaggcaaaggtcgttatgaaattcaaaacgctttaatgcctta 
 
Cj NCTC11168   2701 tgaattgcaagctaaatataaagcaccaaaccaaagaataggagttgatt 
Cj C.I.        2701 tgaattgcaagctaaatataaagcaccaaaccaaagaataggagttgatt 
 
Cj NCTC11168   2751 atgagtagaaaattgacaataaaggcatttaaatacaatcctttaagcaa 
Cj C.I.        2751 atgagtagaaaattgacaataaaggcatttaaatacaatcctttaagcaa 
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Cj NCTC11168   2801 aatttctaaaccacattttgtgacttatgagcttgaagaaactcctttta 
Cj C.I.        2801 aatttctaaaccacattttgtgacttatgagcttgaagaaactcctttta 
 
Cj NCTC11168   2851 tgacggtttttgtatgtttgactttgatccgtgaaaaaatggatgcagat 
Cj C.I.        2851 tgacggtttttgtatgtttgactttgatccgtgaaaaaatggatgcggat 
 
Cj NCTC11168   2901 ctgagttttgactttgtttgtcgtgcagggatttgcggatcttgtgcaat 
Cj C.I.        2901 ctgagttttgactttgtttgtcgtgcagggatttgcggatcttgtgcaat 
 
Cj NCTC11168   2951 gatgattaatggagtgccaaaacttgcttgtaaaactttgactaaagatt 
Cj C.I.        2951 gatgattaatggagtgccaaaacttgcttgtaaaactttgactaaagatt 
 
Cj NCTC11168   3001 atcctgatggagtgatagagcttatgcctatgcctgcatttaggcatatt 
Cj C.I.        3001 atcttgatggagtgatagagcttatgcctatgcctgcatttagacatatt 
 
Cj NCTC11168   3051 aaagatttaagcgtgaatacaggcgagtggtttgaagacatgtgtaagcg 
Cj C.I.        3051 aaagatttaagcgtgaatacaggcgagtggtttgaagacacgtgtaaacg 
 
Cj NCTC11168   3101 tgttgaaagctgggtgcataatgaaaaagaaactgatatttctaaacttg 
Cj C.I.        3101 tgttgaaagctgggtgcataatgaaaaagaaactgatatttctaaacttg 
 
Cj NCTC11168   3151 aagaacgcattgagccagaagttgcggatgaaacttttgaacttgatcgt 
Cj C.I.        3151 aagaacgtattgagccagaagttgcggatgaaacttttgaacttgatcgt 
 
Cj NCTC11168   3201 tgtatagagtgtggaatttgtgtagcttcttgtgcaactaaacttatgcg 
Cj C.I.        3201 tgtatagagtgtggaatttgtgtagcttcttgtgcaactaaacttatgcg 
 
Cj NCTC11168   3251 cccaaatttcatagctgctacagggcttttaagaacagctagatatttac 
Cj C.I.        3251 cccaaatttcatagctgctacagggcttttaagaacggctagatatttac 
 
Cj NCTC11168   3301 aagatccgcatgaccatagaagtgtggaagatttttatgaattagtaggc 
Cj C.I.        3301 aagatccgcatgaccatagaagtgtggaagatttttatgaattagtaggc 
 
Cj NCTC11168   3351 gatgatgatggtgtttttggttgtatgtcattgcttgcttgtgaagataa 
Cj C.I.        3351 gatgatgatggtgtttttggttgtatgtcattgcttgcttgtgaagataa 
 
Cj NCTC11168   3401 ttgccctaaagaattacctttacaaagtaaaatcgcttatatgagaagac 
Cj C.I.        3401 ttgccctaaagaattacctttacaaagtaaaatcgcttatatgagaagac 
 
Cj NCTC11168   3451 aacttgtcgctcaaagaaataaataa 
Cj C.I.        3451 aacttgtcgctcaaagaaataaataa 
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Appendix B 
Amino acid alignment of the FrdA, -B, and -C polipeptide chains from different strains of the 
ε-proteobacteria species W. succinogenes, C. jejuni, and H. pylori: 
Wolinella succinogenes DSM1740 (Ws DSM1740) 
Campylobacter jejuni NCTC11168 (Cj 11168) 
C. jejuni clinically isolated strain (Cj C.I.) 
C. jejuni RM1221 (Cj RM1221) 
Helicobacter pylori 26695 (Hp 26695) 
H. pylori J99 (Hp J99). 
 
 
FrdA 
 
Ws DSM1740        1 mseqftrreflqsacitmgalavstsgvdrafassslpintsgipscdvl 
Cj 11168          1 mniqys-----------------------------------------dal 
Cj C.I.           1 mniqys-----------------------------------------dal 
Cj RM1221         1 mniqys-----------------------------------------dal 
Hp 26695          1 mkityc-----------------------------------------dal 
Hp J99            1 mkityc-----------------------------------------dal 
 
Ws DSM1740       51 iigsgaaglraavaarkkdpslnvivvskvmptrsattmaeggingvidf 
Cj 11168         10 viggglaglraaievaksgqsvtllsicpv--krshsaavqggmqaslan 
Cj C.I.          10 viggglaglraaievaksgqsvtllsicpv--krshsaavqggmqaslan 
Cj RM1221        10 viggglaglraaievaksgqsvtllsicpv--krshsaavqggmqaslan 
Hp 26695         10 iiggglaglrasiackqkglntivlslvpv--rrshsaaaqggmqaslan 
Hp J99           10 iiggglaglrasiackqkglntivlslvpv--rrshsaaaqggmqaslan 
 
Ws DSM1740      101 s---egdsfalhaydtvkggdflvdqdtamkfaehageaiheldyigmpf 
Cj 11168         58 gakgegdnedlhfadtvkgsdwgcdqevarmfaqtapkavrelaawgvpw 
Cj C.I.          58 gakgegdnedlhfadtvkgsdwgcdqevarmfaqtapkavrelaawgvpw 
Cj RM1221        58 gakgegdnedlhfadtvkgsdwgcdqevarmfaqtapkavrelaawgvpw 
Hp 26695         58 akksegdnedlhfldtvkgsdwgcdqqvarmfvttapkairelaswgvpw 
Hp J99           58 akksegdnedlhfldtvkgsdwgcdqqvarmfvttapkairelaswgvpw 
 
Ws DSM1740      148 sr---------------------dkngkvdkryaggaskircnfsadktg 
Cj 11168        108 trvtkgprtvvinaqktvieekeeahglinardfggtkkwrtcyiadatg 
Cj C.I.         108 trvtkgprtvvinaqktvieekeeahglinardfggtkkwrtcyiadatg 
Cj RM1221       108 trvtkgprtvvinaqktvieekeeahglinardfggtkkwrtcyiadatg 
Hp 26695        108 trikkgdrpavvngehvtiterddrhgyilsrdfggtkkwrtcftadatg 
Hp J99          108 trikkgdrpavvngehviiterddrhgyilsrdfggtkkwrtcftadatg 
 
Ws DSM1740      177 hilthtclddalkngvkflmdhqlldigvdngrcegvvlrdirtgtiapv 
Cj 11168        158 hcmlygvaneaikhqvkiidrmeavriihdgkkclgviardltngqliay 
Cj C.I.         158 hcmlygvaneaikhqvkiidrmeavriihdgkkclgviardltngqliay 
Cj RM1221       158 hcmlygvaneaikhqvkiidrmeavriihdgkkclgviardltngqliay 
Hp 26695        158 htmlyavanealhhkvdiqdrkdmlafihhdnkcygavvrdlitgeisay 
Hp J99          158 htmlyavanealhhkvdiqdrkdmlafihhdnkcygavvrdlitgeisay 
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Ws DSM1740      227 raksvvlatggytrvfwnrtstpyiatgdgaasamragva-fkdpemlqf 
Cj 11168        208 iargtmiatggygriy-kqttnavicegtgaaialetglcrlsnmeavqf 
Cj C.I.         208 iargtmiatggygriy-kqttnavicegtgaaialetglcrlsnmeavqf 
Cj RM1221       208 iargtmiatggygriy-kqttnavicegtgaaialetglcrlsnmeavqf 
Hp 26695        208 vskgtllatggygrvy-khttnavicdgagaasaletgvaklgnmeavqf 
Hp J99          208 vskgtllatggygrvy-khttnavicdgagaasaletgvaklgnmeavqf 
 
Ws DSM1740      276 hptgvchggvliteaargeggillnnqgerfmknya-kkmelaprdivsr 
Cj 11168        257 hptpivpsgilltegcrgdggilrdvdgyrfmpdyepekkelasrdvvsr 
Cj C.I.         257 hptpivpsgilltegcrgdggilrdvdgyrfmpdyepekkelasrdvvsr 
Cj RM1221       257 hptpivpsgilltegcrgdggilrdvdgyrfmpdyepekkelasrdvvsr 
Hp 26695        257 hptalvpsgilmtegcrgdggvlrdkfgrrfmpayepekkelasrdvvsr 
Hp J99          257 hptalvpsgilmtegcrgdggvlrdkfgrrfmpayepekkelasrdvvsr 
 
Ws DSM1740      325 sieteiregrafgkgmeayvlldvthlgkekimrnlpqirhigllfenmd 
Cj 11168        307 rmmehirkgkgvkspygdhlwldisilgrahveknlrdvqdicktfngid 
Cj C.I.         307 rmmehirkgkgvkspygdhlwldisilgrahveknlrdvqdicktfngid 
Cj RM1221       307 rmmehirkgkgvkspygdhlwldisilgrahveknlrdvqdicktfngid 
Hp 26695        307 rilehiqkgygakspygdhvwldiailgrnhveknlrdvrdiamtfagid 
Hp J99          307 rilehiqkgygakspygdhvwldiailgrnhveknlrdvrdiamtfagid 
 
Ws DSM1740      375 lvekp---------------------------iairptahysmggidvmg 
Cj 11168        357 padegp-----------------------kgwapvlpmqhysmggirtkp 
Cj C.I.         357 padegp-----------------------kgwapvlpmqhysmggirtkp 
Cj RM1221       357 padegp-----------------------kgwapvlpmqhysmggirtkp 
Hp 26695        357 padskeqtkdnmqgvpanepeygqamakqkgwipikpmqhysmggvrtnp 
Hp J99          357 padseeqtkdnmqgaptnepeygqamakqkgwipikpmqhysmggvrtnp 
 
Ws DSM1740      398 lesmstaipglfaageaacvsihganrlggnslcdtvvtgkiagtnaasf 
Cj 11168        384 -tgesqwlnglfacgeaacwdmhgfnrlggnscaetvvagmivgdyfady 
Cj C.I.         384 -tgesqwlnglfacgeaacwdmhgfnrlggnscaetvvagmivgayfady 
Cj RM1221       384 -tgesqwlnglfacgeaacwdmhgfnrlggnscaetvvagmivgdyfady 
Hp 26695        407 -kgeth-lkglfcageaacwdlhgfnrlggnsvseavvagmiigdyfash 
Hp J99          407 -kgeth-lkglfcageaacwdlhgfnrlggnsvsepvvagmiigdyfash 
 
Ws DSM1740      448 assagfgsgthl-hdltlkwmsrfkevangkgevnemyaireelgavnwd 
Cj 11168        433 cknngevidtnvvkdfltkeyqylkslvdkegkhn-vfeiknrmkeimwd 
Cj C.I.         433 cknngevidtnvvkdfltkeyqylkslvdkegkyn-vfeiknrmkeimwd 
Cj RM1221       433 cknngevidtnvvkdfltkeyqylkslvdkegkyn-vfeiknrmkeimwd 
Hp 26695        455 cleaqieintqkveafikesqdymhfllhnegked-vyeirermkevmde 
Hp J99          455 cleaqieintqkveafikesqdymhfllhnegked-vyeirermkevmde 
 
Ws DSM1740      497 nmgvfrtesrlvaledkhnel-----qarydalripntnpvfntafteyv 
Cj 11168        482 kvaifrtgeglkeavdeleklykdsqdvkvhckeldcanpeleeay---- 
Cj C.I.         482 kvaifrtgeglkeavdeleklykdsqdvkvhckeldcanpeleeay---- 
Cj RM1221       482 kvaifrtgeglkeavdeleklykdsqdvkvhckeldcanpeleeay---- 
Hp 26695        504 kvgvfregkrleealkelqelyarsknicvknkvlh-nnpeleday---- 
Hp J99          504 kvgvfregkkleealkelqelyarsknicvknkvlh-nnpeleday---- 
 
Ws DSM1740      542 elgnillasraarmgaearkesrgshyredyikrddanflkhsmv----- 
Cj 11168        528 rvprmlkialcvaygallrtesrgahyredypkrddlnwmkrtntfwveg 
Cj C.I.         528 rvprmlkialcvaygallrtesrgahyredypkrddlnwmkrtntfwveg 
Cj RM1221       528 rvprmlkialcvaygallrtesrgahyredypkrddlnwmkrtntfwveg 
Hp 26695        549 rtkkmlklalcitqgallrtesrgahtridypkrddekwlnrtlaswpsa 
Hp J99          549 rtkkmlklalcitqgallrtesrgahtridypkrddekwlnrtlaswpsa 
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Ws DSM1740          -------------------------------------------------- 
Cj 11168        578 et-lprieyeeldimkmeippafrgygakgniienplsekrqaevdaire 
Cj C.I.         578 et-lprieyeeldimkmeippafrgygakgniienplsekrqaevdaire 
Cj RM1221       578 et-lprieyeeldimkmeippafrgygakgniienplsekrqaevdaire 
Hp 26695        599 eqdmptieyeeldvmkmeispdfrgygkkgnfiphpkkeerdaeilktil 
Hp J99          599 eqdmptieyeeldvmkmeispdfrgygkkgnfiphpkkeerdaeilktil 
 
Ws DSM1740      587 tmdsngklhlgwkdvvv-----tqfkieerky------------------ 
Cj 11168        627 kmeaegkgryeiqnalmpyelqakykapnqri------------------ 
Cj C.I.         627 kmeaegkgryeiqnalmpyelqakykapnqri------------------ 
Cj RM1221       627 kmeaegkgryeiqnalmpyelqakykapnqri------------------ 
Hp 26695        649 eleklgkdrievqhalmpfelqekykarnmrledeevrargehlysfnvh 
Hp J99          649 eleklgkdrievqhalmpfelqekykarnmrledeevrargehlysfnvh 
 
Ws DSM1740          ---------------- 
Cj 11168        659 -----------gvdye 
Cj C.I.         659 -----------gvdye 
Cj RM1221       659 -----------gvdye 
Hp 26695        699 elldqhnanlkgehhe 
Hp J99          699 dlldqhnanlkgehhe 
 
 
 
 
 
FrdB 
 
Ws DSM1740        1 ---mgrmltirvfkydpqsavskphfqeykieeapsmtifivlnmirety 
C. jejuni 11      1 ms---rkltikafkynplskiskphfvtyeleetpfmtvfvcltlirekm 
Cj C.I.           1 ms---rkltikafkynplskiskphfvtyeleetpfmtvfvcltlirekm 
Cj RM1221         1 ms---rkltikafkynplskiskphfvtyeleetpfmtvfvcltlirekm 
Hp 26695          1 msdnertivvrvlkfdpqsavskphfkeyqlketpsmtlfialnlirehq 
Hp J99            1 msdnertivvrvlkfdpqsavnkphfkeyqlketpsmtlfialnlirehq 
 
Ws DSM1740       48 dpdlnfdfvcragicgscgmmingrpslacrtltkdfedgvitllplpaf 
C. jejuni 11     48 dadlsfdfvcragicgscammingvpklacktltkdypdgvielmpmpaf 
Cj C.I.          48 dadlsfdfvcragicgscammingvpklacktltkdyldgvielmpmpaf 
Cj RM1221        48 dadlsfdfvcragicgscammingvpklacktltkdypdgvielmpmpaf 
Hp 26695         51 dpdlsfdfvcragicgscammvngrprlacktltssfesgvitlmpmpsf 
Hp J99           51 dpdlsfdfvcragicgscammvngrprlacktltssfengvitlmpmpsf 
 
Ws DSM1740       98 klikdlsvdtgnwfngmsqrveswihaqkehdiskleeriepevaqevfe 
C. jejuni 11     98 rhikdlsvntgewfedmckrveswvhneketdiskleeriepevadetfe 
Cj C.I.          98 rhikdlsvntgewfedtckrveswvhneketdiskleeriepevadetfe 
Cj RM1221        98 rhikdlsvntgewfedmckrveswvhneketdiskleeriepevadetfe 
Hp 26695        101 tlikdlsvntgdwfldmtkrveswahskeevditrpekrvepdeaqevfe 
Hp J99          101 tlikdlsvntgdwfsdmtkrveswahskeevditkpekrvepdeaqevfe 
 
Ws DSM1740      148 ldrciecgcciaacgtkimredfvgaaglnrvvrfmidphdertdedyye 
C. jejuni 11    148 ldrciecgicvascatklmrpnfiaatgllrtarylqdphdhrsvedfye 
Cj C.I.         148 ldrciecgicvascatklmrpnfiaatgllrtarylqdphdhrsvedfye 
Cj RM1221       148 ldrciecgicvascatklmrpnfiaatgllrtarylqdphdhrsvedfye 
Hp 26695        151 ldrciecgcciascgtklmrpnfigaagmnramrfmidshderndddfye 
Hp J99          151 ldrciecgcciascgtklmrpnfigaagmnramrfmidshdersdddfye 
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Ws DSM1740      198 ligdddgvfgcmtllachdvcpknlplqskiaylrrkmvsvn--- 
C. jejuni 11    198 lvgdddgvfgcmsllacedncpkelplqskiaymr-rqlvaqrnk 
Cj C.I.         198 lvgdddgvfgcmsllacedncpkelplqskiaymr-rqlvaqrnk 
Cj RM1221       198 lvgdddgvfgcmsllacedncpkelplqskiaymr-rqlvaqrnk 
Hp 26695        201 lvgdddgvfgcmsliachdtcpkelplqssiatlrnrmlkvgksr 
Hp J99          201 lvgdddgvfgcmsliachdtcpkelplqssiatlrnrmlkvgksr 
 
 
 
FrdC 
 
Ws DSM1740        1 mtnesilesysgvtperkksrmpakldwwqsatglflglfmighmffvst 
FrdC11168         1 --mreliegylgksiegkkskmpakldfiqsasglflglfmwvhmlfvst 
Cj C.I.           1 --mreliegylgksiegkkskmpakldfiqsasglflglfmwvhmlfvst 
Cj RM1221         1 --mreliegylgksiegkkskmpakldfiqsasglflglfmwvhmlfvst 
Hp 26695          1 mqqeeiiegyygaskglkksgiyakldflqsatglilalfmiahmflvss 
Hp J99            1 mqqeeiiegyygaskglkksgiyakldflqsatglilalfmiahmflvss 
 
Ws DSM1740       51 illgdnvmlwvtkkfeldfifeggkpi---vvsflaafvfavfiahafla 
FrdC11168       145 ilvsedffnsvvhfle--lkfvydnpvmsyltsflaacvlvvffvhalla 
Cj C.I.          49 ilvsedffnsvvhfle--lkfvydnpvmsyltsflaacvlvvffvhalla 
Cj RM1221        49 ilvsedffnsvvhfle--lkfvydnpvmsyltsflaacvlvvffvhalla 
Hp 26695         51 ilisdeamykvakffegslflkagepa---ivsvvaagiililvahafla 
Hp J99           51 ilisdeamykvakffegslflkagepa---ivsvvaagvililvahafla 
 
Ws DSM1740       98 mrkfpinyrqyltfkthkdlmrhgdttlwwiqamtgfamfflgsvhlyim 
FrdC11168       289 mrkfpinyrqyqilrthskkmnhsdtslwwvqaftgfimfflgsahlifi 
Cj C.I.          97 mrkfpinyrqyqilrthskkmnhsdtslwwvqaftgfimfflgsahlifi 
Cj RM1221        97 mrkfpinyrqyqilrthskkmnhsdtslwwvqaftgfimfflgsahlifi 
Hp 26695         98 lrkfpinyrqykvfkthkhlmkhgdtslwfiqaltgfamfflasihlfvm 
Hp J99           98 lrkfpinyrqykvfkthkhlmkhgdtslwfiqaltgfamfflasihlfvm 
 
Ws DSM1740      148 mtqpqtigpvsssfrmvsewmwplylvllfavelhgsvglyrlavkwgwf 
FrdC11168       439 vtnadkisgdmsgdrvvshfmwlfyavllvcvelhgsiglyrlcvkwgwf 
Cj C.I.         147 vtnadkisgdmsgdrvvshfmwlfyavllvcvelhgsiglyrlcvkwgwf 
Cj RM1221       147 vtnadkisgdmsgdrvvshfmwlfyavllvcvelhgsiglyrlcvkwgwf 
Hp 26695        148 ltepesigphgssyrfvtqnfwllyifllfavelhgsiglyrlaikwgwf 
Hp J99          148 ltepesigphgssyrfvtqnfwllyifllfavelhgsiglyrlaikwgwf 
 
Ws DSM1740      198 dgetpdktranlkklktlmsaflivlglltfgayvkkgleqtdpnid--y 
FrdC11168       589 egknvkesrkklktakwiisifflvlgvlslaafikigyenyqnqtqtta 
Cj C.I.         197 egknvkesrkklktakwiisifflvlgvlslvafikigyenyqnqtqtta 
Cj RM1221       197 egknvkesrkklktakwiisifflvlgvlslaafikigyenyqnqtqtta 
Hp 26695        198 ----knvsiqglrkvkwamsvffivlglctygayikkglenkengiktmq 
Hp J99          198 ----knvsiqglrkikwamsvffivlglctygayikkglenkdngiktmq 
 
Ws DSM1740      246 kyfdykrthhr---- 
FrdC11168       739 miknynganyeyti* 
Cj C.I.         247 miknynganyeyti- 
Cj RM1221       247 miknynganyeyti- 
Hp 26695        244 eaieadgkfhke--- 
Hp J99          244 eaieadgkfhke--- 
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Appendix C 
 
Validation  of  the  solved  C.  jejuni  QFR  crystal  structure  performed  with  the  program 
PROCHECK (by Roman A Laskowski, Malcolm W MacArthur, David  K Smith, David T 
Jones,  E  Gail  Hutchinson,  A  Louise  Morris,  David  S  Moss  &  Janet  M  Thornton): 
Ramachandran  plots  and  residue  properties  of  the  three  polipeptide  chains  FrdA 
(CjQFR2304 – ChainA), FrdB (Chain B), and FrdC (Chain C). 
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